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Abstract
The fact that Joint Protection Programs (JPP) can reduce pain and improve function is based
on small, but definitive Randomized Controlled Trials (RCTs), conducted in the 1980s.
However, changes over time in the nature of hand use, the rapid expansion of technology, and
improvements in our understanding of health literacy mean that these programs are now
outdated. Further, problems with adherence to JPP are well documented. The purpose of this
thesis was 1) to conduct a scoping review to map all the available evidence around joint
protection programs in published and unpublished studies 2) to evaluate the effectiveness of
joint protection programs when compared to usual care/no joint protection/advice on pain
reduction and improvement of hand function for individuals with hand arthritis 3) to conduct
an overview of systematic reviews to establish the current state of evidence evaluating the
effectiveness of joint protection for people with hand RA and OA 4) to investigate the barriers,
facilitators, expectations and patient preferences regarding joint protection programs in people
with hand arthritis 5) to evaluate the Content Validity Index (CVI) of Patient-Rated Wrist
Evaluation (PRWE), Australian/Canadian Osteoarthritis hand Index (AUSCAN) and Thumb
Disability Exam (TDX) in patients with hand arthritis and 6) to design a single center,
investigator-blinded, randomized, 12-month, parallel-group, superiority study for the
evaluation of the efficacy of a hand exercise and a joint protection program on pain Intensity
levels in people with hand osteoarthritis. From the existing literature, we found evidence of
very-low to low quality that the effects of joint protection programs compared to usual
care/control on pain and hand function are too small to be clinically important at short -,
intermediate- and long-term follow-ups for people with hand arthritis. We also found that
awareness of the potential benefits of JP, and prior experience with JP program were very low.
Common potentially modifiable patient-reported barriers to participate in future JP
interventions, included: cost, work commitments distance from home to clinic and times that
the JP intervention were provided. These barriers might be addressed with free and accessible
forms of delivery of JP, which may lead to better uptake and participation in JP. Our findings
also demonstrated very high content validity indices for the PRWHE, AUSCAN, and TDX;
with strong consensus across reviewers. This augments prior statistical evidence supporting
statistical measurement properties, to provide support for the content validity.
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Summary for Lay Audience
The most common location for osteoarthritis (OA) is the hand. Hand OA is responsible for
pain and limitations in hand function that can limit peoples’ ability to work or remain
independent. As hand OA progresses, the joints become deformed. Joint Protection Programs
(JPP) were developed in the 1980’s to help people with hand OA do tasks in daily life, alleviate
pain, and prevent joint deformity. JPP teach people how to change, or pace tasks, and how to
use devices that reduce joint loading. Although studies have shown these programs can be
effective, many people do not fully understand or use JPP. The JPP in use today have not been
updated to reflect the life tasks and tools of the 21st century. Much has changed - like how we
use our phones.
This thesis aimed to investigate the efficacy of JPP and to update the JPP to better address the
important daily tasks that people do, by working with patients and engineers to find the best
solutions. This study will lead to more useful, accessible and effective JPP that will help people
with hand OA avoid pain and prevent joint deformity.
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Chapter 1
1

Introduction
1.1

Osteoarthritis

Osteoarthritis (OA) affects up to 18% of the population above 60. 1 Prevalence of OA is
steadily increasing as the average age and risk factors such as obesity increases. This
painful condition is the main cause of disability in older individuals, and is thus,
unsurprisingly, associated with lower quality of life and a higher risk of depression and
mortality. The condition is characterized by loss of articular cartilage in synovial joints,
accompanied by subchondral bone changes, osteophyte formation at the joint margins,
thickening of the joint capsule, and mild synovitis. Conventional radiographs show joint
space narrowing as a reflection of cartilage loss, osteophyte formation and, in some cases,
subchondral bone changes, but these signs are not consistently associated with symptoms. 2

1.2

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a systemic auto-immune disease.3 RA prevalence and
incidence rates are increasing globally and RA has become a major public health
challenge.4,5 Quality of life for people with RA has been reported to be lower than in
patients suffering from the four main non-communicable diseases.6 The primary clinical
manifestation of RA is the symmetrical inflammatory polyarthritis that usually is starting
in the small joints of the hands and the feet, and then expanding to the bigger joints. 3 The
condition is resulting in tender swelling joints, pain, limited range of motion and stiffness.7
RA is often characterized by irreversible tissue damage and destruction of bone and of the
cartilage which leads to joint deformity and muscle atrophy. 7

1

1.3

Etiology and pathogenesis of hand osteoarthritis

Joints have a layer of articular cartilage which helps to eliminate friction between the bones
when movement is occurred.8 As a person gets older, the tissues of bone and cartilage are
starting to degenerate progressively resulting in a compromise of the functional integrity
of the joint. Ligaments and tendons may play also a potential role to aid the erosion of the
joint and in the development of Heberden’s nodes. 9 Joints from everyday movement are
subjected to mechanical loading however, the stress from the movements is not enough to
cause a healthy joint to develop osteoarthritis. 8 On the other hand, injured or vulnerable
joints such as misalignment have a higher risk of developing osteoarthritis because of joint
thickening and joint space narrowing respectively. 8 OA has been reported as a form of noninflammatory arthritis however, many studies have indicated the upregulation of several
inflammatory pathways.8 Onset to early OA has been linked with changes in the
extracellular matrix of cartilage. A highly negative charged protein named aggrecan assist
the cartilage to maintain its compressive stiffness with electrical repulsion which is
enforced by collagen fibers.10 Typically, OA is classified either as primary or as secondary
type. Primary type is defined when the joint develops OA and has no history of injury or
trauma.11 Secondary type of OA is referred to the development of the disease after an injury
or trauma in the joint that it is usually caused from physical injury, accident or any other
condition or disorder.12,13 Bony abnormalities in the presence of hand OA are the
Heberden’s and Bouchard’s nodes that affect part of the fingers. Heberden’s nodes are
defined as bony abnormalities and are located in the distal interphalangeal joints while
Bouchard’s are located in the proximal interphalangeal joints. 11,14 The prevalence of these
nodes has been extensively investigated and documented however, their etiology and
pathogenesis have not been determined yet. 15 The most commonly affected joint in the
hand is the distal interphalangeal joints which often progresses after 40 to 50 years of age.
The second most commonly affected joint is the carpometacarpal joint of the thumb and
progress around the age of 50 years.16,17 The metacarpophalangeal joint of the thumb may
be also affected from OA while other joints in the hand are more often affected from
secondary type of OA.16,17

2

1.4

Osteoarthritis and risk factors

Several risk factors have been associated with the development of osteoarthritis such as
age, obesity, sex, smoking, race and environment, diet, occupation and genetics. 18 Age has
been linked with an increased risk after the age of 20, with most individuals at the age of
40 will appear to have some damage in their joints whereas 50% of people aged greater
than 65 will present characteristics of OA.19,20 The increased risk in hand OA, is during the
average age of menopause for females approximately at 55 to 60 years whereas the risk is
starting to decrease after that age period. 21 When compared hand OA and knee/hip OA the
risk is increased at the age of 50 years old and then the risk is starting to decrease after that
age of 75 years old.21 Obesity has been reported as a risk factor however, studies in the
literature have presented conflicting findings. Previous studies such as the Baltimore
Longitudinal Study of Aging for men or the National Health Examination Survey for
women found no relationship between OA and obesity respectively. 18,19,22 On the other
hand, subsequent studies have indicated that obesity is a risk factor for developing hand
OA. Carman et al. found that obese individuals had a higher incidence of developing hand
OA when compared to average weight individuals.23 A 10-years study that was conducted
in 1675 subjects indicated a weak association of hand OA and obesity. 24 Reasons why
obesity is a risk factor for OA is poorly understood however, it has been reported that the
higher body weight may increase the mechanical loading in the joints, may affect the
hormone composition, the metabolism of the cartilage as well as the muscles. 24 Hormone
production from the adipose tissue regulates inflammatory activity which has been linked
to OA. Systemic factors such as (leptin, adiponectin, resistin, visfatin and chemerin) are
probably more associated to the higher prevalence of hand OA in obese people than the
mechanical loading factors.25-27 Sex has been reported as a risk factor for developing hand
OA with women being at 2.6 times higher risk in comparison with men. 23 The higher
prevalence of OA in women after the age of 55 indicates that hormones (i.e. estrogen) may
play a role for the development of hand OA. 18,19 As with obesity, the literature around
smoking as a risk factor of developing OA is very ambiguous. Several studies that
conducted in the past were not able to establish a relationship between smoking and OA in
the most affected areas (hip, knee, and hand). 28-30 A subsequent study that was conducted
3

back in 2005 indicated that smoking may have a beneficial effect in terms of lower the risk
for developing hip or knee OA.31 In contrast, Amin and colleagues showed that smoking
was associated with greater cartilage loss and pain in the knee. 32 While the literature shows
conflicting results for smoking as a risk factors it is important to note that this risk or
benefitted relationship has not been thoroughly examined for people with hand OA.

33

Prevalence of OA is very different depending on ethnicity and culture. For instance, an
epidemiological study in China found that females had lower rates of radiographically
confirmed OA in the hip and hand when compared with Caucasian females. 34 This finding
further supports the role of genetics in the risk of developing OA. The role of diet has not
been clearly understood but studies have showed that there is a relationship between hand
OA and vitamin K.35 Several studies have investigated the relationship between an
individual’s occupation and hand OA. More specifically, people with high labor working
occupations that required repetitive movements (i.e. clothing industry) had a higher risk
of developing hand OA.36 A subsequent study confirmed this finding and suggested that
females with hand OA had jobs that required to push something with their joints. 37

1.5

Available treatments for osteoarthritis

Osteoarthritis treatment is mainly symptomatic; there is no cure. Available treatments can
be divided into subgroups for didactical reasons: advice and self-help, conservative
treatments requiring supervision, and surgery.2 Advice and self-help includes patient
education about OA, paracetamol, topical agents, physical agents, and food supplements
such as glucosamine and chondroitin. Conservative treatments requiring supervision
includes non-steroidal anti-inflammatory drugs (NSAIDs), weight loss, acupuncture,
manual therapy, physical exercise, physical aids and supports, growth factor injections
and/or platelet rich plasma, intra-articular corticosteroids, and intra-articular hyaluronic
acids. Surgical treatments include arthroscopic surgery and total joint replacement. Recent
clinical practice guidelines have reached somewhat conflicting conclusions regarding the
usefulness of conservative treatment in osteoarthritis.38-41 Hand OA leads to reduction in
grip strength, difficulties when performing activities of daily living, loss of productive
4

work time and a decreased ability to perform manual activities.42,43 In the clinical setting,
pain is a major symptom among patients with hand OA which also contributes to patient
report of reduced joint function.44,45 Aspirational goals of hand OA treatment are to
maximize long-term health-related quality of life through control of symptoms such as
pain, prevention of structural damage and normalization of function. Management
recommendations advise applying non-pharmacological and pharmacological treatments.46
Medications include non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics to
relieve musculoskeletal signs and symptoms during all phases of treatment; however in
general disease modifying drugs have not been effective. 47-49 Tumor necrosis factor
inhibitors such as adalimumab, etanercept, golimumab and infliximab have a positive role
in inflammatory arthritis, and have been studied in OA. 50,51 Previous studies on psoriatic
arthritis50 and rheumatoid arthritis52 have supported the benefits of using anti-TNF drugs
with respect to pain, swelling, function, quality of life, fatigue and radiographic
progression. Literature is scattered with hypotheses and hopes for a positive effect of antiTNFs on hand OA. On the other hand, non-pharmacological treatments for hand OA may
include joint protection, exercise therapy and muscle strengthening, paraffin bath therapy,
electrotherapy or acupuncture mainly for the management of symptoms.46,53

1.6

Joint protection programs

Joint protection programs are a self-management strategy to help patients with hand
arthritis reduce pain and improve hand function. 54 This self-management approach usually
involves training in safe movement patterns, the use of assistive devices and behavior
modifications such as activity to avoid or pacing in active daily living. 54,55 Joint protection
programs were primarily developed for people with rheumatoid arthritis in the hand and
later this approach was expanded for patients with hand OA. 54,56

1.7

The gap in the knowledge

One of the few handbooks (Kleinert Kutz – Joint protection Handbook for Persons with
5

Arthritis) for joint protection programs was published back in 1988. The book has several
examples of joint protection techniques however, it is evident that these programs are
clearly outdated and have not considered recent adaptations in technology use or how daily
tasks are performed. The American College of Rheumatology conditionally recommends
joint protection techniques for the management of hand OA which indicates that there is
lack of evidence to support their efficacy. 39 More recent systematic review that investigated
the effectiveness of joint protection programs provided strong evidence for people with
rheumatoid arthritis in the hand but no evidence was presented for hand OA. 57 This is an
indication that more evidence is needed on updated joint protection programs for people
with hand OA. Another potential problem is that the literature does not describe adequately
what constitutes joint protection and how the different aspects of the programs are
implemented. For example, description of joint protection is often mentioned as leaflet,
educational sessions or written course material and no other details are presented. 57,58
Furthermore, intervention dosage parameters and what training tools are most effective are
currently unknown. This makes it very difficult to transfer the best available evidence to
clinical practice. Previous reports have indicated that adherence to joint protection has been
suboptimal.59,60 Reasons for poor adherence have not been well documented and it is
unclear what barriers may contribute to poor compliance in joint protection programs.
Previous conducted trials have found that people with rheumatoid arthritis in the hand used
joint protection approaches only when experienced pain symptoms. 56 Patients may not
fully understand that they need to practice joint protection techniques consistently in their
daily life and develop new patterns of daily activity so the cumulative joint loading can be
reduced.

1.8

Objectives of this dissertation

The fact that Joint Protection Programs (JPP) can reduce pain and improve function is
based on small, but definitive Randomized Controlled Trials (RCTs), conducted in the
1980s. However, changes over time in the nature of hand use, the rapid expansion of
technology, and improvements in our understanding of health literacy mean that these
6

programs are now outdated. Further, problems with adherence to JPP are well documented.
JPP can be enhanced by incorporating recent biomechanical and clinical evidence,
technology innovations, and insights gained in collaboration with people with hand OA.
JPP can be more salient, useful and effectively implemented. Therefore, the purpose of this
thesis is to provide evidence to better understand the efficacy of JPP in patients with hand
OA. More specifically, a series of studies were conducted:

1. To conduct a scoping review to map all the available evidence around joint
protection programs in published and unpublished studies
2. To evaluate the effectiveness of joint protection programs when compared to usual
care/no joint protection/advice on pain reduction and improvement of hand function
for individuals with hand arthritis
3. To conduct an overview of systematic reviews to establish the current state of
evidence evaluating the effectiveness of joint protection for people with hand RA
and OA
4. To investigate the barriers, facilitators, expectations and patient preferences
regarding joint protection programs in people with hand arthritis.
5. To evaluate the Content Validity Index (CVI) of Patient-Rated Wrist Evaluation
(PRWE), Australian/Canadian Osteoarthritis hand Index (AUSCAN) and Thumb
Disability Exam (TDX) in patients with hand arthritis
6. To design a single center, investigator-blinded, randomized, 12-month, parallelgroup, superiority study for the evaluation of the efficacy of a joint protection
program on pain intensity levels in people with hand osteoarthritis

1.9

Overview of this dissertation

Chapter 2 is a scoping review which aims to map all the available evidence around joint
protection programs. More specifically, the scoping review examined what are the sources
of evidence around joint protection, what are the main outcomes that are being used in joint
7

protection studies, by whom the program is implemented, what are the current principles
of joint protection and what is available in the “grey” literature for joint protection. Chapter
3 is an evidence synthesis that aimed to investigate the effectiveness of joint protection on
pain intensity and on hand function outcomes in people with hand arthritis. A meta-analysis
of all the eligible RCTs was performed to pool all the extracted outcomes on pain and hand
function. Chapter 4 is an overview of systematic reviews that critically appraise all the
available evidence synthesis reviews and aims to explain why the different reviews provide
different results. Chapter 5 is a cross-sectional survey that aimed to understand the barriers,
facilitators, preferences and expectations in people with hand arthritis. Patients were
recruited from a tertiary clinic in London, Ontario as well as with the help from The
Arthritis Society of Canada social network. Chapter 6 is a measurement study that
quantified the content validity of three self-reported outcomes in terms of their relevancy
and clarity in people with hand arthritis. Chapter 7 is a design of superiority trial that
integrates all the previous information from the previous studies of this thesis and aims to
assess the efficacy of the updated joint protection and hand exercises programs in people
with hand OA. Chapter 8 is a discussion section and overview of this thesis. In Chapter 8
we discuss the strength, limitations and the future research and clinical implications.
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Chapter 2
2

A Scoping Review of Joint Protection Programs for People
with Hand Arthritis

Abstract
Background: Joint protection (JP) can be enhanced by incorporating recent evidence and
innovations in collaboration with people with hand arthritis to be salient, useful and
effectively implemented.
Objective: The purpose of this study is to map the current research on JP principles and
guide future research on JP programs for the management of hand arthritis.
Methods: A search was performed in 4 databases (PubMed, EMBASE, Google
SCHOLAR, CINHAL) from January 1990 to February 2017. A Grey literature was also
conducted through the Google web search engine. A combination of search terms was used
such as hand osteoarthritis, rheumatoid arthritis, joint protection and/or self-management
strategies.
Results: Our search found 8,788 citations which 231 articles were deemed relevant and
after duplication 111 articles were retrieved for a full-text review. In total, 40 articles were
eligible for data extraction. The majority of the articles were (19) randomized controlled
trials (RCTs), (6) systematic reviews and (3) overviews of reviews that investigated joint
protection for hand arthritis. Joint protection was tested mostly in rheumatoid arthritis (RA)
population and to a lesser extent on hand osteoarthritis and was provided mainly by an
occupational therapist.
Conclusion: This review synthesized and critically examined the scope of JP for the
management of hand arthritis and found that RCTs, systematic reviews and overviews of
reviews constituted two-thirds of the current body of literature. Furthermore, it identified
a lack of clarity regarding the specific elements of joint protection programs used in clinical
studies.
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2.1

Introduction

Hand osteoarthritis (h-OA) is one the most common type of osteoarthritis (OA), and it is a
leading cause of disability in the elderly population around the world.1 Asymptomatic hOA is characterized by nodes and deformities in the finger joints. Symptomatic h-OA is
usually associated with pain, stiffness and limited functional ability. 2 Reports from “The
Framingham study” in 2002 showed that the prevalence of symptoms in h-OA was higher
than the symptoms in the knee.1 Management of h-OA typically includes pharmacological
(medications) and/or non-pharmacological interventions such as joint protection programs,
assistive devices, and hand exercises. Currently, there is no cure for h-OA and individuals
with symptomatic h-OA need strategies and approaches on how to maintain their active
daily living and functioning.
Joint protection programs were primarily developed for people with Rheumatoid Arthritis
(RA) and had been reported to be beneficial. 3 Joint protection includes self-management
strategies to alleviate pain, reduce inflammation and reduce the risk of deformities. 4 Also,
joint protection has been developed as an approach to improve the performance of daily
tasks by enhancing the control perceptions and improve the psychological status of the
patient.5 Joint protection is considered a multimodal intervention that aims to alter working
methods by using proper body mechanics and by using assistive devices. It is often
integrated with stretching and hand exercises . 6 Individuals with RA can play an essential
role in the management of their disease progression, but this requires their involvement.
The American College of Rheumatology in 2012 guidelines 7 suggested the use of joint
protection for the management of h-OA however, no definite recommendations have been
made so far. The European League Against Rheumatism (EULAR) evidence-based
recommendations3 reported that the joint protection programs is a well-established
13

approach for the management of RA but whether this method can be generalized to h-OA
remains unclear. A scoping review of joint protection programs will be a narrative
synthesis that aims to map the basic principles of joint protection and identify the primary
sources of the current scientific evidence.

2.1.1

Purpose of the Study

The purpose of this scoping review is to gather, synthesize and critically examine the scope
of joint protection principles for the management of h-OA and guide future research on
joint protection programs for the future management of h-OA. The following questions
were generated:
1. What are the main sources of scientific evidence of the current joint protection
programs?
2. What are the main outcome measures that are used for joint protection?
3. What are the current approaches of the joint protection programs?
4. What is available in “Grey Literature” for joint protection programs?

Methods

2.2

This study followed the steps of reporting guidelines by Arksey and O’ Malley’s. 8 The
steps were the following: identifying the research question (1), identifying relevant studies
(2), study selection (3), charting the data (4) and synthesizing, summarizing and reporting
the results.8

2.2.1

Study identification

The first author (PB) performed the literature search in 4 databases (PubMed, EMBASE,
Google SCHOLAR and CINHAL) from January 1990 to February 2017. A combination
of search terms was used such as hand osteoarthritis or/and rheumatoid arthritis, joint
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protection and/or hand exercises and/or self-management strategies. A Grey literature was
also conducted through the Google web search engine. The grey literature was investigated
through google manual searches in the first 10 pages of results. Also, relevant articles from
the scientific databases and the grey literature were selected from the title and entered into
a word database file.

2.2.2

Study Selection

The title and the abstract from all the articles and the grey literature were independently
screened by 2 investigators (PB) and (GN) and discrepancies were resolved by discussion
with a 3rd investigator (JM). We included all articles and handbooks (grey literature) that
contained information about joint protection programs for people with hand osteoarthritis
and/or rheumatoid arthritis. Studies, where the primary language was not in English, were
excluded from the review process. Also, studies and grey literature that focused exclusively
on assistive devices or orthotic devices or hand exercises were excluded from our review.
Articles with the same data presentation were prioritized as the ones that have the most
details, and the others were eliminated. A flow diagram of the search results and selection
process is shown in Figure 1.

2.2.3

Data Charting

Data were extracted from the first author (PB) from the included studies. Data information
included Author(s) name or source, year of publication, type of research, study population,
age, outcome measures, joint protection approaches, and by whom it was provided, and if
authors made any recommendations.
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2.2.4

Analyzing, synthesizing and reporting the results

Description of the study design, the population that was examined and by whom the joint
protection was delivered. The reported summarized findings were presented in a summary
table (Table 1). To answer our research questions, we categorized each type of study by
level of evidence. Current joint protection approaches/principles and outcome measures
were listed and reported in separate tables (Table 2-3). Grey literature was reported in a
different category (Table 4-6).

Results

2.3

Our search found 8,788 citations. After the duplication 231 articles were deemed relevant
from the title and abstract. Review of abstracts identified 111 articles and were assessed
for a full-text review. In total, 40 articles were eligible for inclusion in the scoping review
(Figure 1). The most common reason that studies were excluded was that either they did
not test joint protection on hand or they talked about patient education in general and not
for joint protection. Approximately 72% of the included articles reported rheumatoid
arthritis (RA) as a patient population and only 20% reported patients with hand
osteoarthritis (h-OA). A small portion of studies (8%) included both populations for joint
protection programs. The average age of the included population was ranging from 48.95
to 67.2 years old. In terms of sex, more than 75% of the included sample size were females
across the studies.

2.3.1

Study Description

The majority of the articles which consisted of 70% of the included articles were: (19)
randomized controlled trials
reviews

32–34 .

5,9,18–25,10–17 , (6) systematic

reviews

26–31 and

(3) overviews of

The rest of the studies were critical review of the literature

studies 38,39 , surveys

4,40 , mixed

methods studies 41 , pilot

42

cohort

and cross-sectional studies 43.

The characteristics of the included studies are summarized in Table 1.
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35–37 ,

2.3.2

Outcome Measures

The outcome measures that were used in the included studies are summarized in Table 2.
Pain was the most evaluated outcome measure, and it was evaluated with Visual Analog
Scale (VAS) or by pain subscale of Health Assessment Questionnaire (HAQ) or by
Numeric Pain Rating Scale (NRS) and by Michigan Hand Questionnaire. Self-report
measures for psychological domains were evaluated with the Arthritis Self -Efficacy Scale
(ASES), Hospital Anxiety and Depression Scale (HADS), Arthritis Helplessness Index
(AHI) and Sense of Coherence (SoC). Disease-specific activity outcome measures were
evaluated with the Disease Activity Score 28 (DAS28), Rheumatoid Arthritis Disease
Activity Index (RADAI), Arthritis Impact Measurement Scale (AIMS2). Quality of life
was assessed with EUROHIS-QOL 8 and health status with SF-12 and EQ-5D-3L.
Functional ability was evaluated with HAQ, Dreiser Functional Index (DFI), Australian
Canadian Osteoarthritis Index (AUSCAN), and Functional Index for Hand Osteoarthritis
(FIHOA). The adherence of joint protection programs was measured with the Joint
Protection Behaviour Assessment (JPBA), and joint deformity was assessed with Hand
Joint Alignment and Motion Scale. Efficacy was measured with general self-efficacy scale
and with global change. Disability was assessed with HAQ and with Disabilities of the
Arm, Shoulder, and Hand (DASH). Performance-based tests were performed to assess grip
and pinch strength as well as hand dexterity. Clinician based outcomes included wrist range
of motion and finger range of motion.

2.3.3

Joint Protection Approaches

In half of the studies, it was not clear who was primarily involved in delivering the joint
protection program. Only two studies reported that the joint protection was provided by
medical staff (nurse or physician) and by a research assistant. Joint protection and energy
conservation were administered mostly with two methods such as an educationalbehavioral approach or as an approach that was focused on personal goals and available
resources. The average time of a standardized joint protection education lasted from 1.5 to
3.25 hours approximately over two sessions. The usual content of the joint protection
17

education was to educate the participants about the disease and how the joints are affected
by h-OA or RA. The education sessions included information about the joint protection
principles with short time demonstrations (15 to 30 minutes) of hand joint protection
approaches usually for household activities. At the end of the joint protection education,
there was a discussion about patients' needs and problems that were mostly supported by a
leaflet. The joint protection tasks are summarized in detail in Table 3. Assistive devices
were not reported in the vast majority of the studies.

2.3.4

Grey Literature

Our grey literature search identified several online sources that are: (1) non-profit
organizations (e.g. National Agricultural Safety Database (NASD), East Sussex Healthcare
NHS, OASIS-Vancouver Coastal Health. Hand Osteoarthritis) (68) (2) educational elearning communities (e.g. Physiopedia) (69) that have available online material for joint
protection for people with hand arthritis and (3) Thesis from post-graduate and doctoral
studies. General joint protection principles for hand consideration included: avoid tight
grasp, avoid pressure on back of knuckles, use both hands when possible, avoid repetitive
hand activities, avoid stress to tip or pad of thumb, avoid to pressure against the radial side
of each finger thumb side, avoid prolonged period of holding hands in the same position,
use more prominent joints to complete a task, plan ahead, use orthotic devices to protect
your joints and respect pain. , and further details are summarized in Table 4-6.

2.4

Discussion

This study aimed to summarize the extent of the evidence for joint protection principles for
the management of RA / h-OA and identified randomized controlled trials, systematic
reviews and overviews of reviews as the primary sources of scientific evidence for the
current joint protection programs. Pain, function, psychological domains, adherence,
quality of life and health-status were the main outcomes that were administered. More
specifically, pain levels were mainly examined by Visual Analog Scale, Health Assessment
Questionnaire, Numeric Rating Scale and self-reported psychological domains Arthritis
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Self-Efficacy Scale, Health Anxiety and Depression Scale, Arthritis Helplessness Index
and Self of Coherence. Function was mostly examined by Australian Canadian
Osteoarthritis index (AUSCAN), Michigan Hand Questionnaire (MHQ) and Health
Assessment Questionnaire (HAQ). While the occupational therapist was primarily
responsible for the delivery of joint protection, in half of the included studies, it was unclear
who was mainly involved in delivering the joint protection program. Also, the current joint
protection programs primarily focused on tasks associated with home care and kitchen, and
the review of the grey literature yielded principles such as avoiding tight grips, awareness
of pain, limiting prolonged periods of holding and use of larger joints.
This scoping study did not evaluate the effectiveness of Joint protection programs but
identified 18 RCTs that can be synthesized to investigate their effectiveness. The two most
recent systematic reviews 26,27 provided recommendations from 8 RCTs in total leading to
the exclusion of 10 additional trials. Therefore, an update of the most recent evidence is
highly recommended.
Joint protection as a multimodal intervention includes the following components (1)
altering working methods, (2) use of proper joint and body mechanics through applying
ergonomic principles, (3) use of assistive devices, and (4) modifying functional
performance and environments.6 It is often integrated with fatigue management, working
splints and flexibility and strengthening exercises. 6 We were unable to extract all the
components mentioned above of joint protection because either there was a lack of
reporting or either the joint protection intervention was not fully implemented. Joint
protection programs may include specific principles and techniques such as avoiding tight
grips or use of larger joints or utilize particular exercises or energy conservation methods.
Therefore, it is crucial to ensure comprehensive reporting of all the components of such
programs when used in clinical studies. In this review, we were unable to extract specific
information on what exactly included in joint protection programs from most of the clinical
studies because the information was not available.
Future research needs to focus on clear and concise reporting of different principles
included in joint protection programs utilized in clinical studies and ensure adequate
representation of men and women. It is crucial to assess the effectiveness of such joint
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protection programs in large-scaled well-designed randomized controlled trials by
incorporating all the components of joint protection and not only parts of joint protection.
The strengths of this review are that we summarized all the reported joint protection
principles in peer-reviewed and grey literature. We highlighted the main outcome measures
that were used in most of the studies to help future clinical studies to select the most
commonly used self-report outcome measures and performance-based tests. We identified
a lack of clarity and lack of detailed description on the components of joint protection that
were tested. Finally, we indicated that many RCTs (n=10) have been published that have
not been considered in a recent evidence synthesis.
Despite the authors’ efforts to follow rigorous guidelines from Arksey and O’Malley 8 , this
scoping study is subjected to several limitations. A thorough literature search was
performed; however, we may have missed research articles that were under development
during the study period. Also, a search of the grey literature was conducted through google
search web engine, but we have decided to stop after the first ten pages of google web.
Therefore, online material that addresses joint protection strategies may have been missed
during the search process.

2.5

Conclusions

This review synthesized and critically examined the scope of joint protection programs for
management of h-OA and found that RCTs, systematic reviews and overviews of reviews
constituted two-thirds of the current body of literature. Furthermore, it identified a lack of
clarity regarding the specific elements of joint protection programs used in studies.

Acknowledgments: PB was supported by the Canadian Institutes of Health Research
(CIHR). GN was supported by Transdisciplinary Bone and Joint Award.

JM was

supported by a Canadian Institutes of Health Research Chair in Gender, Work and Health
and the Dr. James Roth Chair in Musculoskeletal Measurement and Knowledge
Translation.
20

Conflict of Interest: None
Funding Statement: This work was supported by an operating grant from The Arthritis
Society of Canada and by the Canadian Institutes of Health Research (CIHR) with
funding reference number (FRN: 201710GSD-402354-2828

21

2.6

References

1.
Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence
of symptomatic hand osteoarthritis and its impact on functional status among the elderly:
The framingham study. Am J Epidemiol 2002;156(11):1021–7.
2.
Moe RH, Iversen MD. Active approach to hand osteoarthritis: Active approach to
hand osteoarthritis. Rheumatol (United Kingdom) 2016;55(3):389–90.
3.
Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations
for the management of hand osteoarthritis: report of a Task Force of the EULAR
Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
Ann Rheum Dis [Internet] 2007;66(3):377–88. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17046965
4.
Hammond A. The use of self-management strategies by people with rheumatoid
arthritis. Clin Rehabil 1998;12(1):81–7.
5.
Hammond A, Lincoln N, Sutcliffe L. A crossover trial evaluating an educationalbehavioural joint protection programme for people with rheumatoid arthritis. Patient
Educ Couns 1999;37(1):19–32.
6.
Hammond A. Joint Protection: Enabling Change in Musculoskeletal Conditions.
In: International Handbook of Occupational Therapy Interventions. Springer; 2015. p.
607–18.
7.
Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology
2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in
osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64(4):465–74.
8.
Daudt HML, van Mossel C, Scott SJ. Enhancing the scoping study methodology:
a large, inter-professional team’s experience with Arksey and O’Malley’s framework.
BMC Med Res Methodol [Internet] 2013;13(1):48. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3614526&tool=pmcentrez&r
endertype=abstract
9.
Williams MA, Williamson EM, Heine PJ, et al. Strengthening And stretching for
Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic
evaluation. Health Technol Assess (Rockv) 2015;19(42):1–222.
10.
Oppong R, Jowett S, Nicholls E, et al. Joint protection and hand exercises for
hand osteoarthritis: an economic evaluation comparing methods for the analysis of
factorial trials. Rheumatology (Oxford) 2015;54(5):876–83.
11.
Dziedzic K, Nicholls E, Hill S, et al. Self-management approaches for
osteoarthritis in the hand: a 2x2 factorial randomised trial. Ann Rheum Dis
2015;74(1):108–18.
12.
Dilek B, Gözüm M, Şahin E, et al. Efficacy of Paraffin Bath Therapy in Hand
Osteoarthritis: A Single-Blinded Randomized Controlled Trial. [Internet]. Department of
Physical Medicine and Rehabilitation, Dokuz Eylul University, Izmir, Turkey: W B
Saunders; 2013. Available from:
http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=104258900&site=eh
ost-live

22

13.
Niedermann K, Buchi S, Ciurea A, et al. Six and 12 months’ effects of individual
joint protection education in people with rheumatoid arthritis: a randomized controlled
trial. Scand J Occup Ther [Internet] 2012;19(4):360–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21936735
14.
Niedermann K, de Bie RA, Kubli R, et al. Effectiveness of individual resourceoriented joint protection education in people with rheumatoid arthritis. A randomized
controlled trial. Patient Educ Couns 2011;82(1):42–8.
15.
Hammond A, Bryan J, Hardy A. Effects of a modular behavioural arthritis
education programme: a pragmatic parallel-group randomized controlled trial.
Rheumatology (Oxford) 2008;47(11):1712–8.
16.
Masiero S, Boniolo A, Wassermann L, Machiedo H, Volante D, Punzi L. Effects
of an educational-behavioral joint protection program on people with moderate to severe
rheumatoid arthritis: A randomized controlled trial. Clin Rheumatol 2007;26(12):2043–
50.
17.
O’Brien VH, Giveans MR. Effects of a dynamic stability approach in
conservative intervention of the carpometacarpal joint of the thumb: A retrospective
study. J Hand Ther [Internet] 2013;26(1):44–52. Available from:
http://dx.doi.org/10.1016/j.jht.2012.10.005
18.
Hammond A, Freeman K. The long-term outcomes from a randomized controlled
trial of an educational-behavioural joint protection programme for people with
rheumatoid arthritis. Clin Rehabil [Internet] 2004;18(5):520–8. Available from:
http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=106557945&site=eh
ost-live
19.
Stamm TA, Machold KP, Smolen JS, et al. Joint protection and home hand
exercises improve hand function in patients with hand osteoarthritis: a randomized
controlled trial. Arthritis Rheum 2002;47(1):44–9.
20.
Hammond a, Freeman K. One-year outcomes of a randomized controlled trial of
an educational-behavioural joint protection programme for people with rheumatoid
arthritis. Rheumatology (Oxford) [Internet] 2001;40(9):1044–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11561117
21.
Lindroth Y, Brattstrom M, Bellman I, et al. A problem-based education program
for patients with rheumatoid arthritis: evaluation after three and twelve months. Arthritis
Care Res 1997;10(5):325–32.
22.
Neuberger GB, Vogel K, Black SO. P : romoting Self-care in Cli . ents with
Arthritis. 1993;
23.
Lindroth Y, Bauman A, Brooks PM, Priestley D. A 5-year follow-up of a
controlled trial of an arthritis education programme. Rheumatology 1995;34(7):647–52.
24.
Giraudet-Le Quintrec J-S, Mayoux-Benhamou A, Ravaud P, et al. Effect of a
collective educational program for patients with rheumatoid arthritis: a prospective 12month randomized controlled trial. J Rheumatol [Internet] 2007;34(8):1684–91.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17610321
25.
Scholten C, Brodowicz T, Graninger W, et al. Persistent functional and social
benefit 5 years after a multidisciplinary arthritis training program. Arch Phys Med
Rehabil 1999;80(10):1282–7.

23

26.
Siegel P, Tencza M, Apodaca B, Poole JL. Effectiveness of Occupational Therapy
Interventions for Adults With Rheumatoid Arthritis: A Systematic Review. Am J Occup
Ther 2017;71(1):7101180050p1–11.
27.
Carandang K, Pyatak EA, Vigen CLP. Systematic Review of Educational
Interventions for Rheumatoid Arthritis. Am J Occup Ther 2016;70(6):7006290020p1.
28.
Spaans AJ, Van Minnen LP, Kon M, Schuurman AH, Schreuders AR, Vermeulen
GM. Conservative treatment of thumb base osteoarthritis: A systematic review. J Hand
Surg Am [Internet] 2015;40(1):16-21.e6. Available from:
http://dx.doi.org/10.1016/j.jhsa.2014.08.047
29.
Valdes K, Marik T. A systematic review of conservative interventions for
osteoarthritis of the hand. [Internet]. Hand Works Therapy, Sarasota, Florida.: Elsevier
Inc.; 2010. Available from: http://dx.doi.org/10.1016/j.jht.2010.05.001
30.
Eemj S, Jj D, Lm B, et al. Cochrane Database of Systematic Reviews
Occupational therapy for rheumatoid arthritis (Review) www.cochranelibrary.com.
2008;(1).
31.
Steultjens EMJ, Dekker J, Bouter LM, van Schaardenburg D, van Kuyk MAH,
van den Ende CHM. Occupational therapy for rheumatoid arthritis. Cochrane database
Syst Rev 2004;(1):CD003114.
32.
Ekelman BA, Hooker L, Davis A, et al. Occupational therapy interventions for
adults with rheumatoid arthritis: an appraisal of the evidence. Occup Ther Heal care
2014;28(4):347–61.
33.
Vliet Vlieland TPM, Pattison D. Non-drug therapies in early rheumatoid arthritis.
Best Pract Res Clin Rheumatol [Internet] 2009;23(1):103–16. Available from:
http://dx.doi.org/10.1016/j.berh.2008.08.004
34.
Christie A, Jamtvedt G, Dahm KT, Moe RH, Haavardsholm EA, Hagen KB.
Effectiveness of Nonpharmacological and Nonsurgical Interventions for Patients With
Rheumatoid Arthritis: An Overview of Systematic Reviews. Phys Ther
2007;87(12):1697–715.
35.
Beasley J. Osteoarthritis and rheumatoid arthritis: conservative therapeutic
management. J Hand Ther 2012;25(2):163–71; quiz 172.
36.
Swann J. Managing rheumatoid arthritis: joint protection and treatment. Br J
Healthc Assist 2011;5(2).
37.
Hammond A. Rehabilitation in rheumatoid arthritis: a critical review.
Musculoskeletal Care [Internet] 2004;2(3):135–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17041978
38.
Boustedt C, Nordenskiold U, Lundgren Nilsson A, et al. Effects of a hand -joint
protection programme with an addition of splinting and exercise. Clin Rheumatol
2009;28(7):793–9.
39.
Hammond a, Lincoln N. The effect of a joint protection education programme for
people with rheumatoid arthritis. Clin Rehabil [Internet] 1999;13(5):392–400. Available
from:
http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=107089864&site=eh
ost-live
40.
Veitiene D, Tamulaitiene M. Comparison of self-management methods for
osteoarthritis and rheumatoid arthritis. J Rehabil Med 2005;37(1):58–60.
24

41.
Niedermann K, Hammond A, Forster A, de Bie R. Perceived benefits and barriers
to joint protection among people with rheumatoid arthritis and occupational therapists. A
mixed methods study. Musculoskeletal Care 2010;8(3):143–56.
42.
Hammond A. Evaluating joint protection education for people with rheumatoid
arthritis. 1994;
43.
McGee C, Mathiowetz V. Evaluation of hand forces during a joint-protection
strategy for women with hand osteoarthritis [Internet]. Assistant Professor, Programs in
Occupational Therapy and Rehabilitation Science, University of Minnesota, Minneapolis:
American Occupational Therapy Association; 2017. Available from:
http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=120052984&site=eh
ost-live
44.
Williams MA, Williamson EM, Heine PJ, et al. Strengthening and stretching for
rheumatoid arthritis of the hand (SARAH). A randomised controlled trial and economic
evaluation. Health Technol Assess (Rockv) 2015;19(19):221.
45.
Hammond A. Joint Protection: enabling change in musculoskeletal conditions
(Chapter 42). 2015;
46.
Oppong R, Jowett S, Nicholls E, et al. Cost-effectiveness of joint protection and
hand exercise for hand osteoarthritis. In: RHEUMATOLOGY. OXFORD UNIV PRESS
GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND; 2013. p. 147.
47.
Dziedzic K, Nicholls E, Hill S, et al. Self-management approaches for
osteoarthritis in the hand: A 2×2 factorial randomised trial. Ann Rheum Dis [Internet]
2015;74(1):108–18. Available from: http://dx.doi.org/10.1136/
48.
Boustedt C, Nordenskiöld U, Lundgren Nilsson Å. Effects of a hand-joint
protection programme with an addition of splinting and exercise. Clin Rheumatol
2009;28(7):793–9.
49.
Christie A, Jamtvedt G, Dahm KT, Moe RH, Haavardsholm EA, Hagen KB.
Effectiveness of nonpharmacological and nonsurgical interventions for patients with
rheumatoid arthritis: an overview of systematic reviews. Phys Ther [Internet]
2007;87(12):1697–715. Available from: https://academic.oup.com/ptj/articlelookup/doi/10.2522/ptj.20070039
50.
O’Brien A V., Jones P, Mullis R, Mulherin D, Dziedzic K. Conservative hand
therapy treatments in rheumatoid arthritis - A randomized controlled trial. Rheumatology
2006;45(5):577–83.
51.
Gossec L, Pavy S, Pham T, et al. Nonpharmacological treatments in early
rheumatoid arthritis: clinical practice guidelines based on published evidence and expert
opinion. Joint Bone Spine 2006;73(4):396–402.
52.
Hammond A, Jeffreson P, Jones N, Gallagher J, Jones T. Clinical applicability of
an educational-behavioural joint protection programme for people with rheumatoid
arthritis. Br J Occup Ther 2002;65(9):405–12.
53.
Hammond A. Joint protection behavior in patients with rheumatoid arthritis
following an education program a pilot study. Arthritis Rheum 1994;7(1):5–9.
54.
Neuberger GB, Smith K V, Black SO, Hassanein R. Promoting self-care in clients
with arthritis. Arthritis Care Res 1993;6(3):141–8.

25

Table 2-1. Characteristics of the included studies
Year

Study

Population

Provider

SR

RA

N/A

CS

OA

N/A

SR

RA

N/A

RCT

RA

N/A

Book

OA

OT/PT

RCT

OA

N/A

RCT

OA

N/A

SR

OA

OT

Overview

RA

N/A

RCT

OA

OT

RCT

RA

Researcher

Review

Both

OT

Review

RA

N/A

RCT

RA

N/A

Mixed

RA

OT

SR

OA

OT

Cohort

OA

N/A

Overview

RA

OT

RCT

RA

OT)

SR

RA

OT

RCT

RA

OT

RCT

RA

N/A

Overview

RA

PT/OT/MD

RCT

RA

N/A

Author or Source
1. Siegel26

2017

2. McGee43

2017

3. Carandang27
4. Williams44
5. Hammond 45

2016
2015
2015

6. Oppong46

2015

7. Dziedzic47

2015

8. Spaans28

2015

9. Ekelman32

2014

10. Dilek12

2013

11. Niedermann13

2012

12. Beasley35

2012

13. Swann36

2011

14. Niedermann14

2011

15. Niedermann41
16. Valdes29

2010
2010

17. Boustedt 48

2010

18. Vlieland 33

2009

19. Hammond 15

2008

20. Steultjens30

2008

21. Masiero16

2007

22. Quintrec24

2007

23. Christie49

2007

24. O’Brien50

2006
26

25. Gossec51

2006

26. Steultjens 31

2005

27. Veitiene40

2005

28. Hammond 37

2004

29. Hammond 18

2004

30. Stamm19

CPG

RA

N/A

SR

RA

N/A

Survey

Both

N/A

Review

RA

N/A

RCT

RA

N/A

RCT

OA

N/A

RCT

RA

OT

RCT

RA

OT

RCT

RA

OT

Cohort

RA

N/A

RCT

RA

N/A

Survey

RA

N/A

RCT

RA

OT/PT/MD/Nurse

RCT

RA

N/A

Pilot

RA

N/A

RCT

RA

OT

2002

31. Hammond 52
32. Hammond 20

2002
2001

33. Hammond 5

1999

34. Hammond 39

1999

35. Scholten25

1999

36. Hammond 4

1998

37. Lindroth21

1997

38. Lindroth23

1995

39. Hammond 53

1994

40. Neuberger54

1993

RCT, randomized controlled trial; SR, systematic review; CPG, clinical practice
guidelines; CS, cross-sectional study; OA, osteoarthritis; RA, rheumatoid arthritis; OT,
occupational therapist; PT, physical therapist; MD, medical doctor
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Table 2-2. Outcome measures that were reported
Author(s)

Year

Outcome Measures

Siegel

2017

Joint protection behavior, function, pain, fatigue, self-efficacy, stiffness

McGee

2017

Grip Strength, Numeric Rating Scale (NRS), Arthritis Impact Measurement Scale 2 (AIMS2)

Carandang

2016

Williams

2015

Joint protection behavior
The Arthritis Self-Efficacy Scale (ASES), Grip Strength, Finger Range of Motion (ROM), Michigan
Hand Questionnaire (MHQ), Hand Dexterity, European Quality of Life 5 (EQ-5D-3L), Wrist Range of
Motion (ROM), Short-Form 12 (SF-12), Self-Efficacy, Global Change, Pain (MHQ), Adherence

Oppong

2015

Dziedzic

2013

Ekelman

2014

Dilek

2013

Niedermann

2012

Niedermann

2011

morning stiffness, pain, and functional capacity
Visual Analog Scale (VAS), Grip Strength, AUSCAN, Pinch Strength, Dreiser Functional Index, Wrist
Range of Motion (ROM)
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behavior Assessment (JPBA), Health Anxiety
and Depression Scale (HADS), Visual Analog Scale (VAS), Disease Activity Score (DAS 28), Grip
Strength, EUROHIS-QUOL 8, JP-specific self-efficacy (JP-SES)
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behaviour Assessment (JPBA), Health
Anxiety and Depression Scale (HADS), Visual Analog Scale (VAS), Disease Activity Score (DAS 28),
Grip Strength, Hand Joint Alignment and Motion Scale (H -JAM), Health Assessment Questionnaire
(HAQ), Sense of Coherence (SOC), EUROHIS-QUOL 8, Wrist Range of Motion (ROM), JP selfefficacy scale (J-SES),

Niedermann

2010

Disease Activity Score (DAS 28), Health Assessment Questionnaire (HAQ)

Boustedt

2010

Visual Analog Scale (VAS), Grip Strength, Pinch Strength, DASH

Quintric

2009

Hammond

2008

Steultjens

2008

Masiero

2007

Health Assessment Questionnaire (HAQ)
The Arthritis Self-Efficacy Scale (ASES), the Visual Analog Scale (VAS), Health Assessment
Questionnaire (HAQ), RA Self-efficacy (RASE) Scale, the Arthritis Stages of Change Questionnaire
Pain, fatigue, functional abilities (including dexterity), physical independence, qua lity of life (including
well-being and depression). knowledge about disease management, compliance, self -efficacy, range of
motion, muscle strength
Visual Analog Scale (VAS), Health Assessment Questionnaire (HAQ), Arthritis Impact Measurement
Scale 2 (AIMS2)

Christie

2007

O’Brien

2006

Hammond

2004

Pain, function, and patient global assessment.
Grip Strength, Hand Dexterity, Pinch Strength, Arthritis Impact Measurement Scale 2 (AIMS2), finger
flexion ROM goniometry, Jebsen–Taylor hand function test
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behavior Assessment (JPBA), Visual Analog
Scale (VAS), Grip Strength, Rheumatoid Arthritis Disease Activity Index (RADAI), Wrist Range of
Motion (ROM), Arthritis Impact Measurement Scale 2 (AIMS2), EULAR 28,

Stamm

2002

Visual Analog Scale (VAS), Grip Strength, Health Assessment Questionnaire (HAQ)

European Quality of Life 5 (EQ-5D-3L), Osteoarthritis Research Society International (OARSI)
The Arthritis Self-Efficacy Scale (ASES), Grip Strength, Short- Form 12 (v2), AUSCAN, Numeric
Rating Scale (NRS), Pinch Strength, Global Change, functional performance using the grip ability test
(GAT)

28

The Arthritis Self-Efficacy Scale (ASES), Joint Protection behavior Assessment (JPBA), Visual Analog
Scale (VAS), Grip Strength, Health Assessment Questionnaire (HAQ), Self -Efficacy, Patient Knowledge
Questionnaire, Rheumatology Attitudes Index (RAI)
Joint Protection behavior Assessment (JPBA), Visual Analog Scale (VAS), Grip Strength, Hand Joint
Alignment and Motion Scale (H-JAM), Arthritis Impact Measurement Scale 2 (AIMS2), Self -Efficacy,
EULAR 28 tender, Rheumatoid Attitudes Index (RAI)
The Arthritis Self-Efficacy Scale (ASES), Joint Protection behaviour Assessment (JPBA), Visual Analog
Scale (VAS), Grip Strength, Hand Joint Alignment and Motion Scale (H -JAM), Health Assessment
Questionnaire (HAQ), Arthritis Helplessness Index (AHI), Hand Joint Count, Joint Protection
Knowledge Assessment ( JPKA )
Joint Protection behavior Assessment (JPBA), Visual Analog Scale (VAS), Health Assessment
Questionnaire (HAQ), Hand Joint Count, knowledge questionnaire
Stanford Health Assessment Questionnaire, German version of the Freiburg Questionnaire of Coping
with Illness (FQCI), Beck Depression Inventory (BDI)

Hammond

2002

Hammond

2001

Hammond

1999

Hammond

1999

Scholten

1999

Hammond

1998

Lindroth

1997

Health Assessment Questionnaire (HAQ)
Visual Analog Scale (VAS), Arthritis Helplessness Index (AHI), Stanford Health Assessment
Questionnaire

Lindroth

1995

Health Assessment Questionnaire (HAQ), Pain (VAS

Hammond

1994

Joint Protection behavior Assessment (JPBA)

Neuberger

1993

Visual Analog Scale (VAS), Center for Epidemiologic Studies Depression Scale (CES-D)
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Table 2-3. Joint protection Principles/Approaches that were reported
Author(s)
Siegel

Year
2017

McGee

2017

Carandang

2016

Williams

2015

Hammond

2015

Dziedzic

2013

Ekelman

2014

Niedermann

2012

Beasley

2012

Swann

2011

Boustedt

2010

Hammond

2008

Masiero

2007

O’Brien

2006

Hammond

2004

Stamm

2002

Joint Protection Principles
the session was ranging from 45 minutes to 120 minutes
In a standing position, participants maintained standardized glenohumeral and elbow joint positions as well as
hand placements to control for the distal kinetic variance that might result from non -standardized posturing.
Uses guidelines that include techniques such as balancing rest and activity and the use of large joints Stresses
education about disease, symptoms, and prognosis (especially effects of synovitis); incorporates family and
routine
The Number of sessions dependent on clinical need up to a maximum of three sessions or 1.5 hours in total.
Rheumatoid Arthritis, a booklet providing general information about the disease and its management; Looking
After Your Joints When You Have Arthritis, describing various self-management techniques and JP advice;
and Keep Moving – How a few Simple Exercises can Make You Feel Better About Yourself and Your
Arthritis, a booklet providing general exercise information along with suggestions as to specific exercises that
could be performed for all parts of the body
Joint protection: Respect pain; distribute the load over several joints; use the strongest, largest joint to perform
an activity; avoid working in positions of potential deformity; reduce effort by using assistive devices and
avoiding lifting and carrying and avoid prolonged periods of working in the same position. • Energy
conservation: Pace by balancing rest and work and alternate heavy and light activities; use work
simplification; use correct working positions and postures.
distributing the weight of what you lift over several joints (e.g., spread the load over two hands) ▸ avoiding
putting strain on the thumb and repetitive thumb movements ▸ avoiding prolonged grips in one position ▸
using as large a grip as possible ▸ reducing the effort needed to do a task (e.g., use labor-saving gadgets;
avoid lifting heavy objects, and reduce the weight of what you lift) ▸ energy conservation (activity pacing and
planning)
Training includes movement training to promote daily manual work by reducing pain and joint strain,
preventing deformity, and maintaining functional capacity; self-exercise programs for hands; and provision of
information on assistive devices, methods to adapt the environment, and the value, use, and handling of
orthoses.
Demonstrations and supervised practice of hand JP methods, mostly in kitchen activities, and demonstration of
appropriate assistive devices. The interventions consisted of five 45 -minute sessions, four over a three-week
period and one booster session two months later
Respect pain, balance rest and activity, perform the exercise in a pain-free range, avoid positions of deformity,
reduce the effort and force, use larger/stronger joints
The main techniques for joint protection are to (Arthritis Research UK, 2010): Use larger, stronger joint s,
Spread the load over several joints, reduce effort by using labor-saving gadgets, Avoid gripping things tightly,
Avoid positions that push joints towards
Joint protection consists of information about hand anatomy, osteoarthritis, and theoretical and practical
information about pain and how to cope with it [6]. To introduce alternate working methods to reduce
difficulties of daily activities the women tried grip assistive devices and elastic thumb splints during the day
both at the clinic and at home.
joint protection (including 45min demonstration and practice), managing fatigue, aims of splinting, managing
stress and relaxation (45 min practice)
Principles of JP and energy conservation, including a demonstration of various hand -JP techniques, plus a
homework task to identify problem activities and find solutions based on the imparted principles, work
difficulties, etc.
basic principles of joint protection, energy conservation, ‘top tips’ relating to personal and household
activities,
Both education programs consisted of four 2-hour weekly meetings.
joint protection instruction: the need for balance between movement and resting a joint; dividing stress
between as many joints as possible; using larger and stronger joints; using each joint in its most stable plane to
reduce pressure on the joint; avoiding staying in one position, and avoiding vibrations for the finger joints.
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Hammond

2001

Hammond
Hammond

1999
1998

Hammond

1994

Neuberger

1993

principles of joint protection and energy conservation; demonstration of some hand -joint protection methods;
and a homework task to identify problem activities and to find solutions using the principles taught.
Arthritis and Rheumatism council leaflets
Altering ways of moving hands during daily activities to reduce joint strain
Four JP principles were assessed: (1) distributing the load over several joints; (2) using each joint in its most
stable position; (3) reducing effort by use of aids and avoiding lifting; and (4) avoiding positions of possible
joint deformity
Joint Protection Principles
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Table 2-4. Joint protection principles from Physiopedia
•
•
•

•

Use a relaxed grip.
Enlarge handles.
Place the palm on the jar lid, and using the weight of the
body, turn arm at the shoulder to open the jar. A sponge
or wet towel under the jar prevents sliding
Hold the knife or mixing spoon like a dagger, with the
handle parallel to knuckles. Cutting is then changed from
sawing to pulling
Don't carry heavy handbags, pails, and bags by the
handle.
Hold everything no tighter tha n necessary.
Release tight grasp frequently if you must use it.
Use built-up handles on writing utensils, pot handles,
tools, etc.
Use adaptive equipment such as jar openers
Avoid all pressures against the backs of fingers: this
type of pressure contributes to dislocation of the large
joints between the palm and the fingers (metacarpalphalangeal joints).
This occurs while pushing up from a chair using a
closed fist or resting chin on the backs of fingers.
Use palms while holding fingers straight.

•
1.

AVOID TIGHT GRASP

•
•
•
•
•
•

2.

AVOID PRESSURE ON BACK OF KNUCKLES

•

3.

USE BOTH HANDS WHEN POSSIBLE

•

Not specified how

4.

AVOID REPETITIVE HAND ACTIVITIES

•
•

Take breaks
Change activity, i.e., using screwdriver, crocheting

•

The thumb is necessary for 40 percent of hand
activities
Example: opening car doors, ringing doorbells
To protect thumb joints, open milk containers with
heels of the hands rather than thumbs.
Don't rest chin on the side of fingers.
Add levers to keys, handles, and knobs.
Hold handles straight across the palm.
Sit if the task takes more than 10 minutes.
Stand up after sitting for 20-30 minutes.
Reposition yourself often.

5.

AVOID PRESSURE TO TIP OR PAD OF THUMB

6.

AVOID PRESSURE AGAINST THE RADIAL SIDE
OF EACH FINGER THUMB SIDE

7.

AVOID PROLONGED PERIODS OF HOLDING
HANDS IN THE SAME POSITION

•
•
•
•
•
•
•
•
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Table 2-5. OASIS-Vancouver Coastal Health - Protecting Your Hands
•
•
1.

Use your bigger joints to complete a
task

•
•
•
•

2.

Plan ahead

3.

Use splints to protect your joints,
either at rest or during activity

•
•
•
•

Carry your handbag with your shoulder or forearm. Carry only what you
need.
Push or pull items rather than carry them, e.g., use a wheeled cart for
groceries
Carry large or heavy items with two hands. Hug the object close to your
body.
Close drawers/doors with your hip or choose automatic doors when
possible
Push up from a chair using the palm of your hand, not your fingers.
Choose higher chairs or use a firm cushion on your chair.
Vary tasks and change your hand position often. Take breaks every 20 -30
minutes.
Spread heavier tasks throughout the week
Rest your hands before they are tired or sore
Organize your workspace to ensure hands and wrists are in a neutral
posture
Talk to your care team to determine if a hand or thumb splint would be
helpful for you

Writing, gardening

Buy large-handled tools or make your handles
larger with foam tubing

Cooking

Adapted kitchen aids, e.g., finger vegetable
peeler, ergonomic salad spinner

Opening jars and cans

Jar seal-opener, non-slip grip, electric can opener

Twisting tops,
squeezing tubes

Products with pumps

Pinching a key

Use the heel of your hand; sponge or washing
brush
Foam steering wheel cover
Use the lever on the handle to avoid squeezing
for a long time
Keyholder

Reading

Bookholder, books on tape, e-books

Opening mail
Dressing
Opening doors, turning taps
Gripping slippery items, e.g.,
removing credit cards from a
wallet
Self-care, e.g., cutting nails,
washing hair, etc.

Easy-to-squeeze scissors
Button hook, zipper pull
Lever taps and door handles

Wringing out clothes
4.

5.

Change your grip and use adapted
equipment to avoid tight
gripping/squeezing and force
through the thumb

Follow the exercises given to you by
your health care team to keep your
joints moving and your muscles
strong

Driving
Pumping gas

Use a piece of non-slip mat, e.g., Dycem;
accordion-style wallet
Adapted equipment from a pharmacy or medical
supply store

No further instructions were given
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Table 2-6. East Sussex Healthcare NHS
1. Use joints in a stable
position
2. Avoid activities that
do not allow for a
change of position
3. Respect pain
4. Avoid tight grips or
gripping for long periods

5. Avoid deforming
positions

6. Use one large joint or
many joints

•
•
•
•
•

Sit or stand as close as you can when working at a table or bench as this reduces stretching
and bending.
Use a grip that keeps the wrists straight and the fingers in line with the wrist as much as
possible.
Be mindful of how long you have been doing specific activities, joint and muscles do not like to be held
in the same position. They become stiff and work less effectively which leads to pain, damage and
further deformity. When writing, doing hand work, release your grip every 10 to 15 minutes. On long
car trips, get out of the car, stretch and move around at least every one to two hours.

•

If you have arthritis, you may always have some pain. If pain continues for hours after the activity has
stopped, this indicates that the event was too much and should have been changed or stopped sooner.

•

Gripping tightly increases pain and can cause further joint damage. Gripping small objects require
greater force

•

When opening new or tight jars consider using a gripping aid and direct the force through the palm of
your hand rather than just through the fingers. There are several types of jar opening devices. Ask others
to undo the lids, while you close them.
Use a flat hand when possible for cleaning, wiping, dusting.
Try using cups with larger, straighter handles than cups with curved handles.
In general, finger motions should be in the direction of the thumb whenever possible.
Carry objects with your palm open to distribute weight equally over your forearms.
Slide objects along a counter or workbench rather than lifting and carrying them.
Carry light bags on your shoulders rather than with your han ds.
When standing up from a chair or bed, rock forward and use your leg muscles rather than pushing up
from your knuckles or wrists.
Use your hip or lower leg to close drawers.

•
•
•
•
•
•
•
•

claiming source Arthritis Research UK, www.arthritisresearchuk.org.
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Table 2-7. Energy conservation and joint protection from NASD
1.

Respect PAIN as a signal to STOP the activity.

2.

Make a SCHEDULE of daily activities. Write down when PAIN and FATIGUE occur and schedule in REST
BREAKS as needed.
Avoid POSITIONS OF DEFORMITY and FORCES in their direction. Finger motions should be in the direction of
the thumb whenever possible. When getting up from a chair or holding a magazine, use the palms of the hands rather
than the knuckles.
Use the LARGEST and STRONGEST joints available for a job. Save weaker joints for the specific tasks that only
they can handle. For example, carry bags on the shoulder instead of at the elbow, wrist, or fingers.
Avoid staying in ONE POSITION for a LONG PERIOD OF TIME. Don't give your joints the chance to become
stiff. When writing or doing handwork, release your grip every 10 to 15 minutes. On long car trips, get out of the car,
stretch and move around at least every hour. While watching television get up and walk around every 30 minutes.
Use a CART to carry heavy items. If no cart is available, it is better to take several trips to get a job done than to
overload and make one trip.
SLIDE or PUSH items whenever possible.

3.

4.
5.

6.
7.
8.
9.

Avoid making a TIGHT FIST or PINCHING objects tightly. Instead, use a grasp that places your KNUCKLES
PARALLEL to the handle of the tool or utensil being used.
DO NOT start an activity that cannot be STOPPED IMMEDIATELY if pain or fatigue should occur.

NASD, National Agricultural Safety Database
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Figure 2-1. Selection of included articles
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Chapter 3
3

The Effectiveness of Joint Protection Programs on Pain,
Hand Function and Grip Strength Levels in Patients with
Hand Arthritis. A Systematic Review and Meta-Analysis

Abstract
Study Design: Systematic review with meta-analysis
Introduction: Joint protection (JP) has been developed as a self-management intervention
to assist people with hand arthritis to improve occupational performance and minimize
joint deterioration over time.
Purpose of the Study: We examined the effectiveness between JP and usual care/control
on pain, hand function and grip strength levels for people with hand osteoarthritis (OA)
and rheumatoid arthritis (RA).
Methods: A search was performed in 5 databases from January 1990 to February 2017.
Two independent assessors applied Cochrane’s risk of bias tool, and a GRADE approach
was adopted.
Results: For pain levels at short-term, we found similar effects between JP and control
standardized mean difference (SMD) -0.00, 95% CI: -0.42 to 0.42, I 2 =49%, at mid and
long-term follow-up JP was favored over usual care SMD: -0.32, 95% CI: -0.53 to -0.11,
I 2 =0 and SMD -0.27, 95% CI: -0.41 to -0.12, I 2 =9% respectively. For function levels at
mid and long-term follow-up JP was favored over usual care SMD -0.49, 95% CI: -0.75 to
-0.22, I 2 =34% and SMD -0.31, 95% CI: -0.50 to -0.11, I 2 =56% respectively. For grip
strength levels, at long term JP was inferior over usual care Mean Difference (MD) 0.93,
95% CI: -0.74 to 2.61, I 2 = 0%.
Conclusions: This systematic review provides the most updated evidence on the
effectiveness of joint protection programs vs. usual care/control in patients with
rheumatoid arthritis and hand osteoarthritis on clinical outcomes. Evidence of very-low to
low quality indicates that the effects of joint protection programs compared to usual
care/control on pain and hand function are too small to be clinically important at short -,
intermediate- and long-term follow-ups for people with hand arthritis.
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3.1

Introduction

Osteoarthritis (OA) is a degenerative joint disease that affects approximately 27 million
adults and is ranked in the top three causes of disability in the United States 1 . The economic
burden for OA, rheumatoid arthritis (RA), and other rheumatoid conditions in the United
States were estimated to be approximately 128 billion dollars which represent 1.2% of the
2003 U.S. gross domestic product 2 . Today, more than 272,000 people are living with RA,
comprising 0.9% of the Canadian adult population, which will increase to 1.3% over the
next 30 years3 . In Canada between 2008 and 2009, the socioeconomic cost of arthritis was
over 4.4 billion dollars. About 80% of these costs were attributed to the unemployment and
underemployment 4 . Pain from OA has a significant impact on the quality of life, work
productivity and in the usage of healthcare resources among workers 1 . Recent evidence
from a systematic review suggests that the reduction in health care costs for services to
manage arthritis is as necessary as the improvement of the quality of life of this patient
population 5 .
The most common site of OA is in hand, and the most commonly described symptoms are
pain, joint deformity, loss of grip strength and loss of hand function 6 . RA can also affect
small joints in the hands and may cause painful swelling, joint deformity, loss of joint
function and increased disability 4 . Conservative management of hand arthritis includes
both pharmacological (e.g., NSAIDs) and non-pharmacological interventions, such as joint
protection programs, assistive devices, and exercises

7,8 . Currently, there is

no cure for hand

arthritis, but many rehabilitation interventions are targeting towards helping individuals to
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maintain functional performance with activities of daily living (ADLs), mediate symptoms,
and prevent deformities.
Joint protection programs were initially developed for people with RA and had been
expanded to treat patients with hand OA 9 . Joint protection intervention includes education
in altering working habits, use of proper joint and body mechanics by applying ergonomic
principles, use of assistive devices and orthotics, and modifying functional performance
and environments. It is often integrated with fatigue management and flexibility and
strength hand exercises10 . It has been suggested that joint protection for people with RA
may reduce load and effort during daily activities of daily living. Therefore, it is
theoretically resulting in strain reduction on joint structures which have been weakened by
the disease, pain mediation, irritation prevention of the synovial membrane and reduction
of local inflammation and fatigue. Also, it has been suggested that joint protection for
people with hand OA is aiming to reduce loading on articular cartilage, strengthen muscle
support, and improve shock-absorbing capabilities of joints10,11 .
Two recent systematic reviews (SRs)

7,12

examined the effectiveness of joint protection on

people with RA. Each study examined joint protection and provided recommendations
from 5 RCT’s and 3 RCT’s respectively 7,12 . Those 2 SRs reported strong evidence that
joint protection may improve function 7 and pain 7,13 . For people with hand OA, a SR found
that programs of joint protection, advice, and home exercises are effective at improving
grip strength and hand function14 . While those reviews provide valuable insights, they have
important limitations. Both studies reported effects mostly as statistical differences and not
as magnitude of the effects. Also, both reviews did not interpret and discussed the potential
impact of risk of bias when they provide recommendations. Given the limited number of
RCT’s that were included for joint protection for people with hand OA and RA, an
appraisal of the most recent evidence is needed. Therefore, the objective of this systematic
review is to evaluate the effectiveness of joint protection programs when compared to usual
care/no joint protection/advice on pain reduction and improvement of hand function for
individuals with hand arthritis.
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Methods

3.2
3.2.1

Search Strategy

An electronic search was performed to identify RCT’s in PubMed, Google Scholar,
CINAHL, PEDro and EMBASE from January 1990 to February 2017. Several different
combinations of keywords were used such as: “rheumatoid arthritis” or “osteoarthritis”
and/or “joint protection” or “hand osteoarthritis” or “self-management and osteoarthritis”.
The complete search strategy is summarized in Appendix 1. The references of systematic
reviews and overviews found in the electronic search were then hand searched to retrieve
further RCT’s.

3.2.2

Inclusion/Exclusion Criteria

Only randomized controlled trials (RCT’s) were eligible for inclusion by fulfilling the
following criteria: (1) RCT’s included people with RA or hand OA, (2) patients received
joint protection10,11 (3) outcome measures were adequately reported. Studies were excluded
if: (1) were not written in English, (2) they only examined a specific component of joint
protection such as an assistive device or orthosis or they did just hand exercises without
joint protection advice.

3.2.3

Study Selection

Two independent reviewers (PB and MS) performed the electronic search to screen
relevant articles based upon title and abstract. After duplications were removed, inclusion
criteria were applied to retrieve the articles for a full-text review. Disagreements were
resolved using a consensus method via a third reviewer (JM).
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3.2.4

Data Extraction

Two independent researchers (BP and MS) extracted the data from the included RCT's. A
third person checked the data extraction (JM). Data extraction included the following
information: (1) author, (2) year, (3) study population, (4) sample size (5) intervention
method, (6) primary outcome measures, (7) secondary outcome measures (8) results, and
(9) recommendations made by authors (if any). We categorized the follow-up periods as
short-term (3-4 months or less), mid-term (6-8 months) and long-term (12 months or more).

3.2.5

Missing data from Included Studies

When values (Mean and SD) were not available an attempt was made to contact the
corresponding authors to request the data. Additionally, we searched other tables from
previous SR's to identify Means, and SD's of the included RCTs to facilitate our data
analysis.

3.2.6

Risk of Bias Assessment

Two reviewers (PB and MS) independently assessed the risk of bias of each RCT. If there
was a disagreement, consensus came from a third reviewer (JM). Risk of bias assessment
was performed with Cochrane Collaboration’s tool

15

which contains seven domains

(random sequence generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessment, incomplete outcome data, selective reporting
and other bias) to score sources of bias. Each domain can be rated as "low risk of bias,"
"unclear risk of bias" or "high risk of bias." The interpretation of this tool is as follows: 1)
low risk indicates that if bias is present, results will be unlikely to be altered, 2) unclear
risk of bias induces some doubts surrounding the results of the study, and 3) high risk of
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bias indicates that bias may change the results seriously

15 . Publication

bias was planned to

assess with funnel plots if more than ten studies were pooled 16 .

3.2.7

Assessing the quality of individual RCTs

The GRADE guidelines for systematic reviews were used to evaluate the quality of
individual RCTs related to five outcomes: hand function/functional ability, grip strength
and pain/hand pain levels

17–22.

GRADE approach includes the rating of the quality of

evidence such as study limitations, risk of bias, publication bias, imprecision and
indirectness

17–21. The

rating of the quality of individual RCTs per outcome across trials

was carried out to summarize the extent of our confidence that the estimates of the effect
were correct. This GRADE approach resulted in an assessment of the quality of each RCT
for each outcome across trials as high, moderate, low, or very low

17–21 . The

domains of

GRADE approach that may decrease the quality of evidence are: 1) imprecision, 2)
indirectness, 3) limitations in study design, 4) inconsistency and 5) reporting bias. An
optimal information size (OIS) was calculated to define the minimum amount of sample
size needed for precision in the meta-analysis.

3.2.8

Summary Measures

To interpret our data a standard deviation of 0.5 points for pain and function was used to
indicate clinical importance23 . We analyzed outcomes at short-term (3 – 4 months), midterm (6 – 8 months) and long-term (12 months) follow-ups.

3.2.9

Subgroup Analysis and Exploring Heterogeneity

In the presence of clinical or statistical heterogeneity (i.e., Chi2 with p<.05 and I 2 >50%)15,
we planned to perform the following subgroup analyses (a priori): trials at low risk of bias
(low risk of bias in allocation concealment and blinding of outcome assessor if objective
outcomes were used) and type/duration joint protection program received.
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3.2.10

Synthesis of Results

We performed six meta-analyses of trials comparing joint protection programs vs. usual
care/control in patients with rheumatoid arthritis using the outcomes function, pain, and
grip strength at short-, mid- and long-term follow-ups. When necessary, data direction was
adjusted appropriately to reflect improvements in pain reduction and functional ability. We
used the Review Manager 5.3 (RevMan 5.3) software to conduct our review and a randomeffects model to pool outcomes. For outcomes of the same construct that were measured
using a different metric, we used the standardized mean difference (SMD). If all eligible
trials measured an outcome using the same metric, we used a weighted mean difference
(WMD).

3.3
3.3.1

Results
Characteristics of Included studies

Initially, 8,837 articles were identified (Pubmed: 4,161 EMBASE: 1,403 Google Scholar:
3,016 CINAHL: 104 PEDro: 49). After removal of duplicates, 6,027 articles were then
excluded (4,420 non-hand wrist population, 1,376 not talking about joint protection). Of
the 29 studies were deemed relevant from the abstract, 17 met our inclusion criteria and
were included in the analysis (Figure 1). Joint protection programs were examined in 3
RCT’s for hand OA and in 14 RCT’S for patients with RA. The characteristics of the
included RCT’s are summarized in Table 1.

3.3.2

Excluded Studies

Of the 29 studies that were deemed relevant for a full-text review, 12 articles were excluded
for the following reasons:
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1. Ineligible study design – Non-randomized studies (n=1, Boustedt et al. 2009 24 )
2. Used same data/participants with included RCT (n=1, Oppong et al. 2015 25 )
3. Ineligible population – RCT (n=1, Maggs et al. 199626 )
4. Ineligible intervention – RCT (n=7, Grønning et al. 201427 , Grønning et al. 201228 , Lorig
et al. 200929 , Barlow et al. 200830 , Brus et al. 199831 , Riemsma et al. 199732 , Fries et al.
199733 )
5. Both groups examined the same JP intervention with a different approach – RCT (n=2,
Niedermann et al. 201234 , Niedermann et al. 201135 )

3.3.3

Risk of bias and Quality assessment

Overall, all the 17 studies were judged to be high risk of bias (Table 2); (Figure 2).
Selection bias, performance bias, and reporting bias were the main contributors that
influence our results (Figure 2). Funding sources were reported in the majority of the
included RCTs. Quality assessment was ranging from very low to low, and most of the
studies were downgraded for imprecision and high risk of bias. The summary of the
findings is presented in Table 3.

3.3.4

Selection Bias

Randomization and allocation concealment were not reported appropriately in many of the
studies and was the main reason that studies were rated as high risk. More specifically,
randomization sequence generation and allocation concealment were rated as high risk in
8 studies while nine studies were rated low risk of bias (Table 2).
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3.3.5

Performance Bias

Blinding of participants and personnel was rated as high risk in 12 studies because the
blinding procedure was not performed adequately. Only five studies were rated as low risk,
and they managed to blind the participants and providers effectively (Table 2).

3.3.6

Detection Bias

The majority of the studies (10 RCTs) were rated as low risk, and they managed to blind
the outcome assessor effectively. Seven studies rated as high risk because the blinding of
the outcome assessor could not be achieved (Table 2).

3.3.7

Attrition Bias

Sixteen studies were rated as low risk of bias for attrition bias, and only one was rated as
high risk. The RCT that was rated at high risk did not report any dropouts and did not report
if all the participants were analyzed after randomization (Table 2).

3.3.8

Reporting and Other Bias

Most of the studies (16 RCTs) reported the timing of outcome assessment. Description of
co-interventions was unclear in 16 studies because of poor reporting and only 2 RCTs 36,37
performed trial registration and published their protocol. Seven studies 38–44 did not report
their sources of funding and only 2 studies37,45 report adverse effects (Table 2).
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3.3.9

Publication Bias

We assessed publication bias for the meta-analysis of pain and function outcomes (Figure
3-4). The asymmetrical funnel plot (Figure 4) demonstrates that the smaller RCTs produced
exaggerated treatment effects.

3.3.10

Participants

Data from a total of 1,847 participants with hand arthritis were included in this systematic
review. The majority of them (n=1,504) have been clinically diagnosed with RA and only
343 participants with hand OA. The average age of the participants with hand OA was 61
years old, and 70% or more were females. The average age of the participants with RA was
62.8 years old, and more than 70% of the sample was females.

3.3.11

Interventions

Studies that included in this systematic review compared joint protection programs that
had an exercise component, or the participants received instruction on exercise, joint
protection education and either was administered individually or to a group and was mostly
delivered by an occupational therapist. Comparisons consisted of no treatment, advice,
usual care, patient education. Treatment dose and frequency were varied a lot across the
studies but typically was on average 3-5 times per week from 45 minutes to 1.5 hours. A
summary of the interventions and the comparators is presented in Table 1.

3.3.12

Outcomes

Outcomes of interest that were extracted from the included studies were: pain levels 36,42,54–
56,46–53

and was examined with the following outcome measures: (1) Michigan Hand
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Outcome Questionnaire pain subscale (MHQ) (0-100) with lower scores indicating better
pain scores, (2) Numerical Rating Scale (0-10) higher score is worse and (3) Visual Analog
Scale (VAS) (0-100mm) higher score is worse. Self-report hand function42,43,54,56–58,44–
48,50,52,53

was assessed with the following outcome measures: (1) Michigan Hand

Questionnaire (MHQ) (0-100) higher scores indicating better performance, (2)
Australian/Canadian (AUSCAN) Osteoarthritis Hand Index (0-36), (3) Health Assessment
Questionnaire (HAQ) (range from 0-3) higher is worse and (4) Arthritis Impact
Measurement Scales II (AIMS II; upper limb, and hand and finger function subscales)
Subscales range score of 5–25 (25 indicating severe functional difficulties).

Grip

strength45,46,49–53,56 levels were assessed with a Jamar hand-held dynamometer and with a
Smith and Nephew Rolyan Digital Dynamometer.

3.3.13

Effects of interventions on RA

Short-term effects of interventions on pain levels
Three studies were pooled to examine the short-term effect of a joint protection program
vs. usual care on pain levels. We found similar effects between joint protection programs
and usual care/control (very low quality, 3 RCTs, 548 participants with RA, standardized
mean difference (SMD) -0.00, 95% CI: -0.42 to 0.42, I 2 =49%). The analysis is illustrated
in Figure 5.
Mid-term effects of interventions on pain levels
Three studies were pooled to investigate the mid -term effects of a join protection programs
vs. usual care/ control on pain levels. We determined that joint protection was favored over
control (very low quality, 3 RCTs, 358 participants with RA, SMD: -0.32, 95% CI: -0.53
to -0.11, I 2 =0). The analysis is summarized in Figure 5.
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Long-term effects of interventions on pain levels
Four studies were pooled to examine the long-term effects of joint protection programs vs.
usual care/control on pain levels. We determined that joint protection was superior when
compared with control (low quality, 4 RCTs, 857 participants with RA, SMD -0.27, 95%
CI: -0.41 to -0.12, I 2 =9%. The analysis is presented in Figure 5.
Short-term effects of interventions on function levels
Only one study reported values of the function that we could calculate the SMD. We found
that the JP intervention was superior when compared to usual care (very low quality, 1
RCT, 451 Participants with RA, SMD 0.18, 95% CI: -0.01 to 0.36).
Mid-term effects of interventions on function levels
Three studies were pooled to investigate the mid -term effects of joint protection vs. control
on function levels. We determined that intervention groups were superior over control
(very low quality, 3 RCTs, 358 participants with RA, SMD -0.49, 95% CI: -0.75 to -0.22,
I 2 =34%. The forest plot is illustrated in Figure 6.
Long-term effects of interventions on function levels
Six studies were pooled to investigate the long-term effects of joint protection vs. control
on function levels. We determined that intervention groups were superior over control
(very low quality, 6 RCTs, 1,077 participants with RA, SMD -0.34, 95% CI: -0.50 to -0.11,
I 2 =56%. The forest plot is illustrated in Figure 6.
Short-term effects of interventions on grip strength levels
One study reported the short-term effects of joint protection vs. control/usual care on grip
strength levels. We determined that joint protection programs were inferior when compared
to usual care/control (very low quality, 1 RCTs, 400 participants with RA, MD 1.38, 95%
CI: -0.29 to 3.05). The analysis is presented in Figure 7.
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Mid-term effects of interventions on grip strength levels
One study investigated the mid-term effects of joint protection programs vs. usual
care/control on grip strength levels. We found that join protection programs were superior
over usual care/control (very low quality, 1 RCTs, 121 participants with RA, MD -1.39,
95% CI: -5.02 to 2.24). Analysis and the strength of evidence are presented in Figure 7.
Long-term effects of interventions on grip strength levels
Two studies were pooled to examine the long-term effects of join protection programs vs.
usual care/control on grip strength levels. We determined that joint protection programs
were inferior when compared to control (very low quality, 2 RCTs, 478 participants with
RA, MD 0.93, 95% CI: -0.74 to 2.61, I 2 =0). Analysis and the strength of evidence are
presented in Figure 8.

3.3.14

Effects of interventions on hand OA

From the three studies that included participants with hand OA only 1 RCT46 reported clear
means and SD. For short-term effects on pain levels, we found similar effects when joint
protection compared to no joint protection (high risk of bias, relatively small sample size;
257 participants with hand OA, MD -0.10, 95% CI: -0.60 to 0.40) for function levels, we
found that joint protection was no better than no joint protection (high risk of bias,
relatively small sample size; MD -0.20, 95% CI: -1.59 to 1.99). For midterm effects on
pain and function levels, we found similar effects when joint protection compared to no
joint protection (high risk of bias, relatively small sample size; MD -0.30, 95% CI: -0.23
to 0.83), (high risk of bias, relatively small sample size; MD 0.50, 95% CI: -1.38 to 2.38)
respectively. For midterm effects on grip strength levels, we determined that joint
protection was superior when compared to no joint protection (high risk of bias, relatively
small sample size; MD -2.20, 95% CI: -7.53 to 3.13). For long-term effects on pain and
function levels, there was no difference between joint protection and no join protection
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intervention (high risk of bias, relatively small sample size; MD 0.10, 95% CI: -0.45 to
0.65), (high risk of bias, relatively small sample size; MD 1.20, 95% CI: -0.68 to 3.08)
respectively.

3.3.15

Unknown Treatment Effects on Extracted Outcomes

There were five studies for participants with RA and two studies for people with hand OA
that were unable to calculate SMDs or effect sizes due to lack of reporting and are
summarized below.

Hand RA
O'Brien et al. 200657 (n=67) investigated the effectiveness of 3 different joint protection
groups on function and pain at 1, 3 and 6 months follow-up (high risk of bias, relatively
small sample size; low quality). Hammond et al. 2004 49 (n=127) examined the
effectiveness of educational-behavioral joint protection programme vs. a standard
programme on pain, functional ability and grip strength at 24 months follow-up (high risk
of bias, relatively small sample size; low quality). Hammond et al. 2002 50 (n=30) examined
the effectiveness of joint protection first vs. joint protection second on pain functional
ability and grip strength at 3 and 6 months follow-up (high risk of bias, relatively small
sample size; very low quality). Helliwell et al. 1999 40 (n=77) examined the effectiveness
of a joint protection programme vs. control on functional ability at 1 and 12 months followup (high risk of bias, relatively small sample size; very low quality). Lindroth et al. 199754
(n=100) examined the effectiveness of a joint protection programme vs. control at 3 and
12 months follow-up (high risk of bias, relatively small sample size; very low quality).

50

Hand OA
Dilek et al. 201356 (n=46) examined the effectiveness of paraffin bath therapy and joint
protection vs. joint protection on pain, self-report function and grip strength levels in
patients with hand OA at 3 weeks and 3 months follow-up (high risk of bias, relatively
small sample size; very low quality). Stamm et al. 200259 (n=40) assessed the effectiveness
of a joint protection program plus hand exercises vs. a control group (information only),
on grip strength levels, pain and functional ability, in patient with osteoarthritis, at 3 months
follow up (high risk of bias, relatively small sample size; very low quality)
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We were

unable to calculate effect sizes or report between-group (mean/median difference)
improvements for pain and functional levels due to lack of reporting in group means,
standard deviations, standard errors of means, confidence intervals or p-values. Only grip
strength values were reported, and we found similar effects between joint protection
intervention and control with an MD -0.01, 95% CI: 0.12-0.10 (Units: bar) between the
joint protection and control at 3 months follow-up.

3.4

Discussion

We aimed to summarise the current evidence of the effects of joint protection programs vs.
usual care/control in patients with rheumatoid arthritis and hand osteoarthritis on clinical
outcomes of pain, functional ability, and grip strength. Based on the results of this study,
we found no clinically important differences in function, grip strength or pain levels at
short-, mid- and long-term follow-ups. Our study provides more definitive estimates of
joint protection treatment effects for people with rheumatoid arthritis based on our metaanalysis. Imprecision and high risk of bias were the main reasons that the quality of
evidence was downgraded.
Nine different studies reported comparable outcomes and had multimodal JP interventions
that enabled the statistical pooling. For pain levels at short-term, we found similar effects
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between treatment groups and usual care/control. The wide confidence intervals that
crossed the vertical line imply that the studies’ results d id not find a statistically significant
between the tested groups and also, that the sample size was low. While JP as multimodal
intervention reduced pain for people with RA at mid and long-term follow-up, the
magnitude of the pooled estimates was smaller than the predefined clinically important
difference (SMD>0.5). At long-term follow-up, the number of pooled participants (n=857)
exceeded the estimated optimal information size (OIS) (n=685) which it indicates that we
had adequate sample size to be precise in our pain level estimates. The effect sizes of the
pooled estimates regarding function levels were improved from short-term to mid-term
(SMD -0.49, 95% CI: -0.75 to -0.22) and at long-term follow-up slightly declined (SMD 0.34 95% CI: -0.50 to -0.11). While these estimates are lower than the predefined clinically
important difference, it is evident that the hand function at mid -term was improved (SMD
-0.49) very close to the clinically important margin. The upper bound of the 95% CI
indicates an SMD of -0.70 however, due to imprecision issues (n=358<OIS) we cannot be
confident for the treatment effect if it can be clinically worthwhile or not. Regarding grip
strength, our short and long-term effect estimates indicated that joint protection programs
were inferior to usual care/control. At mid-term JP programs were superior to usual
care/control in terms of grip strength levels. However, the tested power was very low
because of the wide confidence intervals and also, that the studies’ results did not observe
a statistically significant difference. Generally, the measurement of grip strength as a
performance-based test provide very useful information in clinical practice because it’s an
indication of hand function. Previous studies have indicated a negative correlation between
grip strength and disease activity for people with RA and showed that the grip strength
becomes worse when the disease is more active 61,62 . While joint protection principles
indicate to maintain your muscle strength and range of movement, it is unclear if the
instructed exercises are optimal to improve hand grip strength. Given the disease activity
and the lack of clarity of joint protection programs, the results of grip strength are even
more ambiguous. For patients with hand OA, only one study reported means and SDs for
pain, function and grip strength and compared a joint protection program vs. no joint
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protection. However, this study was rated as high risk of bias with a relatively small sample,
and therefore, we have very little confidence about the treatment effects.
Previous recent systematic reviews (SR) reported strong evidence that joint protection may
improve function 7 and pain 7,13 . Our findings are not in concordance with those 2 SR, and
this can be attributed to the following main reasons. First, we included more studies (14
RCT’s and 3 RCT’s) in our analysis for people with RA and hand OA respectively. We
reported treatment effects of MD, SMD and 95% confidence intervals to indicate the
magnitude of the effects. Second, we took a more conservative approach while
synthesizing the evidence by using the Cochrane risk of bias tool and using GRADE
approach to rate the quality of the evidence.
Publication bias was assessed with two different funnel plots (Figure 3-4). While an
asymmetry was detected in both figures, we deem that they do not indicate publication
bias. In our meta-analysis, we pooled less than ten studies to examine the effects of
interventions. However, the tested power was low, and it was very difficult to distinguish
from the real asymmetry16 . A statistical heterogeneity was detected at long-term function
levels (p=0.05, I 2 =56%). For that reason, we downgraded the quality of the evidence by 1
level for long-term function levels. A potential explanation for the causes of statistical
heterogeneity it may be due to variations in the treatment effects of a particular study from
the pooled studies. This study43 favors control over the experimental group when
examining the function levels at long-term follow-up which was not consistent with the
other studies. The contributing percentage in the I 2 value when this trial added in the
analysis was an additional 36% which it may be attributed to a false variation from the real
treatment effect.
Strengths of this SR are that we used the most conservative approach to assess risk of bias
with Cochrane risk of bias tool. We interpreted our results by summarizing the results by
providing GRADE rating. We calculated effect sizes and we presented confidence intervals
to indicate the magnitude of the effects and whether the effects were meaningful or not.
We estimated the optimal information size (OIS) to demonstrate whether our results had
precision or not.
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3.4.1

Future Implications

While this is beyond the scope of this systematic review, the current state of the literature
is not clear about the dosage, intensity, and frequency of joint protection programs and
when other aspects are incorporated (e.g., assistive devices, orthotic devices, exercises)
when this therapeutic approach is delivered to people with hand arthritis. We were unable
to extract instructions on joint protection in a specific and measurable way because of lack
of reporting. Future research should aim to be more specific for all the components of joint
protection programs for better head to head comparisons.

3.4.2

Limitations

Our study has some limitations that need to be addressed. While a thorough literature
review was conducted, trials that were under development may have been missed. Also,
we were unable to calculate the effect sizes from some of the included studies, and
therefore, we are uncertain of their effect. We extracted outcome measures for pain, hand
function, grip/pinch strength and we did not analyze further outcomes for the effectiveness
of joint protection.

3.5

Conclusions

This systematic review provides the most updated evidence on the effectiveness of joint
protection programs vs. usual care/control in patients with rheumatoid arthritis and hand
osteoarthritis on clinical outcomes. Evidence of very-low to low quality indicates that the
effects of joint protection programs compared to usual care/control on pain and hand
function are too small to be clinically important at short-, intermediate- and long-term
follow-ups for people with hand arthritis.
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Table 3-1. Summary of the included studies
Population

Groups

Outcomes

Follow ups

Experimental group

Comparison group

-assessment and advice session plus five 30- to
45-minute exercise sessions spread over 12
weeks l content of usual care arm treatment.
-an exercise programme aiming to improve
strength, mobility and dexterity (including four
strength
-exercises for the hand and seven mobility
exercises of all the upper limb joints)
-a home exercise plan with exercises performed
daily
-a standardised protocol for progression or
regression
-strategies to improve programme adherence
including exercise diaries
-no resting orthotic devices, no manual therapy
or electrotherapy, assessment and treatment
documented using a standardised log.
For the remaining 75% of participants, in
addition to receiving the leaflet, they received
one of three interventions: joint protection,
hand exercises, or a combination of the two.
The interventions were all delivered over four
group sessions (held once a week) by nine
occupational therapists (OTs) in two hospital
centres. OTs were rotated every 3 months to
minimise the potential for bias. The rotation
order was determined by the OTs availability to
deliver the specific intervention.
Groups included up to six participants and
lasted for a maximum of one hour (1.5 h for the
combined intervention). Treatment session
duration and participant attendances were
recorded by the OTs on case report forms
(CRFs). Attendance adherence was audited by
the study coordinator (SH), and was defined (a
priori) to be per protocol if participants
attended: session 1, 2, 3 and 4; sessions 1, 2 and
4; sessions 1, 3 and 4; or sessions 1 and 4. Any
participant unable to attend week 1 was booked
on to the following course.
Experimental group treated with dip-wrap
paraffin bath therapy and Joint protection. The
temperature of the paraffin bath was 50C.
Patients dipped both hands into the paraffin,
removed them, and waited for the layer of
paraffin to harden and become opaque. Then
they redipped both hands. These steps were
repeated 10 times. When the last layer
hardened, their hands were wrapped within a
plastic bag and covered with a towel. They then
waited for 15 minutes until the paraffin cooled.
A physiotherapist in the Department of Physical
Medicine and Rehabilitation in the university
hospital conducted these treatments 5 days per
week for a period of 3 weeks.

-individual appointment(s) with a therapist
(number of sessions dependent on clinical
need up to a maximum of three sessions or
1.5 hours in total)
-JP advice
-provision of Arthritis Research Campaign
(ARC) booklets containing further advice and
-exercise information
-functional splinting as deemed necessary by
the therapist
-assistive devices as required
-no resting orthotic devices provided, no
explicit exercise prescription, no manual
therapy (i.e. joint mobilisations) or
electrotherapy assessment and treatment
documented using a standardised log

Study
Williams 2015

n = 490 (374
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
61.3 (SD 12), con.
63.5 (SD 11)

Hand
exercise
plus usual
care
vs.
usual care

-overall hand
function subscale
of the Michigan
Hand Outcome
Questionnaire
(MHQ), (0 – 100)
higher indicating
better performance
-Pain sub-scale of
MHQ (0–100; high
score is worse)
-grip strength
(Newton)

4 and 12
months

Dziedzic
2013

n = 257 (female
66%)
Hand
Osteoarthritis
Age (yr.) = leaflet
& advice 67.2 (SD
9.5), Joint
protection (JP)
65.5 (SD 8.6),
Hand exercises
(Hex) 64.5 (SD 9),
JP and Hex 66 (SD
9.3)

(1) joint
protection
vs no joint
protection
(2) hand
exercises vs
joint
protection
and hand
exercises
combined;

-average pain
severity over the
past 3 days (0–10
numerical rating
scale)
-AUSCAN
function (0-36)
-Grip strength (kg)

3, 6 and 12
months

Dilek 2013

N=46 (40 females)
Hand
Osteoarthritis
Age (yr.) = exp.
58.87 (SD 9.47),
con. 59.95 (SD
8.71)

Paraffin
bath therapy
plus Joint
Protection
vs
Joint
Protection

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-AUSCAN
function
- Grip strength
(Jamar) (kg)

3 weeks and
3 months
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All participants were given standardised
written information on self-management
approaches for hand osteoarthritis (OA)
including general information on looking
after hand joints and using analgesia
(reproduced with permission from the
Arthritis Research UK leaflets ‘Looking after
your joints when you have arthritis’ and
‘Osteoarthritis’,
respectively
(http://www.arthritisresearchuk.org/),
and
the National Institute of Health and Care
Excellence (NICE) good practice guidelines.
Participants were advised to continue with
any self-management approaches they were
currently using and were given advice to
consult their general practitioner if symptoms
continued to be troublesome. For 25% of
participants this was the sole intervention.

Control group received joint protection
techniques

Hammond
2008

n = 218 (108
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
55.56 (SD 13.10),
con. 55.29 (SD
11.84)

Standard
programme
vs
modular
cognitive–
behavioural
approach
programme
(the LMAP)

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-HAQ assessing
functional ability
(0–3 scale)

6 and 12
months

Quintrec 2007

n = 208 (177
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
55.32 (SD 11.80),
con. 54.31 (SD
14.37)

Educational
intervention
program
vs.
Usual care

Functional status,
Health Assessment
Questionnaire
(HAQ) (0-3), 0 (no
functional
limitation) to 3
(serious functional
limitation

12 months

Masiero 2007

n = 85 (57
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
54.2 (SD 9.8), con.
52.2 (SD 11.9)

Drug
treatment
(with
infliximab)
with
educational
behavioral
JP training
vs
Drug
treatment
(with
infliximab)
only

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-Functional status
was evaluated
using the Health
Assessment
Questionnaire
(HAQ), which is
an ordinal score
measure (range 0–
3)

8 months

O'Brien 2006

n = 67 (46
females)
Rheumatoid
Arthritis
Age (yr.) = group1
62.3 (SD 9.95),
group 2 57.3 (SD

-Arthritis Impact
Measurement
Scales II (AIMS II;
upper limb, and
hand and finger
function subscales)
Subscales range

1, 3 and 6
months

Joint
protection
leaflet with
hand
strengthenin
g and

The LMAP included two modules, each with
four 2.5h meetings, and one 2-h review
meeting. To standardize programme delivery, a
two-day training course for each module (led by
A.H.) was completed by therapists. This
explained:
evidence
for
programme
interventions;
patient
education
and
behavioural change methods; tips for good
teaching practice (e.g. voice modulation, eye
contact, open questions, reflecting back,
positive feedback); programme structure; and
role play of sessions emphasizing group
processes, teaching techniques and skills
teaching. A.H. delivered a programme observed
by the therapists. The therapists were then
observed delivering a programme and given
feedback on performance. Module manuals
enabled adherence to programme content.
Participants could attend the two LMAP
modules and review meeting over a 3- to 9month period, as convenient to them. Six people
could attend module 1 (‘Looking After Your
Joints’), 7–10 module 2 (‘Keeping Mobile and
Managing Pain and Mood’) and up to 12 the
review meeting. Each meeting included selfmonitoring, skills training with individualized
feedback and advice, goal-setting and action
planning to follow individually determined
home activity and exercise programmes
working towards recommended frequency
targets.
An intensive education program was proposed
to deliver a large quantity of information about
the disease and the treatment, but also to point
the possibilities to reduce pain and stress at
home, to understand how to use nonchemical
treatment (e.g., physical activities or sports,
social and professional behaviors, nutritional
advice). The interactive multidisciplinary
education program consisted of passive
information on the disease, on medical
treatment, and on lifestyle advice concerning
diet, but also included information on active
coping strategies, joint protection, relaxation,
and physical exercise, with the teaching of an
exercise program to be followed at home.
Sessions were conducted on Thursdays for 6
hours for 8 consecutive weeks.
The Experimental Group continued with their
usual drug treatment (with infliximab) in the
follow-up months, but additional educational–
behavioral JP training was provided. This
training consisted of four meetings based on
approximately 3-h sessions, every 3 weeks, for
groups of 4–6 patients at a time, with one or
more family member (the patients were
encouraged to bring a partner). The education
methods used were group discussion, problem
solving, guided practice, and lectures designed
to facilitate understanding of the program. At
the beginning of each session, feedback was
provided, and the results of and problems with
home practice were discussed. At the end of
each meeting, patients received an illustrated
brochure on the program meeting with a home
guide.
Group 1 received JP and additional instruction
on how to perform a total of eight simple
strengthening and mobilizing (stretching)
‘tendon gliding’ exercises. These encouraged a
maximum range of movement of all small joints
of the fingers, thumb and wrist, as well as radial
finger walking (fingers moving towards the
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Standard programme consisted of five 2-h
meetings including talks each week from a
different member of the team and group
discussion. Meeting 1 included: what is
arthritis, how it affects joints and other parts
of the body, drug treatments and tests,
managing arthritis (rheumatology nurse and
consultant rheumatologist); Meeting 2:
exercise (including stretch programme with
30 min demonstration and practice), rest,
posture and pain management [using heat and
cold, transcutaneous electrical stimulation
(TENS), massage] [physiotherapist (PT)];
Meetings 3 and 4: joint protection (including
45 min demonstration and practice),
managing fatigue, aims of splinting,
managing stress and relaxation (45min
practice), foot care [occupational therapist
(OT)];
Meeting
5:
healthy
diet,
complementary therapies, Social Security
benefits and open discussion (nurse, OT, PT,
social worker). Usually the same OT attended
each week to facilitate discussion and
programme management. Relevant Arthritis
Research Campaign and Arthritis Care
booklets were provided. Eight to 12 people
were invited to attend each programme.

Usual care

The Control Group patients received only
anti-TNFα drugs (infliximab) and continued
with their usual drug monitoring and medical
management regimen in the follow-up
months, but no physiotherapy, occupational
therapy, or other additional treatments were
performed or permitted

Joint protection leaflet which covered the
basic principles of joint protection, energy
conservation, ‘top tips’ relating to personal
and household activities, postural advice,
types of splinting and issues related to
sexuality

8.24), group 3 59.5
(SD 12.92)

Hammond
2004

Hammond
2002

n = 127 (46
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
51, con. 52

n = 30 (27
females)
Rheumatoid
Arthritis
Age (yr.) = 52.3
(SD 12.08

mobilizing
exercises
vs Joint
protection
leaflet with
hand
mobilizing
exercises
vs Joint
protection
leaflet

score of 5–25 (25
indicating severe
functional
difficulties). This
score was then
normalized so that
the potential range
of scores was 0–10
where higher
scores indicate
more problems
-Grip Strength
(Jamar) lbs

Standard
programme

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-TheAIMS2
(Arthritis Impact
Measurement
Scales2) was used
to assess activities
of daily living
(ADL) (0-10, 0
indicates good
function)
-Grip Strength (kg)

vs

Educational
-behavioural
joint
protection
programme

Group 1 –
Education
First
vs
Group 2 –
Education
Second

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-Health
Assessment
Questionnaire
(HAQ) (0-3),
higher scores
indicating poorer
functional ability.
-Grip Strength
(Jamar)

radius only thus avoiding exacerbating ulnar
deviation), pinch grip exercises, strengthening
the intrinsic, and thenar eminence muscles
(using a towel) and wrist extensor muscle
groups with a ‘Theratubes’ resistive band
(Promedics, UK). Group 2 participants received
the joint protection leaflet together with a set of
eight stretching exercises, without any specific
strengthening exercises. Exercises included
wrist flexion, extension and circumduction,
pronation and supination, radial deviation as
well as global flexion and abduction of all
finger
joints, thumb opposition
and
interphalangeal flexion to the end of the
possible range.

24 months

The educational behavioural JP consisted of
four 2-hour weekly meetings. The Educationalbehavioural joint protection programme applied
educational, behavioural, motor learning and
self-efficacy enhancing strategies to increas e
adherence.

The education consisted of four 2-hour
weekly meetings. The standard programme
included talks from the rheumatology teams
on: RA, drug treatments, diet, exercise, pain
management, relaxation and joint protection.

3 and 6
months

The ‘Looking After Your Joints’ programme
included: information about RA and disease
management, joint protection and energy
conservation education. About 5 hours of joint
protection practice was included, using motor
learning, mental rehearsal, problem-solving and
behavioural methods, with the setting of weekly
goals to practise joint protection methods at
home. It also included self-efficacy and
adherence-enhancing
strategies. Structured
teaching methods were used to enhance recall,
such as explicit categorisation, repetition,
checking understanding by asking regular
questions and structured visual aids. An
information pack and a workbook were
provided, containing summaries of the four
sessions and a home programme, as well as
other information about the disease, its
management (including drug therapy), exercise,
rest, energy conservation and splinting; these
were also briefly discussed in the programme.

Same as experimental
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Stamm 2002

Hammond
2001

N=40 (40 females)
Hand
Osteoarthritis
Age (yr.) = exp.
58.87 (SD 9.47),
con. 59.95 (SD
8.71)

n = 127 (46
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
51.56 (SD 9.73),
con. 49.49 (SD
11.49)

3 months
Joint
protection
and home
hand
exercises
(JPE group)
vs
information
session
about hand
OA

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-Health Assessment
Questionnaire
(HAQ)
-Grip Strength
(Martin
vigorimeter)

Standard
programme

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-Function The
AIMS2 (Arthritis
Impact
Measurement
Scales) 0 to 10,
with 0 representing
good function
-Grip Strength
(Jamar)

vs

Educational
-behavioural
joint
protection
programme

6 and 12
months

The JPE group received oral and written
instruction for joint protection and a home hand
exercise program, which was to be performed
daily throughout a study period of 3 months.
The following principles were explained during
the joint protection instruction: the need for
balance between movement and resting a joint;
dividing stress between as many joints as
possible; using larger and stronger joints; using
each joint in its most stable plane to reduce
pressure on the joint; avoiding staying in one
position; and avoiding vibrations for the finger
joints. In addition, patients were trained to
protect their joints, using assistive devices if
necessary to perform Activities of Daily Living
(ADL). Patients were trained to do the
following activities in a protective way:
wringing a cloth; using enlarged grips for
writing; opening jars, cans, or boxes with
Dycem; using a book holder for reading; and
using a rocker or angled knife for cutting food.
Patients were encouraged to find exam- ples for
application of these principles in their own daily
activities, which were discussed. Oral and
written information was provided. The joint
protection instruction and ADL training took 30
minutes for each patient. The exercise program
consisted of 7 exercises: making a fist, making
a small fist (flexing the PIP and DIP joints
only), flexing the MCP joints while keeping the
PIP and DIP joints stretched, touching the tip of
each finger with the tip of the thumb while
keeping each finger flexed, spreading the
fingers as far as possible with the hand lying flat
on a table, pushing each finger in the direction
of the thumb with the hand lying flat on a table,
and touching the MCP V joint with the tip of the
thumb.
The joint protection programme was based on
the health belief model and the theories of social
learning and self-management and was conducted by an experienced rheumatology
occupational therapist. Between three and six
participants usually attended and, with partners
included, numbers were between four and eight.
Participants were provided with an information
pack and workbook detailing the principles of
joint protection, with photographs of a range of
joint protection methods. The programme
applied educational, behavioural, motor
learning and self-efficacy enhancing strategies
to increase adherence to the joint protection
programme, as well as a range of educational
methods to match different group members’
learning styles. Two-thirds of the programme
was spent practising hand-joint protection
methods in small groups with feedback on
performance from each other and the group
leader. People were shown a range of options
for task performance, so that they could select
which methods worked best for them.
Education programmes was of 8 h duration over
four afternoon or evening sessions of 2 h each
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The control group was given oral and written
information about hand OA to ensure that
these persons also received proper attention.
The information about hand OA included
information on joint anatomy and
pathogenesis of OA. During this session,
each control person also received a piece of
Dycem (nonslip matting), which they were
told to use for opening jars throughout the
period of 3 months. Duration of this session
was 20 minutes.

The standard programme included short talks
from nursing, medical, occupational therapy
and physiotherapy staff on the following:
RA; drug treatments; alternative therapies,
diet; exercise, rest and positioning; energy
conservation; joint protection; assistive
devices; splinting; pain and relaxation; and
other methods of controlling pain (e.g. heat
and ice). Some demonstration and practise of
exercise, joint protection and relaxation was
included (15–45 min for each). Meetings
allowed time for discussion and information
leaflets
were
provided.
Education
programmes was of 8 h duration over four
afternoon or evening sessions of 2 h each

Helliwell 1999

Scholten 1999

Hammond
1999

n = 77 (51
females)
Rheumatoid
Arthritis
Age (yr.) = exp.
55, con. 56.5

n = 68 (53
females)
Rheumatoid
Arthritis
Age (yr.) = 48.3
(SD 5.6)

n = 35 (29
females)
Rheumatoid
Arthritis
Age (yr.) = 55.17
(SD 9.39)

Educational
programme
vs
Control

-Health
Assessment
Questionnaire
(HAQ) (0-3)

Arthritis
Training
program
vs
Control

Health Assessment
Questionnaire
(HAQ) (0-5), 0
represents good
function

1 and 12
months

12 months

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-Health
Assessment
Questionnaire
(HAQ) (0-3)
-Grip Strength
(Smith and
Nephew Rolyan
Digital
Dynamometer)

3 and 6
months

The education classes took place over 4 weeks
in four afternoon sessions lasting 2 h. Subjects
were encouraged to bring a partner, although
this happened infrequently. For people who
were still working or who preferred to come
with a partner, evening sessions were arranged.
The format of the sessions was a talk from a
non- medical health professional using
overhead projection, a discussion period and the
distribution of supporting literature. The
content of the sessions included the
pathophysiology of rheumatoid arthritis, drug
treatments, local treatments, mechanisms and
control of pain, stress, exercise and rest, joint
protection, task allocation, splinting and
assistive equipment.
The following
fields
were
covered:
pathogenesis and mechanisms of RA, benefits
and limitations of drug therapy, the impact of
physiotherapy, practical exercise in remedial
gymnastics aimed at relieving pain and muscle
tension, use of joint protection devices,
orthopedic perspectives including methods and
indications of joint replacement, psychological
counseling including coping strategies,
Jacobson stress management and relaxation
exercise, 20 dietetics, information about
unproven cures, and social assistance to
improve the patients’ utilization of public social
resources.
Psychological
counseling
emphasized a general sense of control or
efficacy, and skill in coping with variability of
the disease and its sequelae. Training in the
proper execution of remedial gymnastics was
offered and advice on joint protection was
included in the program. The aim of the exercis e
practice sessions was to keep the patients
mobile by feasible therapeutic exercises
preserving the axis of the joints destroyed by
RA and by reinforcing the weakened muscles.
Within a daily l0-minute training program
nearly every joint had to be moved in the right
position and direction. The patients were taught
performance of everyday activities and how to
use auxiliary devices like special scissors or
knives. The importance of wearing orthotic
devices at night or during manual activities was
emphasized.
The JP group education programme consisted
of four weekly 2-h sessions, plus an optional
home visit within 2 weeks of the end of the
programme. It was led by an experienced
rheumatology occupational therapist. Partners
or significant others were invited to attend.
Between four and eight people attended each
programme. A teaching manual was followed
throughout to standardise the programme
content and delivery. Patients were provided
with a workbook ‘Managing Your Arthritis:
Joint Care Workbook’, ‘Coping with
Rheumatoid Arthritis’ and patient education
leaflets produced by the Arthritis and
Rheumatism Council (ARC) such as
‘Rheumatoid Arthritis’, ‘Your Home and Your
Rheumatism’, ‘Exercise and Arthritis’, ‘Drug
Therapy’, ‘Gardening and Arthritis’, and ‘Diet
and Arthritis’. The ARC videotape ‘Help is at
Hand— getting the better of your arthritis’ is
shown at the first meeting to promote
discussion of members’ own alternate methods
and gadgets they found useful, as well as on the
impact of living with arthritis.
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Not reported/No details

Control/No additional details

Control/No further details

Lindroth 1997

Lindroth 1995

Neuberger
1993

n = 100 (84
females)
Rheumatoid
Arthritis
Age (yr.) = 55.17
(SD 9.39)

Education
programme
vs
Control

-Pain (visual
analogue scale) (0–
100; high score is
worse)

n=92 (84 females)
Rheumatoid
Arthritis
Age (yr.) = exp.
64.8 (SD 13.6),
con. 63.5 (SD
14.5)

Education
programme
vs
Control

-Pain (visual
analogue scale) (0–
100; high score is
worse)
-Health
Assessment
Questionnaire
(HAQ) (0-12)

Group1(exp
erimental) –
LARA*
(selfinstructional
program)
Group 2
(experiment
al)LARA
and range of
motion
(ROM)
exercises
and joint
protection
practices
(JPPs)
Group 3
(experiment
al) LARA,
ROM
exercises
and JPP
Group 4
(control)

-Pain analogue
scale) (0–10; high
score is worse)

n = 53 (35
females)
Rheumatoid
Arthritis
Age (yr.) = 52.56
(SD 14.32)

3 and 12
months

12 months
and 5 years

4 months

A handbook for patients presented facts about
each session. During 8 sessions, 2.5 hours once
a week, group discussions were led by a team of
health professionals. The group members were
encouraged to understand the terms of the
disease process such as inflammation,
seropositive, erosion, and anemia. In the session
on therapy a nurse led discussions about
medication, surgery, and alter- native
treatments. Diet, fasting, and basic nutrition
were discussed with a dietitian. The session led
by a physiotherapist concentrated on pain
management by rest, exercise, and relaxation.
Acupuncture
and
other
forms
of
nonpharmaceutical pain relief procedures were
discussed. Home exercise was explained by addressing the topics of why, how, when, and how
much. The occupational therapist discussed
problems related to hand function, hand
program, and technical aids used to alleviate
hand problems.
Six sessions 2/h each focused on medical
aspects,
pain
management,
available
treatments, stress management, self-awarenes s
and communication skills, exercise, joint
protection and work simplification practices

Control/No further details

The self-instructional program LARA was used
in this study. Practice time consisted of 10-20
min time periods, in which a subject gave a
return demonstration of ROM exercises to the
Investigator. Another 10-20 min time period, on
a different clinic visit, was provided for the
subject to give (3 return demonstration of tasks
using JPPs. The effectiveness of the unit on
joint protection was further tested by asking
subjects to perform four tasks: drinking from a
coffee mug, carrying a handbag, moving a pot
with a handle from one flat surface to another 2
feet away, and transferring a book from one flat
surface to another 2 feet away. One point was
assigned to each task performed satisfactorily,
with a possible sum total of four points. These
tasks were performed by the experimental
group and after reading the third unit of the
instructional program on rest, pacing, and joint
protection.

Did not read the instructional program but
received the same attention time from the
investigators.
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Control

Table 3-2. Risk of bias summary: Review authors’ judgements about each risk of
bias item for each included study

Key:

Low risk of bias,

High risk of bias
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Table 3-3 Summary of Findings - Joint Protection Programs vs Usual care/control in Patients with Rheumatoid Arthritis (short-term)
Population: patients with rheumatoid arthritis
Settings: inpatient clinics.
Intervention: joint protection programs
Comparison: usual care/control
Follow up: short-term (3 – 4 months).

SMD / MD
(95% C.I.)

No of participants
(studies)

Quality of the evidence (GRADE)

SMD -0.00
(-0.42 to 0.42)

548
(3 studies)

⊕⊝⊝⊝
very low1,2

Function:
- MHQ (0-100)
Higher scores indicating better performance.

SMD 0.18
(-0.01 to 0.36)

451
(1 study)

⊕⊝⊝⊝
very low1,2

Grip strength:
-HHD (kg)
Higher values indicate better strength

MD 1.38
(-0.29 to 3.05)

400
(1 study)

⊕⊝⊝⊝
very low1,2,3

Outcomes
Pain:
- MHQ (0-100)
Lower scores indicating better pain scores.
- NRS (0-10)
Higher score is worse
-VAS (0-100)
Higher score is worse.

Abbreviations: VAS; visual analogue scale, NRS; Numerical Rating Scale, MHQ; Michigan Hand Outcome Questionnaire, HHD;
hand held dynamometer, SMD;
standardized mean difference, MD; mean difference, CI; confidence interval.
1
We downgraded by two levels due to high risk of bias.
2
We downgraded by one level due to a relatively small sample size.
3
We downgraded by one level due to indirectness (surrogate outcomes).
4
We downgraded by one level due to publication bias.
5
We downgraded by one level due to inconsistency.
GRADE quality of evidence:
High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it’s substantially different.
Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the
effect.
Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the
estimate of effect.
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Table 3-4. Summary of Findings - Joint Protection Programs vs Usual care/control in Patients with Rheumatoid Arthritis (mid-term)
Population: patients with rheumatoid arthritis
Settings: inpatient clinics.
Intervention: joint protection programs
Comparison: usual care/control
Follow up: mid-term (5 – 8 months).

Outcomes
Pain:
- MHQ (0-100)
Lower scores indicating better pain scores.
- NRS (0-10)
Higher score is worse
-VAS (0-100)
Higher score is worse.
Function:
- HAQ (0-3)
Higher is worse.
-AIMS2 (0 to 10)
Lower scores represent better function
Grip strength:
-HHD (kg)
Higher values indicate better strength

SMD / MD
(95% C.I.)

No of participants
(studies)

Quality of the evidence (GRADE)

SMD -0.32
(-0.53 to -0.11)

358
(3 studies)

⊕⊝⊝⊝
very low1,2

SMD -0.49
(-0.75 to -0.22)

358
(3 studies)

⊕⊝⊝⊝
very low1,2

MD -1.39
(-5.02 to 2.24)

121
(1 study)

⊕⊝⊝⊝
very low1,2,3

Abbreviations: VAS; visual analogue scale, NRS; Numerical Rating Scale, MHQ; Michigan Hand Outcome Questionnaire, HHD;
hand held dynamometer, HAQ; Health
Assessment Questionnaire, SMD; standardized mean difference, MD; mean difference, CI; confidence interval.
1
We downgraded by two levels due to high risk of bias.
2
We downgraded by one level due to a relatively small sample size.
3
We downgraded by one level due to indirectness (surrogate outcomes).
4
We downgraded by one level due to publication bias.
5
We downgraded by one level due to inconsistency.
GRADE quality of evidence:
High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it’s substantially different.
Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the
effect.
Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the
estimate of effect.
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Table 3-5. Summary of Findings - Joint Protection Programs vs Usual care/control in Patients with Rheumatoid Arthritis (long-term)
Population: patients with rheumatoid arthritis
Settings: inpatient clinics.
Intervention: joint protection programs
Comparison: usual care/control
Follow up: long-term (12 – months).

Outcomes
Pain:
- MHQ (0-100)
Lower scores indicating better pain scores.
- NRS (0-10)
Higher score is worse
-VAS (0-100)
Higher score is worse.
Function:
- MHQ (0-100)
Higher scores indicating better performance.
- HAQ (0-3)
Higher is worse.
-AIMS2 (0 to 10)
Lower scores represent better function
Grip strength:
-HHD (kg)
Higher values indicate better strength

SMD / MD
(95% C.I.)

No of participants
(studies)

Quality of the evidence (GRADE)

SMD -0.27
(-0.41 to -0.12)

857
(4 studies)

⊕⊕⊝⊝
low1

SMD -0.34
(-0.48 to -0.20)

1,077
(6 studies)

⊕⊝⊝⊝
very low1,5

MD 0.93
(-0.74 to 2.61)

478
(2 studies)

⊕⊝⊝⊝
very low1,2,3,4

Abbreviations: VAS; visual analogue scale, NRS; Numerical Rating Scale, MHQ; Michigan Hand Outcome Questionnaire, AIMS2;
Arthritis Impact Measurement Scales, HHD;
hand held dynamometer, HAQ; Health Assessment Questionnaire, SMD; standardized mean difference, MD; mean difference, CI;
confidence interval.
1
We downgraded by two levels due to high risk of bias.
2
We downgraded by one level due to a relatively small sample size.
3
We downgraded by one level due to indirectness (surrogate outcomes).
4
We downgraded by one level due to publication bias.
5
We downgraded by one level due to inconsistency.
GRADE quality of evidence:
High quality: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it’s substantially different.
Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the
effect.
Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the
estimate of effect.
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Figure 3-1. Flow diagram
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Figure 3-2. Risk of Bias Graph
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Figure 3-3. Funnel plot for pain levels
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Figure 3-4. Funnel plot for function levels
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Figure 3-5. Short, mid and long-term effects of interventions on pain levels
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Figure 3-6. Mid and long-term effects of interventions on function levels
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Figure 3-7. Short and mid-term effects of interventions on grip strength levels
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Figure 3-8. Long term effects of interventions on grip strength levels
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Chapter 4
4

Joint Protection Programmes for People with Osteoarthritis
and Rheumatoid Arthritis of the Hand: An Overview of
Systematic Reviews

Abstract
Purpose: Joint protection has been introduced as a self-management strategy for people
with rheumatoid arthritis (RA) and osteoarthritis (OA) of the hand. The purpose of this
study was to conduct an overview of systematic reviews (SRs) and critically appraise the
evidence to establish the current effectiveness of joint protection for people with hand RA
and OA.
Method: A comprehensive search was conducted of six databases from January 2008 to
May 2018. SRs that evaluated the effectiveness of joint protection for people with hand
arthritis were eligible for inclusion. The A MeaSurement Tool to Assess systematic
Reviews (AMSTAR) 2 checklist was used to assess the methodological quality of each SR.
Results: Nine SRs were included: two were rated as high quality, and seven were rated as
low quality. Seven of the nine did not take into account risk of bias when interpreting or
discussing their findings, six did not assess publication bias, and five did not register their
protocol. The high-quality reviews found no clinically important benefit of joint protection
for pain, hand function, and grip strength levels. The low-quality reviews reported
improvements in function, pain, grip strength, fatigue, depression, self-efficacy, joint
protection behaviours, and disease symptoms in people with RA.
Conclusions: High-quality evidence from high-quality reviews found a lack of any
clinically important benefit of joint protection programmes for pain, hand function, and
grip strength outcomes, whereas low-quality evidence from low-quality reviews found
improvements in these outcomes.
Reproduced with permission from Bobos P, MacDermid JC, Nazari G, Lalone EA,
Ferreira L, Grewal R. Joint Protection Programmes for People with Osteoarthritis and
Rheumatoid Arthritis of the Hand: An Overview of Systematic Reviews. Physiother
Canada 2020;e20190037. Copyright © Physiotherapy Canada®
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4.1

Introduction

Clinical manifestations of rheumatoid arthritis (RA) can be unpredictable, but pain,
disability, fatigue, joint deformities, and poor quality of life are common features.1
Although medications such as biological agents and drugs are increasingly effective,1,2
arthritis currently has no cure. Conservative management aims to prevent or control joint
deformities, reduce pain and swelling, increase hand function, and improve quality of life.3
Numerous studies investigating various hand pathologies have demonstrated that hand
function is an important factor.4–8 Joint protection was first introduced in the 1960s as a
self-management strategy for people with RA, and the indications were later extended to
other arthritic conditions, such as hand osteoarthritis (OA) and soft-tissue rheumatic
disorders.9 Joint protection consists of a wide range of strategies such as education for
strengthening or stretching exercises, joint protection education for activity and pacing, use
of proper body mechanics, and assistive devices to improve pain, reduce inflammation,
lower additional risk of deformities, and enhance performance. 9,10
Systematic reviews (SRs) are a recognized approach to synthesizing research evidence on
the effectiveness of therapeutic interventions. 11 Because the number of SRs is rapidly
increasing, there is a need to summarize the evidence and inform health care professionals
about conflicting or inconsistent evidence. Although the aim of these SRs in facilitating
evidence-based practice is commendable, poor-quality SRs may contain significant bias
that can mislead readers. An overview of SRs can summarize a large body of evidence and
identify conflicting or inconsistent results and the potential reasons for them. For example,
a 2007 overview that examined non-pharmacological and non-surgical joint protection
interventions for people with hand RA reported high-quality evidence for a positive effect
on function and no difference in pain.12 A subsequent overview in 2009 that examined nonpharmacological and non-surgical interventions for people with hand OA found
insufficient high-quality evidence for these types of intervention. 13 Still another overview
published in 2014 that examined the effectiveness of occupational therapy interventions
for adults with RA found that the evidence to support the use of joint protection was
sufficient.14
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These overviews had some limitations that justify the need to conduct another overview of
SRs. The first limitation is that those reviews are outdated because they are based on SRs
that were published between 2000 to 2013. The second relates to how the SRs were
evaluated. Ekelman and colleagues based their quality assessment on guidelines that had
been described by Stern,14,15 and they categorized the included SRs according to the levels
of evidence for SRs established by the Oxford Centre for Evidence-Based Medicine in
2009.16 Although SRs and randomized controlled trials (RCTs) are considered high-quality
evidence in that categorization, this way of rating methodological quality is imprecise
because it does not consider how an SR or RCT was conducted. Christie and colleagues
assessed the quality of SRs using a nine-item checklist that had been developed from
Oxman and Guyatt in 1991.12,17 Moe and colleagues assessed the methodological quality
of the first version of the A MeaSurement Tool to Assess systematic Reviews (AMSTAR)
checklist.13 Although these instruments do assess SR methods, they have been superseded
by tools that more thoroughly consider risk of bias. 12,13 Therefore, we set out to conduct an
overview of SRs to establish the current state of evidence evaluating the effectiveness of
joint protection for people with hand RA and OA.

4.2
4.2.1

Methods
Study design

We followed a standard methodology for overviews. 18–21 This study was registered in the
International Prospective Register of Systematic Reviews (PROSPERO) database
(Registration No. CRD42018094725).

4.2.2

Eligibility criteria

We included SRs of RCTs in our overview if they met the following criteria:
•

Population: patients with hand RA and hand OA

81

•

Interventions: joint protection programme with other treatments or joint protection
alone

•

Comparison: other treatment or no treatment

•

Outcomes: pain, function, and grip and pinch strength.

4.2.3

Search strategy

A search for SRs that had been published between January 2008 and May 2018 was
conducted on May 15, 2018, in the following databases with no language restriction set:
MEDLINE, Embase, CINAHL, Cochrane Library, Physiotherapy Evidence Database
(PEDro), and Latin American and Caribbean Health Sciences Literature (LILACS). The
search strategy was designed to locate SRs that addressed the effectiveness of joint
protection programmes on pain, function, and grip and pinch strength in patients with hand
RA and hand OA. In addition, the PROSPERO database was searched to identify ongoing
studies of joint protection. Reference lists of included studies were searched to identify and
retrieve other eligible SRs. Our search strategy, which includes words and Boolean
operators, is summarized in the Appendix.

4.2.4

Study selection

Two independent reviewers (PB and GN) screened relevant titles and abstracts. Relevant
studies (SRs) were then screened at full-text review and included if the following criteria
were met: (1) SR of the effectiveness of joint protection programmes (defined by
Hammond 9 ) plus other treatments or joint protection programmes compared with other
treatment or no treatment; (2) studied population included patients with hand RA or hand
OA; and (3) SR of RCTs. Studies were excluded if they (1) were narrative, critical, or
scoping reviews; (2) were not written in English; or (3) described joint protection not as a
whole intervention but only in part (e.g., assistive devices only).
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4.2.5

Quality assessment

Three reviewers (PB, GN, and EAL) independently applied the AMSTAR 2 risk-of-bias
tool to assess the risk of bias of each SR. 22 Disagreements on the AMSTAR 2 rating were
resolved by consensus with the help from a fourth reviewer (JCM) if needed. AMSTAR 2
is composed of 16 items and has adequate interrater reliability for measuring the risk of
bias of SRs and for rating overall confidence in the results of an SR. 22 For each SR, we
considered the 16 items included on the AMSTAR 2 checklist along with the checklist
guidelines and scored the SR as “yes,” “partial yes,” “no,” or, for some domains, “not
applicable.” The AMSTAR 2 rating is based not on an overall score but on identification
of the following critical domains:
•

Protocol registered before commencement of the review (Item 2)

•

Adequacy of the literature search (Item 4)

•

Justification for excluding individual studies (Item 7)

•

Review includes risk of bias of individual studies (Item 9)

•

Appropriateness of meta-analytical methods (Item 11)

•

Consideration of risk of bias when interpreting the results of the review (Item 13)

•

Assessment of presence and likely impact of publication bias (Item 15).

The overall AMSTAR 2 rating of confidence are as follow:22
•

High – no or one non-critical weakness: the SR provides an accurate and

comprehensive summary of the results of the available studies that addresses the question
of interest.
•

Moderate – more than one non-critical weakness: the SR has more than one

weakness but no critical flaws. It may provide an accurate summary of the results of the
available studies that were included in the SR.
•

Low – one critical flaw with or without non-critical weaknesses: the SR has a

critical flaw and may not provide an accurate and comprehensive summary of the available
studies that address the question of interest.
•

Critically low – more than one critical flaw with or without non-critical

weaknesses: the SR has more than one critical flaw and should not be relied on to provide
an accurate and comprehensive summary of the available studies.
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4.2.6

Data extraction

Two review authors (PB and JCM) were trained and calibrated on the use of the data
extraction form. Data extraction was performed by one author (PB) and checked by a
second (JCM). The following descriptive characteristics were extracted from the eligible
SRs: (1) author and year, (2) number of primary studies, (3) population, (4) risk-of-bias
assessment, (5) quality-of-evidence assessment, (6) outcomes reported in the SR, and (7)
conclusions drawn by the authors of the SR.

4.2.7

Data analysis and synthesis

A qualitative synthesis was conducted to summarize the findings across the multiple SRs.
We synthesized the results on the basis of quality of evidence and on the populations
studied. The risk of bias and the quality assessment of primary studies were extracted as
reported in the included SRs. Rather than re-scoring the data from the primary studies
included in each SR, we relied on the judgment and reporting of the SR authors.

4.3
4.3.1

Results
Selection process

Our literature search identified 14 SRs for a full-text review. Of these, 4 were excluded
because they evaluated the effect of hand exercises, 23,24 splints,25 or Web-based multimodal interventions with no mention of joint protection. 26 One SR was excluded because
it did not include any study that had evaluated joint protection as an intervention or
control.27 Overall, nine SRs met our inclusion criteria and were included in our analysis. A
summary of the selection process is presented in Figure 1.
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4.3.2

Characteristics of the included systematic reviews

Five reviews evaluated the effectiveness of joint protection for people with hand OA, 28–32
and three evaluated its effectiveness for people with hand RA;33–35 one review (Bobos and
colleagues36 ) included studies for both hand OA and RA. Risk of bias was evaluated in six
reviews: five used the Cochrane risk-of-bias tool,29,30,33,34,36 and one used a list
recommended by VanTulder and colleagues. 35 Quality of evidence was assessed in six
reviews: two using the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) guidelines,29,36 one using the Jadad scoring checklist,28 one using the
PEDro scale,31 one using the Structured Effectiveness for Quality Evaluation Scale
(SEQES) and levels of evidence,32 and one using a list recommended by VanTulder and
colleagues.35 One review rated the evidence as strong, moderate, mixed, or limited on the
basis of consistent or conflicting results from the RCTs, 33 and Carandang and colleagues
rated the evidence as low, unknown, or high quality to reflect the language used in the
quality assessment (i.e., high risk, unknown risk, and low risk of bias). 34 Six reviews
assessed pain levels and function,29,30,32,33,35,36 four reviews examined grip strength as an
outcome of interest,

29,31,32,36,37

and two reviews assessed behavioural change. 33,34 The

characteristics of the included reviews are summarized and presented in Table 1.

4.3.3

Description of joint protection programmes

Most joint protection programmes used guidelines that included an educational component
that addressed disease and symptom severity (RA or OA) and techniques to influence
behavioural change such as energy conservation, coping skills for pain management,
assistive devices, and the use of large joints. 36 Interventions included on average three to
four 2-hour, face-to-face interventions and home programmes. 33,36 In the majority of
studies, an occupational or physical therapist was primarily responsible for delivering the
programmes.36
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4.3.4

Quality assessment

Two SRs29,36 were rated as high quality, seven as low quality. 28,30–35 Regarding the critical
domains of AMSTAR 2, five reviews did not perform a priori registration, 28,31–34 two did
not perform a comprehensive search,32,34 and three partially met this criterion.28,30,33 Three
reviews did not provide justification for excluding studies, 28,30,31 and four did not use a
satisfactory technique to assess the risk of bias of the primary studies.30–32,35 Seven reviews
did not take into account the risk-of-bias assessment in their interpretation or
discussion,28,30–35 and six reviews28,30-34 did not assess publication bias of the included
studies. The summary of AMSTAR 2 ratings is presented in Table 2.

4.3.5

Findings from high-quality reviews for hand osteoarthritis and
rheumatoid arthritis

Two high-quality SRs reported the effects of joint protection versus usual care or control
and hand exercises versus joint protection for pain, hand function, and grip strength
outcomes for patients with hand RA and OA. 29,36 The review by Bobos and colleagues
reported results from 14 RCTs for people with hand RA and three RCTs for people with
hand OA for pain, grip strength, and hand function. 36 This review found very-low- to lowquality evidence (according to GRADE guidelines) that, compared with usual care or
control, the effects of joint protection programmes on pain and hand function for people
with hand arthritis are too small to be clinically important at short-, intermediate- and longterm follow-up. Pain levels were quantified by pooling the results from five low-quality
primary studies for the short, mid-, and long term for people with hand RA. Pooling the
results indicated that joint protection is no better than usual care or control at short -term
follow-up (3–4 mo). For the mid- (6 mo) and long term (12 mo), joint protection was
favored over usual care or control but did not exceed the cutoff scores for minimal
clinically important difference. For hand function, joint protection was favored over usual
care or control with small effects at mid- and long-term follow-up. The Cochrane review
by Østerås and colleagues29 reported the effects of hand exercise versus no exercise (joint
protection) for patients with hand OA from one study. The overall estimate effect was in
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favor of hand exercises for the short, mid-, and long term for hand pain and function and
for grip and pinch strength. No specific recommendation was made for joint protection,
only for hand exercises.

4.3.6

Findings from low-quality systematic reviews for hand
osteoarthritis

Four SRs summarized findings of reported outcomes for pain, hand function, and grip
strength for people with hand OA.28,30–32 Lue and colleagues reported the results from two
high-quality RCTs (Jadad score > 3) for people with hand OA.28 This review did not report
the effect on outcomes specifically for joint protection studies but concluded that joint
protection was conditionally recommended. Aebischer and colleagues reported findings
from one RCT (risk of bias not reported) for pain and function and found that joint
protection improved solely pain, not function. 30 Ye and colleagues reported findings from
one high-quality RCT (PEDro scale > 6) and found that joint protection improved grip
strength and hand function.31 Valdes and Marik32 reported findings from one high-quality
RCT (SEQES scores for quality of research ) and found that the evidence to support joint
protection for increased hand function was moderate.

4.3.7

Findings from low-quality reviews for hand rheumatoid arthritis

Three SRs provided summarized findings on reported outcomes of function, pain, fatigue,
depression, self-efficacy, behavioural change, and knowledge. 33–35 Siegel and colleagues
reported the results from five high risk-of-bias RCTs and found strong evidence to support
the use of psychoeducational interventions (joint protection) to improve function, pain,
fatigue, depression, self-efficacy, and disease symptoms in people with RA. 33 Carandang
and colleagues reported findings from three RCTs (one with low risk of bias, two with high
risk of bias) and found that the evidence for joint protection and energy conservation
interventions to improve joint protection behaviours was moderate.
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34

Stueultjens and

colleagues reported findings from four RCTs and found strong evidence to support the
efficacy of joint protection.35

4.4

Discussion

Our overview shows that the majority of the evidence supporting the effects of joint
protection for patients with hand arthritis is of low quality. The summarized findings from
the high-quality reviews indicate that, when compared with usual care or control, joint
protection does not improve pain by a clinically important amount at 6- and 12-month
follow-up. Joint protection was superior to usual care or control in improving hand function
but did not exceed the predefined cut-off scores. The majority of the included SRs had very
poor overall methodological quality in the critical domains of AMSTAR 2. Seven of the
nine reviews did not take risk of bias into account in the interpretation and discussion of
findings, six reviews did not assess publication bias, and five reviews did not register their
protocol. Another important finding is that differences in the risk-of-bias and quality
assessment tools seemed to affect the SRs’ overall recommendations (Table 3).
Seven of the nine SRs were rated as low quality, and the majority of the included SRs did
not follow the recommended Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines.38 Six of the nine SRs were published between 2015 and
2018, and only two followed the PRISMA guidelines. Not following these predefined
guidelines may be diminish the usefulness of the results when they are interpreted by
clinicians or policymakers. It is important to note that low-quality evidence implies not that
joint protection has no effect but that the low-quality evidence is insufficient to draw
definite conclusions.
Our included SRs used a variety of risk-of-bias and quality assessment tools. The authors
of the included reviews seemed to lack an understanding of what constitutes risk-of-bias
and quality assessment. Authors have at their disposal a wide variety of tools to critically
appraise and synthesize evidence, and which one they use is a matter of personal
preference. However, the methodological quality of the included reviews may have a very
important effect on estimates of the results and may affect the validity of the authors’
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conclusions.39 For instance, a primary study (RCT) that had been rated with four separate
approaches was reported as being high quality when using the PEDro scale, high quality
when using SEQES, high risk when using only the Cochrane risk-of-bias tool, and very
low quality when using the Cochrane risk-of-bias tool and the GRADE approach
combined.
This overview had several limitations that need to be taken into account when interpreting
our findings. First, the included SRs did not differ significantly in their eligibility criteria. 20
Second, they did not clearly report potential harms. Third, there was minor overlap among
the primary studies, although this is common for reviews. 19,20,28 Next, we focused on SRs
of RCTs and did not include SRs that included other study designs (i.e., prospective or
retrospective observational designs), and it is possible that such inclusion criteria could
lead to publication bias. However, our objective was to summarize the highest level of
evidence available.

4.5

Conclusions

This overview provided high-quality evidence (AMSTAR 2) from two SRs that, compared
with usual care or control, the effects of joint protection programmes on pain and hand
function are too small to be clinically important at short-, intermediate- and long-term
follow-up. It is important to note that the primary studies included in these SRs were graded
as very-low-quality to low-quality evidence.
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Key Messages
What is already known on this topic
Several systematic reviews (SRs) have been published on the effectiveness of joint
protection programmes for patients with osteoarthritis or rheumatoid arthritis of the hand,
but the quality of the evidence synthesized by these SRs varies.
What this study adds
Our review shows that the majority of the current evidence from systematic reviews that
supports the effects of joint protection for patients with osteoarthritis or rheumatoid
arthritis of the hand is of low quality. The summarized findings from the high-quality
reviews indicate that, when compared with usual care or control, joint protection does not
improve pain by a clinically important amount at 6- and 12-month follow-up.

90

4.6
1.

Reference

Lopez-Olivo MA, Siddhanamatha HR, Shea B, et al. Methotrexate for treating

rheumatoid arthritis. Cochrane Database Syst Rev. 2014;6:CD000957.
https://doi.org/10.1002/14651858.cd000957.pub2. Medline:24916606
2.

Singh JA, Christensen R, Wells GA, et al. A network meta-analysis of

randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
CMAJ. 2009;181(11):787–96. https://doi.org/10.1503/cmaj.091391. Medline:19884297
3.

National Institute for Health and Care Excellence (NICE). Rheumatoid arthritis in

adults: management. NICE Guideline NG100. London: NICE; 2009
4.

Nazari G, Bobos P, MacDermid JC, et al. Physical impairments predict hand

dexterity function after distal radius fractures: a 2-year prospective cohort study. Hand
Ther. 2018;23(2):64–9. https://doi.org/10.1177/1758998317751238
5.

Bobos P, Nazari G, Lalone EA, et al. Recovery of grip strength and hand dexterity

after distal radius fracture: a two-year prospective cohort study. Hand Ther.
2018;23(1):28–37. https://doi.org/10.1177/1758998317731436
6.

Bobos P, Lalone EA, Grewal R, et al. Recovery, age, and gender effects on hand

dexterity after a distal radius fracture: a 1-year prospective cohort study. J Hand Ther.
2018;31(4):465–71. https://doi.org/10.1016/j.jht.2017.08.002. Medline:29042160
7.

Bobos P, Lalone EA, Grewal R, et al. Do impairments predict hand dexterity after

distal radius fractures? A 6-month prospective cohort study. Hand. 2018;13(4):441–7.
https://doi.org/10.1177/1558944717701242. Medline:28366013
8.

Shi Q, Bobos P, Lalone EA, et al. Comparison of the short-term and long-term

effects of surgery and nonsurgical intervention in treating carpal tunnel syndrome: a
systematic review and meta-analysis. Hand. 2018;15(1):13–22.
https://doi.org/10.1177/1558944718787892. Medline:30015499
9.

Hammond A. Rehabilitation in rheumatoid arthritis: a critical review.

Musculoskelet Care. 2004;2(3):135–51. https://doi.org/10.1002/msc.66.
Medline:17041978

91

10.

Bobos P, Nazari G, Lalone EA, et al. A scoping review of joint protection

programs for people with hand arthritis. Open Orthop J. 2018;12:500–13.
https://doi.org/10.2174/1874325001812010500
11.

Nazari G, Bobos P, MacDermid JC, et al. The effectiveness of instrument-assisted

soft tissue mobilization in athletes, participants without extremity or spinal conditions,
and individuals with upper extremity, lower extremity, and spinal conditions: a
systematic review. Arch Phys Med Rehabil. 2019;100(9):1726–51.
https://doi.org/10.1016/j.apmr.2019.01.017. Medline:30797743
12.

Christie A, Jamtvedt G, Dahm KT, et al. Effectiveness of nonpharmacological

and nonsurgical interventions for patients with rheumatoid arthritis: an overview of
systematic reviews. Phys Ther. 2007;87(12):1697–715.
https://doi.org/10.2522/ptj.20070039. Medline:17906290
13.

Moe RH, Kjeken I, Uhlig T, et al. There is inadequate evidence to determine the

effectiveness of nonpharmacological and nonsurgical interventions for hand
osteoarthritis: an overview of high-quality systematic reviews. Phys Ther.
2009;89(12):1363–70. https://doi.org/10.2522/ptj.20080398. Medline:19850713
14.

Ekelman BA, Hooker L, Davis A, et al. Occupational therapy interventions for

adults with rheumatoid arthritis: an appraisal of the evidence. Occup Ther Heal Care.
2014;28(4):347–61. https://doi.org/10.3109/07380577.2014.919687. Medline:24867224
15.

Stern P. A holistic approach to teaching evidence-based practice. Am J Occup

Ther. 2005;59(2):157–64. https://doi.org/10.5014/ajot.59.2.157. Medline:15830615
16.

Ghaemi SN. Levels of evidence. Psychiatr Times. 2010;27(1):24–6.

17.

Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J

Clin Epidemiol. 1991;44(11):1271–8. https://doi.org/10.1016/0895-4356(91)90160-b.
18.

Higgins J, Green S. Cochrane handbook for systematic reviews of interventions.

Version 5.1.0. Cochrane; 2015 [cited 2011 Mar]. Available from: https://handbook-51.cochrane.org.
19.

Bobos P, Macdermid JC, Walton DM, et al. Patient-reported outcome measures

used for neck disorders: an overview of systematic reviews. J Orthop Sports Phys Ther.
2018;48(10):775–88. https://doi.org/10.2519/jospt.2018.8131. Medline:29932874

92

20.

Bougioukas KI, Bouras E, Apostolidou-Kiouti F, et al. Reporting guidelines on

how to write a complete and transparent abstract for overviews of systematic reviews of
health care interventions. J Clin Epidemiol. 2019;106:70–9.
https://doi.org/10.1016/j.jclinepi.2018.10.005. Medline:30336211
21.

Nazari G, MacDermid JC, Bobos P. Conservative versus surgical interventions

for shoulder impingement: an overview of systematic reviews of randomized controlled
trials. Physiother Can. 2019 Apr 10;e20180111. Epub 2019 Dec 9.
https://doi.org/10.3138/ptc-2018-0111.
22.

Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for

systematic reviews that include randomised or non-randomised studies of healthcare
interventions, or both. BMJ. 2017;358:1–9. https://doi.org/10.1136/bmj.j4008.
Medline:28935701
23.

Magni NE, McNair PJ, Rice DA. The effects of resistance training on muscle

strength, joint pain, and hand function in individuals with hand osteoarthritis: a
systematic review and meta-analysis. Arthritis Res Ther. 2017;19:131.
https://doi.org/10.1186/s13075-017-1348-3. Medline:28610637
24.

Bergstra SA, Murgia A, Te Velde AF, et al. A systematic review into the

effectiveness of hand exercise therapy in the treatment of rheumatoid arthritis. Clin
Rheumatol. 2014;33:1539–48. https://doi.org/10.1007/s10067-014-2691-2.
Medline:24952308
25.

Kjeken I, Smedslund G, Moe RH, et al. Systematic review of design and effects

of splints and exercise programs in hand osteoarthritis. Arthritis Care Res.
2011;63(6):834–48. https://doi.org/10.1002/acr.20427. Medline:21630479
26.

Srikesavan C, Bryer C, Ali U, et al. Web-based rehabilitation interventions for

rheumatoid arthritis: a systematic review. J Telemed Telecare. 2018;25(5):263–75.
https://doi.org/10.1177/1357633x18768400. Medline:29669470
27.

Spaans AJ, Van Minnen LP, Kon M, et al. Conservative treatment of thumb base

osteoarthritis: a systematic review. J Hand Surg Am. 2015;40(1):16–21.e6.
https://doi.org/10.1016/j.jhsa.2014.08.047. Medline:25534834

93

28.

Lue S, Koppikar S, Shaikh K, et al. Systematic review of non-surgical therapies

for osteoarthritis of the hand: an update. Osteoarthr Cartil. 2017;25(9):1379–89.
https://doi.org/10.1016/j.joca.2017.05.016. Medline:28602781
29.

Østerås N, Kjeken I, Smedslund G, et al. Exercise for hand osteoarthritis: a

Cochrane systematic review. J Rheumatol. 2017;44(12):1850–8.
https://doi.org/10.3899/jrheum.170424. Medline:29032354
30.

Aebischer B, Elsig S, Taeymans J. Effectiveness of physical and occupational

therapy on pain, function and quality of life in patients with trapeziometacarpal
osteoarthritis: a systematic review and meta-analysis. Hand Ther. 2016;21(1):5–15.
https://doi.org/10.1177/1758998315614037. Medline:27110291
31.

Ye L, Kalichman L, Spittle A, et al. Effects of rehabilitative interventions on pain,

function and physical impairments in people with hand osteoarthritis: a systematic
review. Arthritis Res Ther. 2011;13(1):R28. https://doi.org/10.1186/ar3254.
Medline:21332991
32.

Valdes K, Marik T. A systematic review of conservative interventions for

osteoarthritis of the hand. J Hand Ther. 2010;23(4):334–51.
https://doi.org/10.1016/j.jht.2010.05.001. Medline:20615662
33.

Siegel P, Tencza M, Apodaca B, et al. Effectiveness of occupational therapy

interventions for adults with rheumatoid arthritis: a systematic review. Am J Occup Ther.
2017;71(1):7101180050. https://doi.org/10.5014/ajot.2017.023176. Medline:28027042
34.

Carandang K, Pyatak EA, Vigen CLP. Systematic review of educational

interventions for rheumatoid arthritis. Am J Occup Ther. 2016;70(6):7006290020.
https://doi.org/10.5014/ajot.2016.021386. Medline:27767950
35.

Steultjens, EEMJ, Dekker, JJ, Bouter, LM, et al. Occupational therapy for

rheumatoid arthritis: a systematic review. Arthritis Rheum. 2002;47(6):672–85.
https://doi.org/10.1002/art.1081.
36.

Bobos P, Nazari G, Szekeres M, et al. The effectiveness of joint-protection

programs on pain, hand function, and grip strength levels in patients with hand arthritis: a
systematic review and meta-analysis. J Hand Ther. 2019;32(2):194–211.
https://doi.org/10.1016/j.jht.2018.09.012. Medline:30587434

94

37.

Bobos P, Nazari G, Lu Z, et al. Measurement properties of the hand grip strength

assessment: a systematic review with meta-analysis. Arch Phys Med Rehabil. Epub 2019
Nov 13. https://doi.org/10.1016/j.apmr.2019.10.183. Medline:31730754
38.

Moher D, Shamseer L, Clarke M, et al. Preferred Reporting Items for Systematic

Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;1:1.
https://doi.org/10.1186/2046-4053-4-1. Medline:25554246
39.

Verhagen AP, De Vet HCW, De Bie RA, et al. The art of quality assessment of

RCTs included in systematic reviews. J Clin Epidemiol. 2001;54(7):651–54.
https://doi.org/10.1016/s0895-4356(00)00360-7

95

Table 4-1. Characteristics of the included systematic reviews
Author
(Year)

Bobos et al.36

Population

No. of studies
of joint
protection
included

Risk-of-bias tool

Quality of evidence

Reported outcomes
for joint protection

OA and RA

14 for RA, 3
for OA

Cochrane

GRADE

Pain, function, grip
strength
Function, pain,
fatigue, depression,
self-efficacy,
behaviour

RA

5

Cochrane

Evidence was considered
strong, moderate, mixed,
and limited on the basis of
consistent or conflicting
results from RCTs

Lue et al.28

OA

2

Not assessed

Jadad’s scoring checklist (0–
5)

Unclear

Østerås et al.
(2017)29

OA

1

Cochrane

GRADE

Pain, hand function,
grip and pinch
strength

Behavioural change

Siegel et

al.33

Carandang et
al.34

RA

3

Cochrane

Low, unknown, and high
quality; adapted to reflect
the language used in the
quality assessment (e.g.,
high risk, unknown risk, low
risk of bias)

Aebischer et
al.30

OA

1

Cochrane

Unclear

Pain, function

Ye et al.31

OA

1

Not assessed

PEDro scale

Grip strength, hand
function

Valdes &
Marik 32

OA

1

Not assessed

SEQES and LOE

HAQ; VAS for pain
and hand function;
grip strength

Methodological quality of
RCTs and CCTs rated using
Pain, functional
RA
4
a list recommended by
ability, knowledge
VanTulder et al. (1997)
OA = osteoarthritis; RA = rheumatoid arthritis; GRADE = Grading of Recommendations Assessment,

Steultjens et
al.35

List recommended
by VanTulder and
colleagues (1997)

Development and Evaluation; RCT = randomized controlled trial; PEDro = Physiotherapy Evidence
Database scale; SEQES = Structured Effectiveness for Quality Evaluation of Study; LOE = levels of
evidence; HAQ = health assessment questionnaire; VAS = visual analog scale; CCT = controlled clinical
trials

96

Table 4-2. AMSTAR 2 Rating
Question

1. Research
question and
inclusion
criteria aligned
with PICO
2. A priori
protocol used *
3. Study design
selection
explained
4.
Comprehensive
search carried
out *
5. Duplicate
study selection
used
6. Duplicate
data extraction
used
7. List of
excluded
studies
included, with
justification *
8. Included
studies
described in
adequate detail
9. Satisfactory
technique used
for assessing
risk of bias*
10. Sources of
funding of
included studies
reported in
review
11. If meta analysis,
combination of
data justified
12. If meta analysis, risk of
bias of included
studies taken
into account

Bobos et
al.36

Siegel et
al.33

Lue et
al.28

Østerås
et al.29

Carandang
et al.34

Aebischer
et al.30

Ye et
al.31

Valdes
&
Marik32

Steultjens
et al.35

+

?
No
outcomes,
comparator

–

+

+

?
No
comparator

–

+

+

+

–

–

+

–

+

–

–

+

+

+

+

+

+

+

+

+

+

?
Did not
justify
language
restriction

?
Did not
justify
language
restriction

?
Did not
justify
language
restriction

+

–

?
Did not
justify
language
restriction

+

–

+

+

+

+

+

+

+

+

–

+

+

+

+

+

+

+

–

+

+

+

+

?
No list of
excluded
studies

+

+

?
No list of
excluded
studies

?
No list of
excluded
studies

–

+

+

?
No
outcomes,
comparator

+

+

+

+

+

+

+

+

–

?
Lack of
blinding

+

+

–

–

–

–

+

–

–

+

–

–

–

–

+

+

N/A

N/A

+

N/A

+

N/A

N/A

+

+

N/A

N/A

+

N/A

–

N/A

N/A

–
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13. Risk of bias
taken into
account in
+
–
interpretation
and discussion *
14. Satisfactory
explanation
+
N/A
given for any
heterogeneity
15. Publication
bias in included
+
–
studies
*
assessed
16. Review
authors reported
on any of their
+
–
own conflicts of
interest
Overall quality
High
Low
* Indicates a critical domain.

–

+

–

–

–

–

–

N/A

+

N/A

+

N/A

N/A

–

–

+

–

–

–

–

+

+

+

–

+

+

+

+

Low

High

Low

Low

Low

Low

Low

AMSTAR 2 = A MeaSurement Tool to Assess systematic Reviews; – = no; + = yes; ? = partial yes;
N/A = not applicable; PICO = Patient Intervention Comparator Outcome.
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Table 4-3. Summary of Recommendations Made for Joint Protection
Author
(Year)

Quality of
evidence

Recommendations

Bobos et al.36

High

Siegel et al.33

Low

Lue et al.28

Low

Very-low- to low-quality evidence that the effects of joint protection programmes
compared with usual care or control on pain and hand function are too small to be
clinically important at short-, intermediate- and long-term follow-ups for people
with hand arthritis
Strong evidence to support the use of physical activity and psychoeducational
interventions (joint protection) to improve function, pain, fatigue, depression, selfefficacy, and disease symptoms in people with RA
Joint protection conditionally recommended

Østerås et
(2017)
Carandang et
al.34

High

No specific recommendation made for joint protection, only for hand exercises

Low

Moderate evidence for joint protection and energy conservation interventions
improving joint protection behaviours

Aebischer et
al.30

Low

Ye et al.31

Low

Main finding: moderate to high evidence that multimodal physiotherapy and
occupational therapy–related interventions have beneficial effects on pain; no
statistical evidence for improvement of function, only narrative; joint protection
improved pain but not function
Evidence suggests that programmes of joint protection, advice, and home
exercises are effective at improving grip strength and hand function

Valdes &
Marik32

Low

Steultjens et
al.35

Low

al.29

Moderate evidence to support joint protection education and providing adaptive
equipment to increase hand function and reduce pain

Results of best-evidence synthesis show that there is strong evidence for the
efficacy of instruction on joint protection (an absolute benefit of 17.5 to 22.5,
relative benefit of 100%)
RA = rheumatoid arthritis.
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Figure 4-1 Flow diagram showing the selection process.
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Chapter 5
5

Barriers, Facilitators, Preferences and Expectations of Joint
Protection Programs for Patients with Hand Arthritis. A
Cross-sectional Survey

Abstract
Objectives: The objective of this survey is to investigate the barriers, facilitators,
expectations and patient preferences regarding joint protection (JP) programs in people
with hand arthritis.
Design: Cross-sectional survey
Setting: Tertiary clinic
Participants: Patients with hand arthritis: osteoarthritis (OA), rheumatoid arthritis (RA),
psoriatic arthritis (PsA) and other forms of arthritis.
Primary and secondary outcome measures: This study utilized a survey among people
with hand arthritis. Descriptive statistics and percentages were reported for all the data
about the barriers, facilitators and preferences around JP.
Results: A total of 192 patients consented to participate. Most of the patients (82%) were
unaware of JP. Factors that may act as barriers to participation and were regarded as “a
very big concern” were: cost of the program (44%), time of offering the program (39%),
work commitments (36%) and having a centre/clinic close to the house (28%). Factors that
may act as facilitators and rated as “extremely helpful” were: research that shows that JP
works (26%) and having the centre/clinic close to the house (25%). An online format for
JP was the most preferred option (54%). Half (46 %) preferred a timeframe of 1 hour, 3
times per week and 44 % preferred a 2-hour program, for 3 times per week.
Conclusions: Awareness of the potential benefits of JP, and prior experience with JP
program were very low. Common potentially modifiable patient-reported barriers to
participate in future JP interventions, included: cost, work commitments, distance from
home to clinic and times that the intervention were provided. These barriers might be
addressed with free and accessible forms of delivery of JP, which may lead to better uptake
and participation in JP programs.
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Reproduced with permission from Bobos P, MacDermid JC, Ziebart C, Boutsikari EC,
Lalone EA, Ferreira L, Grewal R. Barriers, Facilitators, Preferences and Expectations of
Joint Protection Programs for Patients with Hand Arthritis. A Cross-sectional Survey. BMJ
Open 2021; Copyright © BMJ Open®

Strengths and limitations of this study
•

The survey was adapted to people with hand arthritis from a validated questionnaire
developed to assess the barriers, facilitators and preferences to exercise used in
other clinical populations.

•

A small sample of people with experience of JP prevented us from adequately
exploring the perceptions of patients who had completed the program.

•

The survey was designed for English speakers with hand arthritis therefore, people
speaking other languages were not represented.

5.1

Introduction

Osteoarthritis (OA) is characterized as a degenerative joint disease that affects
approximately 27 million adults in the USA and is one of the leading causes of disability.
1

Osteoarthritis affects 60-70% of the population above the age of 65 years, and is likely to

increase further in the future, due to the aging population. 2,3 The most common site of OA
is the hand and it typically involves the interphalangeal (proximal and distal) and first
carpometacarpal joints. 4 In a clinical setting, pain is a major symptom among patients with
hand OA as it contributes to a reduction in joint function. 1,4 Currently there is no cure for
hand OA, but goals of treatment include maximizing long-term health-related quality of
life, by controlling symptoms such as pain, prevention of structural damage and
normalization of function.5
Joint protection (JP) is a self-management strategy for patients living with arthritis to help
preserve joint function and reduce pain.6 JP involve training on “safer movement patterns,
the use of adaptive devices (e.g. built up handles, hands free technologies) and behavior
modifications (e.g. activities to avoid, pacing)during physical activity.6 However, JP can
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be implemented in many different ways, and patient preferences are rarely reported as
being considered in program design. There are many unknown barriers that may reduce
participation in JP programs, and these may be related to personal beliefs, preferences or
circumstances. For example, patients may believe that JP will not slow joint damage, may
not like engaging in groups or may have life/location issues that make it difficult to attend
clinics. Identifying these barriers at group and individual levels may be a strategy to design
and customize future JP to increase participation in JP programs.
Considering preferences and customizing JP may be critical to improving adherence. Prior
reports suggest that adherence is a major concern. Previous systematic review and metaanalysis indicated that only 6 out of the 17 trials used strategies to maximize adherence for
JP.7 Although the evaluation of adherence from these trials was ranging from low to
moderate adherence has not been properly studied in the published literature yet. The
purpose of this cross-sectional survey is to investigate the barriers, facilitators, expectations
and patient preferences regarding joint protection programs in people with hand arthritis.

5.2
5.2.1

Methods
Patient and Public Involvement

Patients or the public were not involved in the design, or conduct, or reporting, or
dissemination plans of our research.

5.2.2

Study Design

This study utilized a cross-sectional survey among people with hand arthritis that was open
for response from March 2019 to February 2020. Ethical approval was granted by Hamilton
Research Ethics Board (HiREB) at McMaster University, Hamilton, Canad a (Project
Number: 3727). Patients were asked to provide consent to proceed and complete the survey
questions.
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5.2.3

Inclusion criteria and exclusion criteria

Participants were eligible to complete the anonymized survey if they were able and willing
to provide informed consent, were between 18 to 85 years old, they have been diagnosed
with hand arthritis and they could read and write English. Participants which have not been
diagnosed with hand arthritis or they could not answer the survey questions, or they did
not understand English were excluded from the study.

5.2.4

Setting and recruitment

Participants were recruited through advertisements in the main website of The Arthritis
Society of Canada and from the Roth McFarlane Hand and Upper Limb Centre (HULC) at
St. Joseph’s Health Care Hospital in London, Ontario. Research assistants and research
coordinators from HULC contacted people with hand arthritis who had previously
expressed interest in participating in research. Also, an informative poster was setup at
HULC patient waiting area providing details about the study. Two separate approaches
were used for data collection. An online form to complete the survey and a paper-based
version of the survey form at HULC clinical research lab.

5.2.5

Data protection

No participant identifying information was collected in this anonymized survey. Data were
kept at the HULC clinical research laboratory where only authorized personnel have
access, and all paper-based files were stored in a locked cabinet. Electronic files were
stored in encrypted file and apart from the study investigators no other person had access
to the electronic records.
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5.2.6

Survey

The survey was adapted to people with hand arthritis based on previous experience of the
study investigator (JCM) with JP, from a validated questionnaire initially developed to
assess the barriers, facilitators and preferences to exercise for people with osteoporosis and
for shoulder arthritis.8,9 The survey consisted of 31 questions with sections related to
barriers, facilitators, expectations and patient preferences for joint protection programs in
people with hand arthritis. The survey questions are presented in the Web Appendix.

5.3
5.3.1

Data analysis
Quantitative

Descriptive statistics and percentages were reported for all the data about the barriers,
facilitators and preferences around JP programs. In 2014 (Statistics, Canada), 16.5% of
Canadians (around 4.8 million people) reported that they had been diagnosed with any form
of arthritis by a health professional. The Ontario province represents the 18.5% of 4.8
million which is 888,000 individuals with arthritis approximately. Sample size calculation
was based on a population size of 888,000 individuals, a confidence level of 95% and with
7% margin of error and it was determined that 196 individuals were needed to complete
the survey.10 Data analyses were completed using STATA 16.0 version.

5.3.2

Qualitative

Some of the survey questions (Questions 7, 8, 10, 11, 12, 13) were written responses. For
these questions qualitative data analyses techniques were used. Data were analyzed by
response line to identify emerging codes. Relationships and similarities among codes were
discussed leading to the formation of themes. Themes were particularly identified to
provide new information to the quantitative responses, in an effort to better understand the
barriers and facilitators to use of JP programs.
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5.4

Results

A total of 192 patients consented to participate and completed our survey. They provided
information about JP barriers and facilitators regarding their possible prospective
participation in a JP program, the impact of JP programs on domains of their everyday life
and their preferred frequency of use of JP. Out of the 192 survey respondents, 92 (50%)
were diagnosed with Rheumatoid Arthritis (RA) in the hand, 38 (21%) with hand OA, 29
(16%) with Psoriatic Arthritis (PsA), 13 (7%) had a diagnosis other than hand arthritis, and
10 (5%) reported none from the options provided. The majority of participants were aged
between 34 to 54 years old representing the 53% of the sample of this survey. Thirteen
(n=13) people disqualified from the survey, because three of them were under 18 years old
and ten of them had arthritis in lower extremities and therefore, they were deemed
ineligible to participate. The demographic description of the included sample is presented
on Table 1.

5.4.1

Awareness of joint protection programs

Regarding patients’ awareness of JP programs, from the 164 patients in total who had hand
arthritis, most (82%) had never heard about JP programs before, 11% had heard about JP
but had never taken part in such a program. A small percentage of respondents (5%) had
previously taken part in a JP and only 4% were currently participating in a JP program.
Amongst the 13 participants who took part in JP, 5 people participated in a program in an
outpatient hospital department, 3 at a family’s physician office, 2 in an inpatient unit, 2 in
a rehabilitation center and 1 home. The JP program was provided most commonly by an
occupational therapist (46%), a family physician or specialist (38%), and to a lesser extent
by a physiotherapist (15 %) (Table 1).
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5.4.2

Use, frequency and perceived impact of joint protection programs
on outcomes

Out of 13 patients who participated in a JP program, five of them continued using the
principles of the program at least once a week, four of them kept using them always, one
participant applied them less than once a week while 3 of them while 3 of them did not use
them at all. In Table 2, four patients that participated in the joint protection provided
examples what joint protection principles they used. Within this small subsample of ten
patients’ experiences (Figure 1), eight patients reported “no change” to “very much better”
in terms of impact on stiffness, pain, grip strength, hand function and swelling. Two
patients reported feeling slighting worse to much worse in stiffness, pain, grips strength,
hand function and swelling (Figure 1).

5.4.3

Information and awareness of the existence of joint protection
programs

The majority of the respondents have never heard about joint protection programs until
they undertook this survey, according to their comments in an open-ended question within
the survey. None were informed about the existence of the joint protection programs by a
family physician or a local community center. A small percentage of 14% were informed
by a specialist about the existence of the JP programs, 10% of them heard it from television,
5% by their therapist and 3% from family or friends.

5.4.4

Factors affecting prospective participation in joint protection

Factors reported by 87 participants that were reported as important barriers to participation
in a future JP are described in Figure 2. Factors that may act as barriers to participation and
were regarded as “a very big concern” included: cost of the program (44%), time of offering
the program (39%), work commitments (36%) and having a centre/clinic close to the house
(28%). Factors that may act as facilitators to participation and rated as “extremely helpful”
were: research that shows that joint protection works (26%) and having the centre/clinic
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close to the house (25%). All the barriers and facilitators that may affect participation are
presented in Figure 2.

5.4.5

Qualitative Data

A total of 73 participants provided additional information in open-ended responses to
describe their barriers and facilitators to engaging in a joint protection program. Three
major themes emerged: personal factors; environmental factors; and health factors. For the
personal factors, common barriers were energy, other personal or work commitments, and
fear of further injury. Environmental factors included having a centre close to the house,
transportation, cost of the program, building accessibilities and social support from family
or friends to participate with. Health condition factors included comorbidities associated
with the disease, complications related to the disease, flare ups, and depression. For
example, one participant noted that arthritis-related health issues limited participation: RA
said “[permanent] RA voice loss, [permanent] RA lung damage”, and another patient
mentioned “flare ups”.
Facilitators mentioned in open-ended responses included: having the centre/ clinic close to
my house, transportation to the centre where program is provided, cost of the program,
time when the program was offered, my work commitments, my personal commitments,
support from family/ friends, having a friend to participate with, research that shows joint
protect works and another patient finding joint protection helpful. A number of the barriers
mentioned in open-ended responses related to health factors not specifically identified on
the survey: flare ups, fear of further injury, and comorbid conditions were not listed as
potential barriers in the survey.

5.4.6

Preference on method of delivery of Joint protection

An online format for JP was the most preferred option representing slightly over half of
the respondents (54%). Amongst the remaining respondents there were preferences for at
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home (20%), clinic (17%), videos (6%) and printed material (2%). Patient were open to a
variety of health providers for JP programs, and stated preference for occupational
therapists (22%), physiotherapists (20%), family physician or specialists such as
rheumatologists(19%), hand therapists (17%), other patients with arthritis (13%), and
kinesiologists with the other choices comprising 2%.

5.4.7

Preference of frequency of joint protection

Participants reported their top preference in terms of frequency and their possible
prospective participation in a JP. Half of them (46 %) preferred a timeframe of 1 hour, 3
times per week for 10 weeks and 44 % preferred a 2 hour, 3 times a week for 5 weeks
program.

5.4.8

Usefulness of joint protection components

Patient preferences for content in JP suggest that information about joint loading, reduction
of joint stress, feedback on correctness and carefulness in tasks, information about pacing
activities, advice from health professionals or other patients and demonstration of how to
do things in ways that minimize effort and maximize efficiency, a JPP were considered as
moderately to extremely useful (Figure 3). Respondents indicated that the following
information would be moderately or extremely useful: activity pacing and how joint
positions affect joint loading, ways to reduce joint loading and feedback on task
performance. They indicated preference as “moderately” or “extremely useful” the
following approaches: advice from health professionals, demonstrations/feedback on task
performance, and advice from other patients (Figure 3).

5.4.9

Perceived importance of joint protection programs

Patients rated the following potential outcomes of JP as “extremely important ”: pain
reduction (92%), joint deformity prevention (83%), hand function (82%) and grip strength
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(75%). On average 84 out of 192 of patients reported how often they use one or more of
the following rehabilitation modalities such as heat, cold, exercise, joint protection, splints
and modified equipment (Figure 4). Modalities such as heat, exercise and splints were
reported that were used “very frequently” by 15% of the respondents. Heat (32%), exercise
(25%) and cold modalities (19%) were used as “frequently” by the participants. On the
other hand, modalities such TENS/electrical devices (68%), splints (46%), joint protection
(48%) and modified equipment (43%) were never used by the respondents (Figure 4).

5.5

Discussion

This study found that very few patients with arthritis were aware of or had participated in
a JP program, yet slightly more than half favored a JP program which could be offered 3
times per week at 1-2 hours of engagement in an online format. This suggests a profound
need for better accessibility to JP programs for people with arthritis as a component of their
overall self-management strategy.
It is also clear one single method of delivery is unlikely to meet all needs since variation in
preferences was clear. An online format for JP was the most preferred option representing
slightly over half of the respondents (54%). Other preferred options were JP programs that
could be completed at home (21%) or at a clinic (16%). Our findings need to be tempered
by two considerations. Firstly, some of the other preferred options overlap, for example
preferences like “at home” or “videos” could include virtual components. Secondly, since
the majority of the respondents (82%) were unaware of JP and were rarely using it, their
preferences were based on a priori assumptions not on experience with such programs.
However, preferences prior to participation are important since this is the time when
patients make decisions about participation.
It was remarkable that so few respondents had participated in JPP, given that there is
systematic review evidence demonstrating the effectiveness of these programs both for
patients with RA and OA.14 The included trials in this meta-analysis were of low
methodological quality however, the effects of JP on function outcomes for people with
rheumatoid arthritis in the hand were beneficial. In the few people who have used JP in our
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survey the experiences were mostly positive in terms of perceived benefit in symptom
control and very limited perceived harm. Lack of awareness of JPP was greater than
anticipated and may reflect a lack of access to programs, a lack of awareness in clinicians
who should be recommending JPP or a lack of interest in participating. Self-management
strategies are important for patients with arthritis since is it a chronic disease. In fact, many
of the patients in this survey were participating in some aspect of self -management. JP
effectiveness has been supported by systematic reviews. 6,7,14 Therefore, our finding that
only 10 had participated in suggests that there is a substantial gap in awareness, delivery
and accessibility of these programs.
Respondents identified several challenges to participate in JP programs. This suggests that
flexibility in how/when programs are offered is a critical factor in program planning.
Patients placed high importance on participation in JP if research findings show that this
program actually works. Pain reduction outcomes, joint deformity prevention, hand
function and grip strength outcomes were all judged as being “extremely important” by the
patients. Since all of these outcomes are important to patients it may be that adherence
could to JP could be improved by clear explanations of how JP can benefit each of these
outcomes both a conceptual level and with the current research evidence that suggests
benefits to these outcomes.
The level of participation preferred by potential participants in JP in this study equates to
3-6 hours/week, and is similar to that performed in clinical trials of JP in patients with
osteoarthritis and rheumatoid arthritis in the hand. 15–17 Half of the respondents ranked the
online format as the first choice over all the other methods of delivery of JP with home
program being the second most preferred choice. This finding is consistent with a recent
study where patients with RA reported that a home version of a hand exercise program,
which was held online was very useful and authors suggested that this might contribute to
better adherence in long term.18 Data from an RCT of behavioral and hand exercises
interventions in women with arthritis also suggested home programs may increase
participation.19 The recent pandemic has forced many countries to re-evaluate how care is
delivered to maintain social distancing or self-isolation.20 The pandemic has heighted the
lack of access to care for people with arthritis as this care is considered non-essential. At
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the same time, it has opened up the pathway for innovation and acceptance of alternative
delivery models that provide remote accessibility. Since our data was collected prepandemic, we can only assume that preference for online programs would have increased.
While the efficacy of JP interventions with hand exercises has been evaluated it is difficult
for patients with hand arthritis to have confidence that an online or remote intervention is
equally effective method to control their symptoms without being tested in future trials.7
This underlines the importance of trials and post-trial implementation studies to provide
more definitive evidence on the impact of virtual JP programs.
The third most preferred choice of JP delivery was at the clinic. Our previous studies of
information access preferences in patients with fibromyalgia 21,22 indicated that face-to face
interaction with health care providers was the most preferred way of getting information
and it likely that this is the positive aspect for attend ing a clinical site. Previous review has
indicated that patient-centered interaction styles related to the provision of emotional
support and allowing patient involvement in the consultation process may enhance the
therapeutic alliance between clinician and patient.23 Effective communication between the
clinician and the patient is relied on verbal but also on non-verbal factors, and this can
usually be achieved in an in-person encounter.24 The value of face-to-face interaction may
mean that online interventions although theoretically more accessible, may not instigate
the same level of engagement or adherence.
Another key finding of this study is that the cost of the JP program, working commitments,
the time that JP is offered as well as the distance from home to clinic were regarded as the
main barriers and could substantially decrease participation in JP. Financial burden, time
has been previously described for patients with rheumatoid arthritis as a perceived
barrier.25,26 From the qualitative analysis barriers associated with health factors were novel,
and not well captured in the survey.
Respondents identified a variety of perceived important outcomes with pain reduction,
joint deformity prevention and hand function being the main predominant ones. This is
consistent with the core set outcome measures that has been proposed from OMERACTOsteoarthritis Research Society International (OMERACT-OARSI) set of responder
criteria.27 Clinical outcomes for hand OA such as aesthetic damage in the joints and
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measured performance and function have been recommended by patients. 28,29 Based on
patients’ perceived benefit, JP programs appeared to have neutral to positive impact on
stiffness, pain, grip strength, hand function and swelling. While this is consistent with a
recent meta-analysis7,14 there was a very low number of respondents that used JP in our
sample.
Our study has several limitations that need to be taken into account when interpreting our
study findings. Since the survey was designed for English speakers with hand arthritis,
people speaking other languages were not represented. Potentially cultural, language and
health system issues could affect preferences. The survey responses were recorded online,
and patients did not have access to electronic devices could not participate in the survey.
However, we offered a paper version survey for individuals as an alternative. Finally, the
small sample of people with experience of JP prevented us from adequately exploring the
perceptions of patients who had completed the training.

5.6

Future research and clinical implications

While this survey is a first step to understand what factors affect participation rates in
people who are candidates for JP, studies that collect patient perceptions of draft programs
in a co-design process are needed to create a patient-preference based JP program. It is
possible that preferences will change or become more specific through a co-design process.
A future trial to compare alternative delivery models is highly needed. Our survey
identified principles of JP that the patients perceived as extremely important and it is
unclear if these components were present in the published efficacy trials, since these studies
have inadequate reporting.7 Adherence to guidelines such as Template for Intervention
Description and Replication (TiDIER) and presentation of theoretical assumptions for the
content of programs would improve fidelity across studies and in converting current JP
programs to online formats.30 One of the most important findings of our work is the lack
of awareness about, and participation in JP in a sample of people for who current best
evidence suggest this would be effective. Education of health care professionals about this
option and improved accessibility to programs is indicated to improve clinical outcomes.
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5.7

Conclusions

Awareness of the potential benefits of JP, and prior experience with JP program were very
low. Common potentially modifiable patient-reported barriers to participate in future JP
interventions, included: cost, work commitments distance from home to clinic and times
that the JP intervention were provided. These barriers might be addressed with free and
accessible forms of delivery of JP, which may lead to better uptake and participation in JP.
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Table 6-1. Sample characteristics
Variable
Age (years)
18 – 24
25 – 34
35 – 44
45 – 54
55 – 64
65 – 74
75 – 84
Diagnosis (hand)
Osteoarthritis
Rheumatoid arthritis
Psoriatic arthritis
Other form of arthritis
None of the above
Joint Protection
I am currently taking part in a joint protection program
I have previously taken part in a joint protection program
I have heard about joint protection but have not taken part in a program
I have not heard about any joint protection programs
Setting
Inpatient- rehabilitation unit
Inpatient- hospital
Outpatient- hospital
Home care
A rehabilitation centre/ clinic
Family Physician
Joint protection provider
Family physician or specialist
Occupational therapist
Physiotherapist
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%

n

3%
11%
26%
26%
23%
7%
1%
22%
51%
16%
7%
5%

5
19
45
45
39
12
2
182
38
92
29
13
10

4%
5%
10%
82%

6
7
17
134

8%
8%
38%
8%
15%
23%

1
1
5
1
2
3

38%
46%
15%

5
6
2

Table 6-2. Examples provided of joint protection from patients that used them
Example 1
Example 2

Example 3

“Learned how to do things safer for my hands, re-enforced pacing”
“Wearing thumb caps for working in the garden, wrist guards while using my hands.
Splints for hands and feet”
“I choose to use larger muscles and joints to aid me in completing day to day tasks,
and I use splinting to reduce pain, weakness, and fatigue”
“I wore resting splints for 30 years. I have a key turner and a right-angled knife. I try

Example 4

to always use the largest joints. My taps and light switches are modified. I changed my
cupboard handles. I use lightweight plates and an electric toothbrush”
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Figure 6-1. Individuals who took part into joint protection (n=10) where to asked to
what extent did the joint protection (JP) affect stiffness, pain, grip strength, hand
function and swelling. Only 2 out of 10 individuals that participated in JP
experienced slightly worse to much worse outcomes
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Figure 6-2. Factors perceived either as facilitators or barriers that may affect
participation in a joint protection program.
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Figure 6-3. Participants were asked to rate the following components of joint
protection from “extremely useful” to “extremely useless
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Figure 6-4. Individuals were asked how often they used the following modalities to
manage their symptoms
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Chapter 6
7

Evaluation of the Content Validity Index of the
Australian/Canadian Osteoarthritis hand Index, the PatientRated Wrist/Hand Evaluation and the Thumb Disability
Exam in people with hand arthritis

Abstract
Background
The Australian/Canadian Osteoarthritis Hand Index (AUSCAN), the Patient -Rated
Wrist/Hand Evaluation (PRWHE) and the Thumb Disability Exam (TDX) are patientreported outcome measures (PROM) designed to assess pain and hand function in patients
with hand arthritis, hand pain and disability, or thumb pathology respectively. This study
evaluated the content validity of AUSCAN, PRWHE and TDX in people with hand
arthritis.
Methods
This study enrolled participants with hand arthritis to rate the items of all 3 PROM in terms
of relevance and clarity. The Content Validity Index (CVI) was computed for each item
in each scale (I-CVI) as well as for the overall scale (S-CVI). Kappa was used to determine
the inter-rater agreement among the raters.
Results
Overall, 64 individuals with hand arthritis (27% with OA, 67% with rheumatoid arthritis
and 6% with psoriatic arthritis) participated in the study. The I-CVI for all items and all
scales were very high (I-CVI > 0.76) and the modified Kappa agreement among the raters
demonstrated excellent agreement (k>0.76).The S-CVI for all PROMs was very high for
relevance (AUSCAN = 0.92, 95% CI 0.90 to 0.94; PRWHE = 0.85, 95% CI 0.82 to 0.88
and TDX = 0.87, 95% CI 0.85 to 0.89) and for clarity (AUSCAN = 0.99, 95% CI 0.98 to
1.00; PRWHE = 0.95, 95% CI 0.93 to 0.97 and TDX = 0.91, 95% CI 0.89 to 0.94),
respectively.
Conclusions
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This study demonstrated very high content validity indices for the AUSCAN, PRWHE and
TDX; with strong consensus across raters. This augments prior studies demonstrating
appropriate statistical measurement properties, to provide confidence that all three
measures assess important patient concepts of pain and disability.
Keywords: osteoarthritis, rheumatoid arthritis, psoriatic arthritis, content validity, hand
arthritis

Reproduced with permission from Bobos P, MacDermid JC, Boutsikari EC, Lalone EA,
Ferreira L, Grewal R. Evaluation of the content validity index of the Australian/Canadian
osteoarthritis hand index, the patient-rated wrist/hand evaluation and the thumb disability
exam in people with hand arthritis. Health Qual Life Outcomes 2020;18(1):302. Copyright
© BMC Health Qual Life Outcomes ®

7.1

Introduction

Hand osteoarthritis (OA) is one of the most common musculoskeletal diseases and a
leading cause of disability with an increasing prevalence mainly attributed to increased life
expectancy.1,2 Clinical characteristics of hand OA typically involve pain, reduced hand
function, decreased hand grip strength, poor quality of life 3,4 joint degeneration, bony
enlargements and joint swelling.5 Rheumatoid arthritis, although leading to bone tissue
abnormalities, loss of joint function and impact on quality of life similarly to OA, is a
distinct pathology that mainly targets synovial and soft tissue structures. 6
Patient-reported outcome measures (PROMs) are often administered to assess any healthrelated changes that may have occurred as a consequence of health-management
interventions.7,8 Many properties are important 9–13 during an instrument development such
as reliability and validity but a key property is considered to be content validity. 14 Content
validity can be defined as the degree of which the instrument or the questionnaire is an
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adequate reflection of the construct being measured. 15 Based on the Consensus-based
Standards of the selection of health Measurement Instruments (COSMIN) initiative content
validity is considered as one of the most important measurement properties. 14 While
reliability, responsiveness and other types of validity can be pivotal for an outcome
assessment they may be insufficient to establish the validity of a PROM.16 When PROMs
include irrelevant items and lack of clarity they are inefficient, and may have weaker
measurement properties.14 Most importantly, if key aspects are missing or the questions
are not relevant responses, they may not reflect patient status or concerns, and may be
biased because patients may get frustrated. 17
The Australian/Canadian Osteoarthritis Hand Index (AUSCAN)

18 ,

the Patient-Rated

Wrist/Hand Evaluation (PRWHE)18 and the Thumb Disability Exam (TDX)19 are clinical
tools designed to assess pain and hand function in hand arthritis.

18–21

Both AUSCAN and

PRWHE have demonstrated construct validity with verbal rating scale, had high internal
consistency, and correlated with each other at baseline and follow-up time points in patients
with early thumb carpometacarpal OA. 18 However, previous studies have reported
inconsistent results about construct validity of AUSCAN.22–24 Haugen et al showed that
AUSCAN total index lacks construct validity with items contributing to separate scales of
pain, stiffness, and physical functioning.24 Also, a recent update of PRWHE was performed
to improve the clarity and applicability of items, but this version has not been compared to
the AUSCAN and it is important to assess the content validity of the revised scale. The
TDX is a more recently developed scale that has not been compared to either the PRWHE
or AUSCAN. Although, previous studies have demonstrated appropriate statistical
measurement properties, content validity evaluations are needed to ensure that the
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constructs being evaluated are those intended, and that items are interpreted probably by
potential respondents. Limited investigation of content validity has been reported for any
of these three questionnaires. Therefore, we aimed to investigate the quantification of
content validity index by asking patients with hand arthritis to rate each of the instruments
items in terms of relevance and clarity.

7.2

Primary Objective

To evaluate the Content Validity Index (CVI) of the Australian/Canadian Osteoarthritis
Hand Index (AUSCAN), the Patient-Rated Wrist/Hand Evaluation (PRWHE), and the
Thumb Disability Exam (TDX) in patients with hand arthritis.

7.3
7.3.1

Methods
Study Design

This study was a cross-sectional design that investigated the content validity of patientreported outcomes (AUSCAN, PRWHE and TDX) for hand arthritis. Ethical approval was
granted from the Hamilton Integrated Research Ethics Board (HiREB).

7.3.2

Inclusion criteria:

1. The participant was able and willing to provide informed consent
2. Participants were between 18 - 85 years old
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4. The participant had hand arthritis.
5. The participant can read and write English.

7.3.3

Exclusion criteria

1. Hand pathologies or conditions other than arthritis
2. Inability to answer the survey questions in English.

7.3.4

Setting and Recruitment

Participants were recruited through poster advertisements at The Roth McFarlane Hand
and Upper Limb Centre (HULC) at St. Joseph’s Health Care Hospital in London, Ontario
and through The Arthritis Society main website. The patients that expressed interest to
participate in the study received a letter of information about the survey. Both electronic
and paper versions of the survey were available for participants. An email with the link of
the online survey was sent out to the participants that were interested to complete the
electronic version. The electronic version was hosted on Qualtrics from May 2019 till
February 2020 which is a secure data collection platform.25 Participants were asked to
provide consent to proceed into the survey questions. Allthe items were rated for relevance
and clarity in an order (AUSCAN, PRWHE, TDX). Participants were asked to rate the
relevance and clarity of each item of AUSCAN, PRWHE and TDX.
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7.3.5

Patient-reported Outcome Measures

The Australian/Canadian Osteoarthritis Hand Index (AUSCAN) is a 15-item self-reported
disease specific questionnaire measuring pain (5-items), function (9-items) and stiffness
(1-item) in the hand on a scale from 0 – none to 4 – extreme for all items.18,20 The PatientRated Wrist/Hand Evaluation (PRWHE)is a self-administered questionnaire which has 2
subscales of pain (5-items) and function (10-items). The PRWHE was originally developed
and tested for people with distal radius fracture (DRF) 21,26,27 and later validated as
applicable to the wrist/hand for multiple conditions including arthritis as the PRWHE. 18,28
Each item is scored from 0 to 10 scale which 10 indicates the worst possible pain or
disability. The Thumb Disability Exam (TDX) is composed of 20 questions divided into 3
sections: hand function (11-items), pain (5-items) and satisfaction (4-items). Each item for
hand function is scored from 1 – not difficult to 5 – unable, for level of pain 1 – never to 5
– always and for satisfaction from 1 – very satisfied to 5 – very dissatisfied. 19

7.3.6

Data Analysis

Descriptive statistics were used to capture the demographics characteristics (age, diagnosis,
medications and whether they had surgery or not) of the included sample. A Content
Validity Index (CVI) value was computed for each item on the AUSCAN, PRWHE and
TDX (I-CVI) as well as for the overall scale (S-CVI). To calculate an item-level CVI (ICVI), patients with hand arthritis were asked to rate the relevance of each item, on a 4point scale. Four ordinal points were used foreach scale which was 1=not relevant,
2=somewhat relevant, 3=quite relevant, 4=highly relevant. Then, for each item, the I-CVI
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was computed as the number of patients giving a rating of either 3 or 4, divided by the
number of raters—that is, the proportion in agreement about relevance and clarity which is
between 0 and 1. The S-CVI was calculated by averaging across the I-CVIs of each PROM.
To calculate the modified kappa statistic, the probability of chance agreement (Pc) was first
calculated for each item by the following formula: Pc= [N! /A! (N -A)!] *0.5N with N being
the number of raters (patients with arthritis) and A is the number of patients that agree that
the item was clear or relevant.29 Then Kappa was calculated of entering the probability of
chance agreement (Pc) and content validity index of each item (I-CVI) in the following
formula: K= (I-CVI - PC) / (1- PC).29 Kappa values of 0.74 and above were considered as
excellent, 0.60 to 0.74 as good and 0.54 to 0.59 as fair. 30 We performed a Shapiro-Wilk as
the omnibus test for assessing univariate normality of each S-CVI distribution, in both
relevance and clarity subscales of PROMs. Then, the S-CVI scores were compared with a
paired student’s t-Test if normality assumption was met or with Wilcoxon paired signedranks test, if assumptions of normality were violated. 31 We conducted all the analyses with
STATA (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX:
StataCorp LLC)

7.4

Results

Overall, 64 individuals with hand arthritis (27% with hand OA, 67% with rheumatoid
arthritis in the hand and 6% with psoriatic arthritis) participated in the study. Four
individuals were excluded from the analysis because their arthritis was not affecting their
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hand. The majority of the participants (66%) were taking pain medication on a daily basis
(Table 1). All individuals completed the electronic version of the survey.

7.4.1

Content Validity Index and Modified Kappa agreement of
the AUSCAN

The I-CVI and the S-CVI supported the content validity of the hand pain, stiffness and
function items and subscales of the AUSCANs (Table 2). Five items of pain subscale were
rated for relevancy and clarity with I-CVI scores ranging from 0.86 to 0.96 and from 0.92
to 1.00 respectively. For 1-item in stiffness subscale the I-CVI was found 0.93 for
relevancy and 1.00 for clarity. For function subscale, 9-items were rated for relevancy and
clarity with an I-CVI ranging from 0.88 to 0.97 and from 0.98 to 1.00 respectively. The SCVI for AUSCAN was found 0.92,95% CI: 0.90 to 0.94 for relevance and 0.99, 95% CI:
0.98 to 1.00 for clarity. The modified Kappa agreement for every item of the AUSCAN
demonstrated excellent agreement (K ranging from 0.86 to 1.00)

7.4.2

Content Validity Index and Modified Kappa agreement of
the PRWHE

The I-CVI and the S-CVI of the PRWHE for pain subscale and function subscales all
supported the content validity of the PRWHE (Table 3). Five items of pain subscale were
rated for relevancy and clarity with I-CVI values ranging from 0.79 to 0.89 and from 0.87
to 0.94, respectively. For function subscales, 10 items were rated for relevancy and clarity
with I-CVI values ranging from 0.79 to 0.95 and from 0.92 to 1.00 respectively. The S-
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CVI for PRWHE was 0.85, 95% confidence intervals (CI): 0.82 to 0.88 for relevance and
0.95,95%CI: 0.93 to 0.97 for clarity. The modified Kappa agreement for every item of
PRWHE demonstrated excellent agreement (K ranging from 0.79 to 1.00).

7.4.3

Content Validity Index and Modified Kappa agreement of
the TDX

The I-CVI and the S-CVI supported the content validity of the TDX for hand function, pain
and satisfaction subscales (Table 4). Eleven items of hand function were rated as relevant
and clear with I-CVI values ranging from 0.82 to 0.93 and from 0.94 to 0.98 respectively.
For pain subscale, five items were rated as relevant and clarity with I -CVI scores ranging
from 0.78 to 0.85 and from 0.77 to 0.86 respectively. For the satisfaction subscale, four
items were rated as relevant and clear based on I-CVI demonstrating scores from 0.83 to
0.95 and from 0.88 to 0.91. The S-CVI of TDX was rated as relevant and clear based on
scores of 0.87,95% CI: 0.85 to 0.89 for relevancy and 0.91, 95% CI: 0.89 to 0.94 for clarity.
The modified Kappa agreement demonstrated excellent inter-rater agreement on item
ratings (K ranging from 0.77 to 0.98).

7.5

Discussion

This study established a high level of content validity for AUSCAN, PRWHE and TDX
for patients with hand arthritis. The content validity index was very high for all the
individual items for each questionnaire (I-CVI> 0.77) and for the overall score (S-CVI >
0.85) in terms of relevancy and clarity, exceeding the recommended benchmarks of 0.78
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respectively.29 The Kappa inter-rater agreement of >0.75 was excellent across all the
individual items for all PROMs (AUSCAN, PRWHE and TDX) among the raters. 29
Together these data provide confidence in our assessment since multiple raters agreed on
the high content validity scores obtained.
For the AUSCAN the content validity was established during development using a formal
clinimetric process where patients in a tertiary care centre rated items by importance and
frequency to establish relevance.20 This study provides additional support for the content
validity in a community sample of people living with hand arthritis, and by adding new
data on the clarity of the items.
Content validity of PRHE was established during the development of the PRWHE by using
semi-structured interviews in patients with distal radius fracture and expert opinion.
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Later the extension to the PRWHE compared relevance to DASH, based on a comparative
trial in a mixed clinical population with hand problems. However, neither were quantified,
described specific findings in-depth or focused on patients with arthritis. Thus, this study
provides novel information on the content validity of the items of the PRWHE, with
specific reference to those with hand arthritis. All items of PRWHE were found with very
high content validity index in terms of relevance (I-CVI > 0.79) and clarity (I-CVI > 0.87).
It might have been expected that the AUSCAN would have more relevance to our sample,
than the PRWHE since it a disease-specific PROM. Both point estimate and CI
comparisons indicate that AUSCAN had slightly higher overall scores in terms of
relevancy (S-CVI = 0.92, 95% CI: 0.90 to 0.94) and clarity (S-CVI = 0.99, 95% CI: 0.98
to 1.00) than the PRWHE (S-CVI=0.85, 95% CI :0.82 to 0.88 for relevancy and S135

CVI=0.95, 95% CI: 0.93 to 0.97 for clarity). Although the CIs of the respective S-CVIs
indicate that there was a small statistically significant difference (Table 5) between
compared S-CVI values (AUSCAN vs TDX and AUSCAN vs PRWHE), all PROMs met
standards of very high content validity. Further, since 6 to 8 additional raters assessed the
PRWHE that did not assess the AUSCAN, the small differences may reflect differences in
rater pools rather than an actual difference in perceptions.
The TDX is relatively new developed PROM (Noback et al. 2017) 19 that was tested in
patients with basal joint arthritis. The TDX demonstrated very high content validity index
when assessed in terms of relevancy (S-CVI = 0.87, 95% CI: 0.85 to 0.89) and clarity (SCVI = 0.91, 95% CI: 0.89 to 0.94). All the individual items of the TDX had a very high
content validity index (I-CVI >0.77). No previous studies have reported the content validity
index of TDX. The item generation of TDX included the review of items from relevant
scales (Michigan Hand Questionnaire (MHQ)33 , Disabilities of the Arm, Shoulder, and
Hand (DASH)34 , AUSCAN 20 , PRWHE27 and McGill Pain questionnaire35 ). Then, the
development process included item reduction and pilot testing and then final item
reduction.19 Thus the items may have benefited from content validity efforts made in
developing the scales. Since the thumb is so important for overall hand function, it is not
surprising that this thumb questionnaire was found to have validity for patients with hand
arthritis.
Our kappa statistics indicated excellent agreement between patient raters after correcting
for chance agreement. (K> 0.77). The assessment from a large pool of patients (n> 60)
generated similar scores between the I-CVI and K scores. This has been previously
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described in the literature when the number of raters increasing and the probability of
chance (Pc) decreases the K agreement and I-CVI values tend to converge.29
This study provided novel data on the content validity index in 3 different PROMs in
patients with hand arthritis. Since few studies address content validity, this is important to
support the conceptual foundations of these measures and support their use in clinical
practice. While the computation of CVI is relatively easy, its major weakness is the failure
to adjust for chance agreement. However, the authors tried to mitigate this problem by
calculating a modified kappa agreement. 29,36 A potential limitation is that the items of the
PROMs were not randomized but the items were rated for relevance and clarity in an order
(PRWHE, AUSCAN, TDX). Since all three scales were brief, we would think it is unlikely
that there was an order effect, especially since the highest scores were found in the
questionnaire administered in the middle. CVI is one method of assessing content validity
and as a quantitative process are ideally suited to rating existing items, not to identification
of potential gaps in important constructs. Ideally CVI should be augmented by qualitative
techniques like cognitive interviewing or understanding the dimensions of the underlying
construct to be measured. Also, all three questionnaires demonstrated high content validity,
and existing evidence confirms that all three provide strong psychometric properties then
practical considerations might be the predominant difference that would guide selection.
For example, the AUSCAN requires that a licensee fee be paid to the developer, whereas
the other questionnaires are copyrighted but freely available for all users.
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7.6

Conclusions

This study demonstrated evidence of very high content validity index for all the individual
items and for the overall scale of AUSCAN, PRWHE and TDX for patients with hand
arthritis, with high agreement across raters. This augments prior statistical evidence
supporting statistical measurement properties, to provide support for the content validity.
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Table 7-1 Demographics of study participants
n

Percentage %

1

12%

8

13%

13

20%

17

27%

19

27%

5

78%

1

2%

17

27%

43

67%

4

6%

42

66%

10

16%

12

19%

49

77%

15

23%

Variable
Age, years
18-24
25-34
35-44
45-54
55-64
65-74
75-84
Diagnosis
Osteoarthritis
Rheumatoid arthritis
Psoriatic arthritis
Frequency of Medication
Daily
Upon pain
Other
Surgery
No
Yes
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Table 7-2. Content Validity Index of item relevancy and clarity, and Modified
Kappa agreement of the Australian and Canadian Osteoarthritis Index (AUSCAN)
Relevance
Item
Rate your pain
At rest
Gripping
Lifting
Turning
Squeezing
Rate your stiffness
After first wakening in the morning
Rate your difficulty when
Turning taps/faucets on
Turning a round doorknob or handle
Doing up buttons
Fastening jewellery
Opening a new jar
Carrying a full pot with one hand
Peeling vegetables/fruits
Picking up large heavy objects
Wringing out wash cloths
S - CVI

Clarity

Interpretation

Agreement

I-CVI *

Pc**

K***

Agreement

I-CVI *

Pc**

K***

49/57
55/57
55/57
54/57
55/57

0.86
0.96
0.96
0.95
0.96

< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5

0.86
0.96
0.96
0.95
0.96

49/50
49/49
49/50
46/50
50/50

0.98
1.00
0.98
0.92
1.00

< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5

0.98
1.00
0.98
0.92
1.00

Excellent
Excellent
Excellent
Excellent
Excellent

52/56

0.93

< 10 -5

0.93

48/48

1.00

< 10 -5

1.00

Excellent

51/58
0.88
< 10 -5
54/59
0.92
< 10 -5
52/59
0.88
< 10 -5
52/59
0.88
< 10 -5
57/59
0.97
< 10 -5
56/59
0.95
< 10 -5
56/59
0.95
< 10 -5
55/59
0.93
< 10 -5
52/59
0.88
< 10 -5
0.92 (95% CI: 0.90 to 0.94)

0.88
0.92
0.88
0.88
0.97
0.95
0.95
0.93
0.88

51/51
1.00
< 10 -5
53/53
1.00
< 10 -5
52/52
1.00
< 10 -5
53/53
1.00
< 10 -5
53/53
1.00
< 10 -5
52/53
0.98
< 10 -5
53/53
1.00
< 10 -5
51/51
1.00
< 10 -5
50/51
0.98
< 10 -5
0.99 (95% CI: 0.98 to 1.00)

1.00
1.00
1.00
1.00
1.00
0.98
1.00
1.00
0.98

Excellent
Excellent
Excellent
Excellent
Excellent
Excellent
Excellent
Excellent
Excellent

NOTE: *I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was computed using the
formula: pc= [N! /A! (N -A)!] *.5N where N= number of experts and A= number of experts who agree that the item is
relevant or clear, ***K(Modified Kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation
criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair=K of 0.40 to 0.59; Good=K of 0.60
to 0.74; and Excellent=K>0.74. I-CVI, item-level content validity index; scale-level content validity index, average (SCVI/Ave).
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Table 7-3. Content Validity Index of item relevancy and clarity and Modified Kappa
agreement of Patient Rated Wrist/Hand Evaluation (PRWHE)
Relevance
Item
1. Pain subscale
Rate your pain: At rest
Rate your pain: When doing a task
with a repeated wrist movement
Rate your pain: When lifting a
heavy object
Rate your pain: When it is at its
worst
How often do you have pain?
2. Function
A. Specific Activities
Turn a doorknob using my affected
hand
Cut meat using a knife in my
affected hand
Fasten buttons on my shirt
Use my affected hand to push up
from a chair
Carry a 10lb object in my affected
hand
Use bathroom tissue with my
affected hand
B. Usual activities
Personal care activities (dressing,
washing)
Household work (cleaning,
maintenance)
Work (your job or usual everyday
work)
Recreational activities
S – CVI/Ave

Clarity

I-CVI *
0.80
0.83

Pc**
< 10 -5
< 10 -5

K***
0.80
0.83

Agreement
50/53
49/53

54/64

0.83

< 10 -5

0.83

57/64

0.89

< 10 -5

50/63

0.79

53/63

Interpretation

I-CVI *
0.94
0.92

Pc**
< 10 -5
< 10 -5

K***
0.94
0.92

Excellent
Excellent

50/53

0.94

< 10 -5

0.94

Excellent

0.89

49/53

0.92

< 10 -5

0.92

Excellent

< 10 -5

0.79

47/54

0.87

< 10 -5

0.87

Excellent

0.84

< 10 -5

0.84

52/52

1.00

< 10 -5

1.00

Excellent

54/63

0.86

< 10 -5

0.86

53/53

1.00

< 10 -5

1.00

Excellent

51/63
50/63

0.81
0.79

< 10 -5
< 10 -5

0.81
0.79

53/53
51/52

1.00
0.98

< 10 -5
< 10 -5

1.00
0.98

Excellent
Excellent

58/63

0.92

< 10 -5

0.92

52/53

0.98

< 10 -5

0.98

Excellent

50/63

0.79

< 10 -5

0.79

51/52

0.98

< 10 -5

0.98

Excellent

53/61

0.87

< 10 -5

0.87

50/53

0.94

< 10 -5

0.94

Excellent

57/60

0.95

< 10 -5

0.95

49/53

0.92

< 10 -5

0.92

Excellent

52/60

0.87

< 10 -5

0.87

49/53

0.92

< 10 -5

0.92

Excellent

0.90

51/53
0.96
< 10 -5
0.95 (95% CI: 0.93 to 0.97)

0.96

Excellent

Agreement
51/64
54/64

54/60
0.90
< 10 -5
0.85 (95% CI: 0.82 to 0.88)

NOTE: *I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was computed using the
formula: pc= [N! /A! (N -A)!] *.5N where N= number of experts and A= number of experts who agree that the item is
relevant or clear, ***K(Modified Kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation
criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair=K of 0.40 to 0.59; Good=K of 0.60
to 0.74; and Excellent=K>0.74. I-CVI, item-level content validity index; scale-level content validity index, average (SCVI/Ave).
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Table 7-4. Content Validity Index of item relevancy and clarity, and Modified
Kappa agreement of the Thumb Disability Exam (TDX)
Item
A. Please indicate your ability to
perform these activities with the
affected hand
Turn a Key
Pick up a coin
Write
Squeeze Toothpaste
Hold a glass of water
Turn a doorknob
Use a knife to cut food
B. Please indicate your ability to
perform the following task while
using both your hands
Open a jar
Button a shirt/blouse
Tie your shoes
Wring a dishcloth/washcloth
II. The following questions refer to
the level of pain in your thumb
How often did you have pain in your
thumb at rest?
How often did the pain in your thumb
interfere with your daily activities?
How often did the pain in your hand
interfere with recreational activities?
How often did the pain in your thumb
interfere with your sleep?
How often did the pain in your thumb
worsen your mood?
III. The following questions ask
about your satisfaction with the
indicated hand or thumb over the
past week.
Motion in your affected thumb
Strength of your affected hand
Pain level of your affected hand
Overall function of your hand
S-CVI

Relevance

Clarity

Interpretation

Agreement

I-CVI *

Pc**

K***

Agreement

I-CVI *

Pc**

K***

54/61
52/61
56/61
52/60
50/61
52/61
54/61

0.89
0.85
0.92
0.87
0.82
0.85
0.89

< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5

0.89
0.85
0.92
0.87
0.82
0.85
0.89

51/53
49/51
51/54
51/53
51/54
51/53
51/53

0.96
0.96
0.94
0.96
0.94
0.96
0.96

< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5
< 10 -5

0.96
0.96
0.94
0.96
0.94
0.96
0.96

Excellent
Excellent
Excellent
Excellent
Excellent

57/61
53/61
55/61
53/61

0.93
0.87
0.90
0.87

< 10 -5
< 10 -5
< 10 -5
< 10 -5

0.93
0.87
0.90
0.87

50/51
49/50
50/51
49/51

0.98
0.98
0.98
0.96

< 10 -5
< 10 -5
< 10 -5
< 10 -5

0.98
0.98
0.98
0.96

Excellent
Excellent
Excellent
Excellent

50/61

0.82

< 10 -5

0.82

40/52

0.77

< 10 -5

0.77

Excellent

49/60

0.82

< 10 -5

0.82

44/51

0.86

< 10 -5

0.86

Excellent

51/60

0.85

< 10 -5

0.85

44/52

0.85

< 10 -5

0.85

Excellent

47/60

0.78

< 10 -5

0.78

44/52

0.85

< 10 -5

0.85

Excellent

51/60

0.85

< 10 -5

0.85

42/52

0.81

< 10 -5

0.81

Excellent

0.83
0.95
0.90
0.91

47/53
0.89
< 10 -5
48/53
0.91
< 10 -5
48/53
0.91
< 10 -5
46/52
0.88
< 10 -5
0.91 (95% CI: 0.89to 0.94)

0.89
0.91
0.91
0.88

Excellent
Excellent
Excellent
Excellent

48/58
0.83
< 10 -5
54/57
0.95
< 10 -5
52/58
0.90
< 10 -5
53/58
0.91
< 10 -5
0.87 (95% CI: 0.85to 0.89)

NOTE: *I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was computed using the
formula: pc= [N! /A! (N -A)!] *.5N where N= number of experts and A= number of experts who agree that the item is
relevant or clear, ***K(Modified Kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation
criteria for Kappa, using guidelines described in Cicchetti and Sparrow (1981): Fair=K of 0.40 to 0.59; Good=K of 0.60
to 0.74; and Excellent=K>0.74. I-CVI, item-level content validity index; scale-level content validity index, average (SCVI/Ave).
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Excellent

Table 7-5. Comparison of content validity index (S-CVI) of Relevance and Clarity
Relevance

Clarity

PRWHE

TDX

AUSCAN

Paired
t-Test

Paired
t-Test

PRWE

TDX

0.85
(95% CI:
0.82-0.88)
p=0.523

Paired
t-Test

AUSCAN

p <0.001

0.87
(95% CI:
0.85-0.89)
p = 0.001

0.92
(95% CI: 0.900.94)

PRWE

PRWHE

TDX

AUSCAN

Wilcoxon
Signed ranks

Wilcoxon
Signed ranks

TDX

0.95
(95% CI:
0.93-0.97)
p = 0.153

Wilcoxon
Signed ranks

AUSCAN

p = 0.001

0.91
(95% CI: 0.890.94)
p = 0.002

0.99
(95% CI: 0.981.00)

Paired t-Test: Student’s t-Test for Matched Pairs; Wilcoxon Signed Ranks: Wilcoxon Matched-Pairs Signed-Ranks;
Australian and Canadian Osteoarthritis Index (AUSCAN); Thumb Disability Exam (TDX); Patient Rated Wrist/Hand
Evaluation (PRWHE)
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Chapter 7
8

The Efficacy of a Joint Protection Program on Pain Intensity
and Hand Function levels in People with Hand Osteoarthritis.
A Protocol for a randomized controlled trial

Trial Summary
What is the principal research question? In patients with hand osteoarthritis does a joint
protection program decrease pain intensity at 3 months compared to hand exercises.
PICOT Format
Population: Adult patients with primary type of hand osteoarthritis
Intervention: Joint protection program
Comparator: Hand exercises and joint protection
Outcome: Pain Intensity levels
Timeline: 1-year follow-up
Outcome: Primary outcome: Pain intensity levels at 3-months will be our primary outcome
(dependent variable) and will be investigated by the Visual Analog Scale (VAS). It consists
of a unidirectional 10 cm responsiveness scale with two anchors at either end of the scale;
0 - “no pain” and 10 - “worst possible pain”. Patients will be instructed to draw a vertical
mark on the scale indicating their pain level. Secondary outcomes: Secondary outcomes
that will be collected consist of the Global Rating of Change, quality of life with EQ-5D,
the Australian/Canadian Osteoarthritis Hand Index (AUSCAN), the Patient-Rated
Wrist/Hand Evaluation and hand grip strength that will be assessed with a handheld
dynamometer
Timeline: The maximum follow-up will be 1 year. The target of this trial is to demonstrate
superiority of joint protection versus the exercise and joint protection on pain reduction at
3 months follow-up.
Study Design: This study will be a single center, investigator-blinded, randomized, 12month, parallel-group, superiority study
Trial registration: ClinicalTrials.gov (intended)
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8.1
8.1.1

Introduction
Impact of Osteoarthritis

Osteoarthritis (OA) is characterized as a degenerative joint disease that affects
approximately 27 million adults in the USA and is one of the leading causes of disability. 1
Osteoarthritis affects 60-70% of the population above the age of 65 years, and is likely to
increase further in the future.2,3 The most common site of OA is the hand and it typically
involves the interphalangeal (proximal and distal) and first carpometacarpal joints. 4 In a
clinical setting, pain is a major symptom among patients with hand OA as it contributes to
a reduction in joint function.1,4 Currently there is no cure for hand OA, but goals of
treatment include maximizing long-term health-related quality of life, by controlling
symptoms such as pain, prevention of structural damage and normalization of function.

8.1.2

Age, Sex and Disease Progression in hand OA

Approximately 60–70% of the population above the age of 65 seek medical attention for
OA, and the majority of these are women. 5–7 Hand OA has a strong genetic influence,
indicating that if their mother had severe hand OA, they are likely to experience a similar
disability.5,6 The biological mechanisms by which increases hand OA disability for
females, is poorly elucidated. However, it may be a result of the smaller size of hand joints,
hormonally regulated soft tissue laxity, pregnancy-induced laxity and sex-differences in
pain.5–7 Gender may affect hand OA given the higher repetitive loading in paid and unpaid
work tasks performed more often by women. However, men tend to be under-represented
in studies of hand OA, so we may know less about how it manifests in men. Age has a
pivotal effect to diseases as OA and at pain outcomes because of the degeneration nature
of articular cartilage as we age.5–7 Additionally, pain intensity levels for people with hand
OA may vary depending on the disease progression and the structural modification. 7 This
suggests that age, sex and disease progression must be considered in the design stage as
potential confounding factors.
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8.1.3

Why Joint Protection and hand exercises are important?

Joint protection programs (JPP) are a self- management strategy for patients living with
arthritis to help preserve joint function and reduce pain. 8 JPP involve training on “safer
movement patterns, the use of adaptive devices (e.g. built up handles, hands free
technologies) and behavior modifications (e.g. activities to avoid, pacing). Originally
shown to be effective for rheumatoid arthritis, the concept has been expanded to treat
patients with OA.9–11 Osteoarthritis causes excessive fluid to surround the joint, which
when occurs for an extended period of time, causes the ligaments surrounding the joint to
become elongated and no longer adequately stabilize the joint. 12,13 Overtime, the cartilage
weight bearing surfaces become eroded and patients experience pain especially with joint
loading. Unlike the lower extremity where joint loading takes place through weight
bearing, joint loading in the upper limb is determined by the tasks performed. The lack of
soft tissue support makes joints in the hand susceptible to deformity during tasks of daily
life.14 Muscle imbalance can further exacerbate deformity, and thus the kinematics of how
tasks are performed are critical to cumulative loading.

8.1.4

The need for a trial in hand OA

Magni et al. has indicated clinically unimportant pain-relieving effects of hand exercises
for people with hand OA.15 A subsequent study reported that it is unclear if a combination
of hand exercises and joint protection program can provide better pain outcomes for people
with hand OA.16 Both reviews15,16 highlighted the low-quality certainty that was associated
for pain outcomes. The majority of the included studies were rated as high risk of bias
mostly for: selection, performance and detection bias domains.17–19 Furthermore, problems
with adherence to JPP and hand exercises were not documented. Hand dysfunction because
of pain is a very common problem in hand OA. Hand exercises and joint protection are
currently recommended in clinical practice but for people with rheumatoid arthritis only. 20–
23

Also, these recommendations are not supported by high-quality evidence as

recommended by Grading of Recommendations, Assessment, Development, and
Evaluation (GRADE) group.24 To address this, we will design a long-term evaluation of a
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joint protection program in large group of people living with hand OA. As part of this
evaluation, it is important to integrate strategies to maximize program adherence. The null
hypothesis of the study is that there will be no difference in pain outcomes between the two
arms at 3-months follow-up. It is unclear if a combination of hand exercises and joint
protection program can provide better pain outcomes for people with hand OA.

8.2
8.2.1

Objectives of the Study
Primary Objective

The first objective of this study is to assess if a JPP when compared to hand exercises and
joint protection, can reduce pain intensity levels in people with hand osteoarthritis, at 3months follow up

8.2.2

Secondary Objectives

1. To assess if JPP when compared to hand exercises and joint protection, can improve
hand function in people with hand osteoarthritis, at 6-months follow up

2. To assess if JPP when compared to hand exercises and joint protection, can improve
quality of life in people with hand osteoarthritis, at 12-months follow up

8.3
8.3.1

Methods
Study design

This study will be a single center, investigator-blinded, randomized, 12-month, parallelgroup, superiority study. The study flow is presented in Figure 2.
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8.3.2

Setting

This study will be conducted in a single center specialized tertiary hand clinic (Hand and
Upper Limb Centre – HULC) in London Ontario Canada. Advertisements will be placed
at regular intervals in local and regional newspapers and on social media platforms. This
will be accompanied by regular posting of advertisements on hospitals, community
noticeboards and in The Arthritis Society main webpage. Local health practitioners will be
made aware of the study through information and advertising packages. Participants with
hand OA will be contacted to schedule an initial visit at HULC. All participants who meet
the eligibility criteria and provide an informed written signed consent, will be offered an
opportunity to enroll in the study. Participants with hand OA will then complete a
demographic data such as age, gender/sex, email address, height, weight, years of service,
rank, educational level, use of NSAIDs and a set of outcome measures.

8.3.3

Eligibility Criteria

Our sample will include:
1. Participants (males and females) between 18 and 85 years old
2. Participants with primary type of hand osteoarthritis (non-traumatic)
3. Radiographic findings of OA
4. Meeting the ACR Classification criteria
5. Individuals able to speak and write in English
6. Have access to electronic devices (e.g. computer) and internet.
Participants will be excluded if they have:
1. Neurological disorders
2. Rheumatoid arthritis or any other type of arthritis than hand osteoarthritis
3. Dementia or any other cognitive condition that could interfere with the trial
procedures
4. Age less than 18 years
5. Upper limb joint surgery, or fracture, in the previous 6 months
6. Being on a waiting list for upper limb orthopedic surgery
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7. Pregnancy

8.3.4

Interventions

Exercises and Joint Protection (Ex+JP)
Participants that will be randomized to the Exercises and Joint protection (Ex+JP) arm will
have a specific exercise program plus a joint protection that described above. The exercise
program will include seven mobility exercises and four strength exercises against
resistance. More specifically, they will perform: MCP flexion, tendon gliding, radial
walking, eccentric wrist extension, gross grip, finger abduction and adduction, wrist
circumduction and finger pinch. This intervention will involve a total of six sessions (1
hour per session). Individuals will be provided with an exercise booklet containing pictures
and instructions describing the program, as well as the resistance materials required. They
will be asked to perform the program daily at home between clinic sessions, for a period
of approximately 12 weeks. The dosage consists of 1 set and 10 repetitions for each
exercise. Adherence to the exercise program is pivotal in ensuring that the dosage will be
carried out. Patients adherence in home exercise programs is usually poor, but it will be
enhanced through the use of exercise diaries.

8.3.5

Joint Protection (JP)

Joint protection will include patient education, problem-solving to promote behavior
modification; energy conservation; and selective use of splints and adaptive devices and
provision of The Arthritis Society booklets containing further advice. The following
principles will be explained during the joint protection instruction: the need for balance
between movement and resting a joint; dividing stress between as many joints as possible;
using larger and stronger joints; using each joint in its most stable plane to reduce pressure
on the joint; avoiding staying in one position; and avoiding vibrations for the finger joints.
In addition, patients were trained to protect their joints, using assistive devices if necessary,
to perform Activities of Daily Living (ADL). Patients were trained to do the following
activities in a protective way: wringing a cloth; using enlarged grips for writing; opening
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jars, cans, or boxes with Dycem; using a book holder for reading; and using a rocker or
angled knife for cutting food. Patients will be encouraged to find examples for application
of these principles in their own daily activities, which were discussed. Oral and written
information will be provided. Participants that will be randomized to the JP arm will have
individual appointments with a therapist (number of sessions dependent on clinical need
up to a maximum of three sessions or 1.5 hours in total). They will be no resting splints
provided, no explicit exercise prescription, no manual therapy (i.e. joint mobilizations) or
electrotherapy, with assessment and treatment to be documented using a standardized log.

8.3.6

Outcomes

Pain intensity levels at 3-months will be our primary outcome (dependent variable) and
will be investigated by the Visual Analog Scale (VAS). 25 It consists of a bidirectional 10
cm responsiveness scale with two anchors at either end of the scale; 0 - “no pain” and 10 “worst possible pain”. Patients will be instructed to draw a vertical mark on the scale
indicating their pain level.25 Secondary outcomes that will be collected consist of the
Global Rating of Change26 , quality of life with EQ-5D27 , the Australian/Canadian
Osteoarthritis Hand Index (AUSCAN)28 , the PRWHE and grip strength.29 While several
domains can be assessed in OA trials, the Outcome Measures in Arthritis Clinical Trials
(OMERACT) expert group30 has identified 3 core variables (pain, function and global
assessment) that require inclusions in OA studies. 30

8.3.7

Participant Timeline

Outcome measures will be collected through Patient Reported Outcomes; at baseline (1430 days after randomization for all participants), at 3-months, 6-months and 12-months.

8.3.8

Sample Size Estimation

Response to treatment will be based on OMERACT-OARSI criteria.30,31 According to
these criteria, a response has occurred if the patients experience a reduction of ≥50% from
baseline and an absolute reduction of ≥20% in OA pain intensity (10 cm VAS). If we
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consider a 20% as a clinical important margin on VAS pain scale, 80% power at 5%
significance level and assuming a scenario of 25% loss of follow-up a total sample size of
347 patients will be needed (Figure 1)

8.3.9

Recruitment

Participants will be recruited through the email list of The Arthritis Society and from the
Hand and Upper Limb Centre (HULC) at St. Joseph’s Health Care Hospital in London,
Ontario. This will be conducted by contacting people who have previously expressed
interest in participating in research initiatives through the organization. The Arthritis
Society is a non-profit organization a with a well-established network and facilitates at the
Federal and Provincial level to raise awareness and community engagement for people with
arthritis in more than 40 communities across Canada. The HULC Centre is a respected,
world renowned center of excellence in education, research, and treatment of patients with
complex conditions affecting hands, wrists, elbows and shoulders requiring specialized
care. Patients that are covered under OHIP have accessibility to the HULC clinic. One of
the most common conditions that is treated at HULC is patients with arthritis.

8.3.10

Allocation

We will use block randomization with blocks of randomly selected sizes through a central
web- based randomization system in a 1:1 ratio for the two arms. Central randomization
will be conducted using a central randomization web-based program. The randomization
process will be initiated by the trial coordinator who will access the web-based system and
enter the patient’s information and confirmation of eligibility criteria. In order to secure
the allocation concealment only once the participant will be registered in the trial then the
random allocation will be generated by central randomization. Therefore, we will control
for any confounding factors during randomization, but also to eliminate “selection
bias”.19,32
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8.3.11

Blinding

To avoid performance bias, participants will be aware that two procedures (active
treatments) are being compared. However, they will be unaware that one treatment is a
control, as neither the consent forms nor the verbal explanations referred to the attention
control intervention as a control treatment. Thus, participants could reasonably expect an
improvement regardless of treatment received. All interventions will be delivered by
physiotherapists who work at HULC which they are certified hand therapists. They will be
independent of the recruitment and randomization procedures, and they will attend a
training session delivered by the trial team. Participants will receive ongoing support and
guidance regarding the intervention. Therapists will be trained to deliver both the
experimental and control interventions without knowing which one it is. Contamination
will be minimized through monitoring the treatment logs completed at each session. To
protect against detection bias18 , the outcome assessor will be blind to group allocation and
independent of the treatment delivery. Participants will be requested not to disclose group
allocation to the outcome assessor. If an outcome assessor will be unblinded, this will be
recorded

8.4
8.4.1

Data Collection
Primary outcome

Hand pain will be the primary outcome measure at 3 months, and it will be measured using
a 100mmVAS by asking “on this line, where would you rate your pain, using the last 7
days as a timeframe. It consists of a bidirectional 100 mm responsiveness scale with two
anchors at either end of the scale; 0 - “no pain” and 10 - “worst possible pain”. Patients
will be instructed to draw a vertical mark on the scale indicating their pain level. 25 The
VAS scale is valid and retest reliable in an outpatient clinical practice setting.33
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8.4.2

Secondary Outcomes

The Patient-Rated Wrist/Hand Evaluation (PRWE)is a self-administered questionnaire
which has 2 subscales of pain (5-items) and function (10-items). The PRWE was originally
developed and tested for people with distal radius fracture (DRF) and later validated as
applicable to the wrist/hand for multiple conditions including arthritis as the PRWHE.45
Each item is scored from 0 to 10 scale which 10 indicates the worst possible pain or
disability.
The Australian and Canadian Osteoarthritis Index (AUSCAN) is a 15-item self-reported
disease specific questionnaire measuring pain (5-items), function (9-items) and stiffness
(1-item) in the hand on a scale from 0 – none to 4 – extreme for all items.28
Global rating of change (GROC) is patient-reported outcome that will be evaluated at 3-,
6- and 12-months follow-up. Participants will be asked to rate their overall change in hand
pain on a six- point Likert scale (completely recovered, much improved, improved, no
change, worse, much worse). GROC has been used to evaluate outcomes in clinical trials
of OA pain.26,35,36
Hand grip strength will be evaluated at baseline, at 3-, 6- and 12-months follow-up with a
Jamar hand-held dynamometer.29 The testing procedure for evaluating hand grip strength
will use a standardized positioning with Jamar grip dynamometers that will be calibrated.
Participants will be requested to complete three trials of hand grip strength bilaterally with
a 15 s time break across the three measurements. The mean of the three trials will be
calculated. For each trial, participants were seated comfortably in a chair, had their elbow
flexed with the forearm and wrist in a neutral position. They will be asked to hold the grip
for 2 to 3 s to ensure that the maximum hand grip strength had been achieved. Hand grip
strength assessment has been found a valid and reliable procedure. Pooled results from a
recent meta-analysis have indicated an ICC 0.95, 95% CI: -0.93 to 0.97 for upper extremity
conditions.37 Regarding the minimum clinically important difference (MCID) of hand grip
strength that was based on a distribution-based method indicated that MCID estimates are
of 0.84 kg (affected side) and 1.12 kg (unaffected side) in the carpometacarpal
osteoarthritis.37
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The standard format of the EQ-5D-5L descriptive classification system developed by the
EuroQoL Group consists of five dimensions of health, each with three levels of problems.
It is a brief self- reported generic measure of current health that consists of five dimensions
(Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression), each
with three levels of functioning (no problems, some problems, and unable to/extreme
problems). The EQ-5D-5L appears to be a valid extension of the 3-level system which
improves upon the measurement properties, reducing the ceiling while improving
discriminatory power and establishing convergent and known-groups validity.38

8.5

Data Management

Data will single entered into the database by the study personnel. We will have 2 full-time
clinical research coordinators and 2 research assistants with research-related duties that
will include to prepare all study forms and materials, complete and maintain ethics
approvals, maintain study databases, assist with data collection, database setup and
management. The trial coordinator will be primarily responsible for subject recruitment
and maintaining consent documentation, production of intervention tools (handbooks),
maintaining and updating the trial policies and procedures manual, monitoring staff
compliance with hospital research policies and certifications manual, updating participants
in study processes and outcomes and support to the team conduct of the research.

8.6
8.6.1

Statistical Methods
Statistical Analysis

Participants will be analyzed according to the treatment group to which they will be
randomized (intention-to-treat analysis). Descriptive statistics will be used to summarize
for the baseline characteristics. For the primary outcome, Generalized Linear Modeling
(GLM) will test the between group differences over time, with age and gender as
covariates. The magnitude of the treatments will be reported as effect sizes for the whole
group and by gender. Clinically important differences along with 95% confidence intervals
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will also be calculated/reported for between- and within-group differences. The secondary
outcomes will be analyzed in a similar manner to the primary outcome measure. In case of
missing data, Multiple Imputation (MI) will be performed to resolve any missing data
issues.

8.7

Data Monitoring

The data monitoring ethics committee (DMEC) will be independent of the trial and it will
be tasked with monitoring ethical, safety and data integrity. The DMEC will be assembled
by 1 rheumatologist, 1 physical therapist and 1 senior statistician. All adverse events
occurring after entry into the study and until hospital discharge will be recorded.

8.8

Auditing

All sites will be visited to ensure smooth implementation of the interventions within the
trial. This quality control process involved the same clinical research fellow auditing
treatment logs and notes and observing experimental arm intervention sessions.

8.9
8.9.1

Ethics and Dissemination
Research Ethics Approval

The protocol will be reviewed and approved by the institutional research ethical board
(REB) with respect to scientific content and compliance with applicable research and
human subjects’ regulations
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8.9.2

Informed Consent Process

All patients will provide written informed consent to participate in the study. If patients are
not capable of providing consent the informed consent will be requested from the substitute
decision maker.

8.9.3

Confidentiality

Data collection will adhere to Health Insurance Portability and Accountability Act
(HIPAA) guidelines.

8.9.4

Declaration of Interests

The authors declare no conflict of interest

8.9.5

Access to Data

Data will be stored at HULC lab which is very secure place and only authorized personnel
have access to that area. Data can be available upon request to St. Joseph’s Hospital Health
Care London.

8.9.6

Ancillary and Post-trial Care

No specific post-trial care will be required

8.9.7

Dissemination and Policy

The study results will be presented in the Osteoarthritis Research Society international
conferences. Data obtained from this trial will be published in open access peer review
journal.
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8.10

Feasibility

Successful enrolment of the patients is always a potential pitfall of clinical research. At
HULC we have enrolled in the past more than 2000 patients in our clinical studies and have
(Canada Foundation for Innovation) CFI-funded patient testing infrastructure to complete
this work. HULC is situated as one of the biggest upper extremity unit in Canada. Over
14,000 patients visited annually this facility for therapy providing direct access to cohort
of patients required for this work. Based on these experiences, we will develop an
ambitious and impactful timeline that is reasonable given our expertise and resources. The
cost will involve no special equipment, but only the payments of research and clinical
personnel. The patient parking and commuting will be covered from our lab during the
follow-up days.

8.11

Significance

While medications such as non-steroidal anti-inflammatory drugs and analgesics relieve
musculoskeletal signs and symptoms; disease modifying drugs have shown to not be
effective.3,39,40 Tumor necrosis factor inhibitors have a positive role in inflammatory
arthritis41,42 , but did not show any effect in reducing pain for hand OA. 43,44 Considering
the lack of efficacy and the view of high costs of TNF inhibitors, 45 self-management is
fundamental to “living well while creating a future without arthritis”. Thus, it is important
that research define strategies that are best to lessen pain and improve function and preserve
joints. Our research will accomplish that aim in several ways. Most importantly, the
exercise and the joint protection programs will be provided in an online version for open
access use that will be free of charge.
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Outcome: Pain levels (0 – 10) Visual Analogue Scale.
Alpha α error = 0.05;
Beta β error = 0.2;

N=size per group;
zx = the z-score/standard normal deviate for a two-sided x;
δ = a clinically acceptable margin;
S2 = Pooled standard deviation of both comparison groups;

Figure 8-1. Sample Size calculation
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Figure 8-2. Flow diagram
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Chapter 8
9

General discussion and future directions
9.1

Overview of this dissertation

The purpose of this thesis was to provide evidence to better understand joint protection
interventions for people with hand arthritis. Arthritis is mainly symptomatic and treatment
strategies like joint protection may help to preserve joint function and mediate pain. There
are several factors that may affect the efficacy of joint protection intervention and how
these techniques are implemented into practice. To better understand these factors, we
conducted a thorough literature to investigate existing gaps on joint protection programs to
identify existing gaps in knowledge. We conducted 5 studies and we design a protocol for
a superiority trial to test the efficacy of standardized updated joint protection techniques
with hand exercises.
The first study that we conducted was a scoping review to map all the available evidence
in published and unpublished material around joint protection. This was an important step
because we found many trials that were never synthesized and analyzed together. We also
found that the most commonly reported responsible person for joint protection delivery
was an Occupational Therapist. We mapped all the available joint protection principles
from the grey literature, and we found that were many joint protection techniques that were
never mentioned or it was unclear if were ever tested.
The literature search from the first study enabled an evidence synthesis of all the available
RCTs for people with rheumatoid arthritis and osteoarthritis in the hand. We assessed the
efficacy of joint protection in three main outcomes (pain, function and grip strength) and
we found that there was low quality certainty of small effects on pain outcomes that did
not reach the clinically important margin for people with rheumatoid arthritis in the hand.
For people with hand OA, we found that the effects of joint protection were unknown
because there was lack of reporting and we were unable to calculate the effects.
The third study was an overview of systematic reviews that was focused to gather the
evidence from systematic reviews and to understand why nine different systematic reviews
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had findings in different directions. We assessed all included reviews and only 2 reviews
were of high quality. The majority of the reviews were mainly repeating the results from
the primary studies without re-analyzing and calculating the effects, but their
recommendations were based mainly on statistical significance. Our overview identified
that reviews used different critical appraisal tools and rarely these tools were taken into
account when results were interpreted from the authors.
The fourth study was a survey that aimed to understand individuals’ barriers, facilitators,
expectations and preferences. An important finding was that the majority of the people that
participated in the study never heard of joint protection. This a very important finding
because it highlights that there is a major gap in implementation of JPP between research
and clinical practice. Several barriers were identified such as cost of the program, time
when the program was offered and work commitments. Also, participants expressed their
preferences about the joint protection components that they think are useful to them. More
than 70% of respondents reported as extremely useful to find new ways to do tasks
differently to reduce joint loading.
The fifth study was a measurement study that tried to quantify the content validity of three
self-reported outcomes that are commonly used for people with hand arthritis. In this study
we used statistical methods to calculate the content validity index for each of item of the
scale, for the overall scale and kappa agreement among the raters. We found very high
content validity index for the three self-reported outcomes in terms of their relevancy and
their clarity for people hand arthritis. This finding will further support the use of these three
self-reported outcomes in clinical studies to measure the construct that the scales represent.
The sixth study was a protocol design for a superiority trial. In this design, we considered
all the previous findings that were identified in the systematic review, the survey and the
measurement study of the three patient-reported outcomes. Our evidence synthesis found
that no high-quality trials exist to test the efficacy of JP interventions in people with hand
OA. Another important step was that we factored in the design of the trials the information
that we gathered from our survey so the JPP can meet the patients’ expectations and
preferences. We performed sample size calculation and we found that approximately 347
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patients are needed to demonstrate superiority of the experimental arm. The trial protocol
adhered to the SPIRIT checklist guidelines. 1

9.2

Clinical and research implications

In our systematic review we found low quality certainty evidence that joint protection did
not improve pain and function scores by a clinically important amount. However, at mid and long- term follow-up the effects of JP interventions were very close to be clinically
meaningful for people with rheumatoid arthritis. The fact that the effects of JPP were
unknown for people with hand OA further justifies the rationale of conducting a future trial
with adequate power to detect if a real d ifference exists. In our systematic review, we were
unable to extract specific information about JP therefore, we were uncertain what was
actually implemented as joint protection programs.
In our survey we identified that very few patients with arthritis were aware of or had
participated in a joint protection program, given that there is systematic review evidence
demonstrating the effectiveness of these programs both for patients with rheumatoid
arthritis and osteoarthritis in the hand. Lack of awareness of JPP was greater than
anticipated and potentially reflects lack of access to programs, lack or interest in
participating and lack of awareness from clinicians who should be recommending JPP.
Trends for patients with arthritis to engage in a broad array of conservative approaches,
and their responses to this survey suggest patients would engage in JP if accessible
programs were offered. Given the evidence supporting JPP as an important component of
self-management of arthritis, this appears to be a substantial gap between research and
clinical practice. Therefore, education of health care professionals about this option will
potentially improve accessibility to programs and potentially improve clinical outcomes.
In our measurement study we provided new information to support the conceptual
foundations of the three selected patient reported outcome measures. The high content
validity index of these self-reported questionnaires indicates that these measures can be
used with confidence in future clinical studies and in clinical practice. Their evaluation of
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relevance and clarity of all the individual items from each outcome measure by including
patient input as experts is considered very important and was never quantified before.
Our trial protocol design takes into account all the gathered information from survey, but
most importantly results from our meta-analysis indicate that there is a need for a trial for
people with hand OA. In this trial, we will implement standardized JP interventions and
hand exercises in a specific and measurable way, and we will use strategies to maximize
adherence. This trial can provide more useful and effective JPP for people living with hand
arthritis and it will contribute to longer-term multi-site studies that combine JPP with
wearable sensors.2

9.3

Limitations

In this dissertation we conducted 5 studies and we designed a protocol for a superiority
trial to provide more useful and effective patient centered JPP. Although, we have some
interesting findings our work has several limitations that need to be taken into account
when interpreting our findings.
First, the underlying methodology that was used to critically appraise the included RCTs
as well as the half standard deviation units that was used as a cut-off score for clinically
important benefit was a very conservative approach. We deem that even with a lower
threshold the findings would have been inconclusive since the confidence intervals did not
exclude even lower thresholds.
Second, in our survey we did not collect further descriptive data such socioeconomic status,
education, sex and gender and therefore, this limited our ability to explore potential
associations between other factors and participation rates in joint protection programs.
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10.1

Appendix 2. Letter of Information/ Consent

A Study of joint protection for hand arthritis exercise preferences in Osteoarthritis
Principal Investigator: Dr. Joy Christine MacDermid
Student Investigator:
Co-Investigator: Pavlos Bobos
School of Rehabilitation Sciences
McMaster University
Hamilton, Ontario, Canada
•

Purpose of the Study:

You are invited to take part in this study about expectations from joint protection and
preferences for exercise. We want to identify the key expectations and preferences for joint
protection and the critical barriers and facilitator for exercise in people with arthritis. We
are hoping to learn how to design better joint protection programs and exercise programs.
•

Procedures involved in the Research:

You will find two questionnaires attached with this consent form. You will be asked to
complete both questionnaires. The questions will include queries about your preferences
for exercise and about your thoughts about joint protection. You will also be asked
questions about your diagnosis and management of arthritis. You will also be asked for
some demographic/background information like your age and area code.
•

Potential Harms, Risks or Discomforts:

There are no foreseeable risks involved in participating in this study. You may feel worried
about your responses. There are no right and wrong answers and your responses will be
kept confidential, so you do not need to worry about this. You do not need to answer
questions that you do not want to answer or that make you feel uncomfortable.
•

Potential Benefits
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We cannot promise any personal benefits to you for your participation in this study. The
results from this study may benefit society and the scientific community by providing
health care providers with a better understanding of barriers and facilitators for exercise
and preferences for joint protection in people with arthritis.
•

Confidentiality

Your data will not be shared with anyone except with your consent or as required by law.
All personal information such as your name and e-mail address will be removed from the
data and will be replaced with a number. A list linking the number with your name will be
kept in a secure place separate from your file. The data, with identifying information
removed will be securely stored in a locked office in the research laboratory.
For the purposes of ensuring the proper monitoring of the research study, it is possible that
a member of the Hamilton Integrated Research Ethics Board may consult your research
data. However, no records which identify you by name or initials will be allowed to leave
the hospital. By signing this consent form, you or your legally acceptable representative
authorizes such access. If the results of the study are published, your name will not be used
and no information that discloses your identity will be released or published without your
specific consent to the disclosure.

•

Participation and Withdrawal:

If you volunteer to be in this study, you may withdraw at any time. You have the option
of removing your data from the study. You may also refuse to answer any questions you
don’t want to answer and still remain in the study. The investigator may withdraw you
from this research if circumstances arise which warrant doing so.
•

Information about the Study Results:

If you would like to receive a summary of this study’s results, there is a provision for you
to indicate so at the end of the consent form.
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Questions about the Study: If you have questions or need more information about the
study itself, please contact me at:
This study has been reviewed by the Hamilton Integrated Research Ethics Board (HIREB).
The HIREB is responsible for ensuring that participants are informed of the risks associated
with the research, and that participants are free to decide if participation is right for them.
If you have any questions about your rights as a research participant, please call the Office
of the Chair, Hamilton Integrated Research Ethics Board at
•

CONSENT

I have read the information presented in the information letter about this study.
I have had the opportunity to ask questions about my involvement in this study and to
receive additional details I requested.
I understand that if I agree to participate in this study, I may withdraw from the study
at any time or up until September 1, 2019.
I have been given a copy of this form.
I agree to participate in the study.
Signature: ______________________________________ Date:
________________________
Name of Participant (Printed) ___________________________________
1. I agree to have my responses from this project used in future related projects.
[ ] yes
[ ] no
2. [ ] Yes, I would like to receive a summary of the study’s results.
Please send them to me at this email address
______________________________________
_____________________________________________________
[ ] No, I do not want to receive a summary of the study’s results.
3. I agree to be contacted about a follow-up interview, and understand that I can always
decline
the request.
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[ ] Yes, please contact me at:
__________________________________________________
[ ] No
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10.2

Appendix 3. Survey Questionnaire

Patient opinions on joint protection programs

Start of Block: "Information about this survey"
Q50 Patient opinions on joint protection programs
This survey was developed to gain a better understanding of your priorities and goals,
specific to joint protection. Your answers to these questions will help us to create more
effective joint protection programs for patients living with arthritis in the future.

o

End of Block: "Information about this survey"

Start of Block: Block 1
Q1 Please select one of the following options

o I have been diagnosed with hand osteoarthritis (1)
o I have been diagnosed with hand rheumatoid arthritis (2)
o I have been diagnosed with psoriatic arthritis (3)
o I have been diagnosed with some form of arthritis other than hand (4)
o None of the above (5)
Skip To: End of Survey If Please select one of the following options = None of the above

Q2 Please indicate your age below
▼ Under 18 (1) ... 85 or older (9)

Skip To: End of Survey If Please indicate your age below = Under 18
Skip To: End of Survey If Please indicate your age below = 85 or older
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Q3 Please select one of the four following options

o I am currently taking part in a joint protection program (1)
o I have previously taken part in a joint protection program (2)
o I have heard about joint protection but have not taken part in a program (3)
o I have not heard about any joint protection programs (4)
Skip To: End of Block If Please select one of the four following options = I have not
heard about any joint protection programs
Skip To: End of Block If Please select one of the four following options = I have heard
about joint protection but have not taken part in a program

Q4 Where did you attend the joint protection program? Check all that apply.

▢
▢
▢
▢
▢
▢
▢

Inpatient- rehabilitation unit (1)
Inpatient- hospital (2)
Outpatient- hospital (3)
Community recreation center (4)
Home care (5)
A rehabilitation centre/ clinic (6)
Family physician’s office (7)

182

Q5 Who provided the joint protection program? Check all that apply.

▢
▢
▢
▢
▢
▢

Family physician or specialist (1)
Occupational therapist (2)
Physiotherapist (3)
Hand therapist (4)
Kinesiologist (5)
Patients (6)

Q6 To what extent did the joint protection program affect the following?
Very
much
worse
(1)

Much
worse
(2)

Slightly
worse
(3)

No
change
(4)

o
o

o
o

o
o

o
o

Grip
strength
(3)

o

o

o

Hand
function
(4)

o

o

Swelling
(5)

o

o

Stifness
(1)
Pain (2)

Much
better
(6)

Very
much
better
(7)

o
o

o
o

o
o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Slightly
better (5)

Q7 What other benefits, if any, did joint protection principles cause in your well-being?
Please specify.
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

Q8 What other harms, if any, did joint protection principles cause in your well-being?
Please provide examples.
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

Q9 How often did you use joint protection principles after learning them?

o Not at all (1)
o Occasionally (once a week or less) (2)
o Quite often (once a week at least) (3)
o Always (4)
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Q10 Give some examples for how joint protection principles affected you
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

o

End of Block: Block 1

Start of Block: Block 1
Q12 Where did you hear about joint protection program? Check all that apply.

▢
▢
▢
▢
▢
▢
▢

From my family physician (1)
From my therapist (2)
From my specialist (e.g. rheumatologist, surgeon) (3)
From my family or friends (4)
From newspapers/ television/ internet/ radio (5)
From my local community center (6)
Other (7) ________________________________________________

Q11 Everyone has barriers and facilitators that affect their ability to participate in health
programs. Please list up to three barriers that might make it difficult for you to participate
in a future joint protection program.
________________________________________________________________
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________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

Q13 Please list up to three factors that might make it easier for you to participate in a
future joint protection program.
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
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Q14 To what extent are the following factors a concern that would make it harder for you to participate in a joint protection
program?
neither a
a very big
a moderate
a slight concnern
slightly
moderately helpful
concern or
concern (1)
concern (2)
(3)
helpful (5)
(6)
help (4)

extremely helpful
(7)

Having the centre/clinic
close to my house (1)

o

o

o

o

o

o

o

Transportation to the
centre where program is
provided (2)

o

o

o

o

o

o

o

Time when the program
was offered (5)

o
o

o
o

o
o

o
o

o
o

o
o

o
o

My work commitments
(6)

o

o

o

o

o

o

o

My personal
commitments (7)

o

o

o

o

o

o

o

Support from
family/friends (8)

o

o

o

o

o

o

o

Cost of the program (4)
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Having a friend to
participate with (9)

o

o

o

o

o

o

o

Research that shows joint
protection works (10)

o

o

o

o

o

o

o

Another patient finding
joint protection helpful
(11)

o

o

o

o

o

o

o
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Q15 Most joint protection programs have pieces that cover:1. Things that affect the loading of your joints2. Products that can be used
to make tasks easier3. Pacing4. How to organize tasks to make it easier for your joints5. Ways to manage symptoms 6. How to get or
use helpCovering all this information requires about 30 hours of teaching and demonstration. What schedule would you prefer f or this
type of program? Check one.

o 3 hours, 5 times per week, for 2 weeks (1)
o 2 hours, 3 times per week, for 5 weeks (2)
o 1 hour, 3 times per week, for 10 weeks (3)
Q16 How likely would you be to participate in a program if it is delivered in the following formats? Please rank the options below in
order of preference (most preferred option at the top). Your can slide or place the option in it's order.
______ Online (internet) (1)
______ Videos (television, DVDs, YouTube etc) (2)
______ Printed material mailed upon request (pamphlet, guidebook etc) (3)
______ In clinic (4)
______ At home (5)
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Q17 Who would you like to teach you about joint protection? Check all that apply

▢
▢
▢
▢
▢
▢
▢

Family physician or specialist such as rheumatologist (1)
Occupational therapist (2)
Physiotherapist (3)
Hand therapist (4)
Kinesiologist (5)
Patients living with arthritis (6)
Other, please specify (7) ________________________________________________

190

Q18 How useful do you think the following components of a joint protection program would be to you?
Neither
Extremely
Moderately
Slightly
Slightly
Moderately
useful nor
useful (1)
useful (2)
useful (3)
useless (5)
useless (6)
useless (4)

Extremely
useless (7)

Information on how
joint positions can
affect joint loading
(1)

o

o

o

o

o

o

o

Ways to do tasks
differently to reduce
joint loading (2)

o

o

o

o

o

o

o

Feedback on if I am
doing tasks correctly
(3)

o

o

o

o

o

o

o

Information about
pacing & organizing
activities (4)

o

o

o

o

o

o

o

Advice from health
professionals about
joint protection (5)

o

o

o

o

o

o

o
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Advice from other
patients with arthritis
about what worked
for them (6)

o

o

o

o

o

o

o

Demonstrations of
how to do things
better (7)

o

o

o

o

o

o

o

Time to discuss tasks
that I am currently
having difficulty with
(8)

o

o

o

o

o

o

o

Sensors that I could
wear to tell me how
much different
activities are loading
my joints (9)

o

o

o

o

o

o

o

Information about
assistive tools or
devices that I could
use to make daily
tasks easier (10)

o

o

o

o

o

o

o
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Information about
where to find
assistive tools or
devices (11)

o

o

o

o
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o

o

o

Q19 How important would the following outcomes be to you?
Extremely important
Very important (2)
(1)

Moderately
important (3)

Slightly important
(4)

Not at all important
(5)

Preventing joint
deformity (1)

o

o

o

o

o

Reducing pain (2)

o

o

o

o

o

Improving hand
function/ activity (3)

o

o

o

o

o

Maintaining grip
strength (4)

o

o

o

o

o
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Q20 Would you like someone to contact you to see how you are doing after the joint protection program?

o Yes (1)
o No (2)
Skip To: End of Block If Would you like someone to contact you to see how you are doing after the joint protection program? = No

Q21 If you were to do it as a web-based program, how would you like to be contacted for follow-up? Rank these options from 1 to 3,
with 1 being your most preferred option. Your can slide or place the option in it's order.
______ Twice per week (1)
______ Once a week (2)
______ Once every two weeks (3)
______ Once early and once at 6 month (4)
______ Other, please specify (5)

Q22 After a web-based or in-person program, would you like someone to contact you to discuss your progress?

o Yes (1)
o No (2)
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Skip To: End of Block If After a web-based or in-person program, would you like someone to contact you to discuss your pro... = No
Q23 When would you like to be contacted after the completion of the program?

o After a week (1)
o After two weeks (2)
o After a month (3)
o After two months (4)
o Every 6 months (5)
o Every year (6)
Q24 How would you like to be contacted for follow-up? Rank these options from 1 to 3, with 1 being your most preferred
option. Your can slide or place the option in it's order.
______ By telelphone (1)
______ By email (2)
______ By mail (3)
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Q25 Whom would you prefer to speak with at your follow-up meeting? Rank these options from 1 to 4, with 1 being your most
preferred option. Your can slide or place the option in it's order.
______ The person who provided the joint protection program (1)
______ Another participant from the joint protection program who I had met (2)
______ Any person living with arthritis who knows about joint protection (3)
______ Any knowledgeable health professional (4)

o

End of Block: Block 1

Start of Block: Block 4
Q26 Would you participate in web-based forums about joint protection (like a posting board, Facebook group or email list)?

o Yes (1)
o No (2)
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Q27 How often do you use the following?
Never (1)
Very rarely (2)
Heat (1)

o
o
Exercise (3)
o
Joint protection (4)
o
TENS machine or
other electrical o

Rarely (3)

Occasionally (4)

Frequently (5)

Very frequently (6)

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o

o
o

o
o

o
o

o
o

o
o

o

o

o

o

o

o

Cold (2)

devices (5)
Splints (6)
Modified
equipment (7)
Other (8)
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Q28 Have you had surgery because of your arthritis?

o Yes, please specify (1) ________________________________________________
o No (2)
Skip To: End of Block If Have you had surgery because of your arthritis? = No

o

End of Block: Block 4

Start of Block: Block 4
Q29 How often do you use your medication?

o Daily (1)
o When you feel pain (2)
o Other, please specify (3) ________________________________________________
Q30 Is there anything you would like us to know as we work on developing a new joint protection program for people with hand
arthritis?
________________________________________________________________
________________________________________________________________
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________________________________________________________________
________________________________________________________________
________________________________________________________________

Q31 We are planning to develop a new joint protection program that would be updated and based on patient input. Would you be
interested in participating in the following? Check all that apply

▢
▢
▢

Helping develop a new joint protection program (1)
Participating in a study of a new joint protection program (2)
Being a learner after the joint protection program has been tested (3)

Q32 If you would like to be contacted about the above, how would you prefer to be contacted?

o By telephone (1) ________________________________________________
o By post mail (2) ________________________________________________
o By email (3) ________________________________________________
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Q33 Would you like to receive a summary of the results this survey

o if yes, please provide your email (1) ________________________________________________
o No (2)
Q34 Would you be willing to answer a few more questions that would help us understand what outcomes we should be measuring in
our research about hand arthritis? This will take another 5 minutes.

o Yes (1)
o No (2)
Skip To: End of Survey If Would you be willing to answer a few more questions that would help us understand what outcomes w... =
No

o

End of Block: Block 4

Start of Block: Block 4
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Q35 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
not
relevant
(1)

Do you think the instruction or the item is?

somewhat
relevant (2)

quite
relevant (3)

highly
relevant (4)

not clear at
all (1)

needs major
revision (2)

needs minor
revision (3)

very clear (4)

Rate the amount
of pain in your
wrist - At rest (1)

o

o

o

o

o

o

o

o

Rate the amount
of pain in your
wrist - When
doing a task with
a repeated
wrist/hand
movement (2)

o

o

o

o

o

o

o

o

Rate the amount
of pain in your
wrist - When
lifting a heavy
object (3)

o

o

o

o

o

o

o

o
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Rate the amount
of pain in your
wrist - When it is
at its worst (4)

o

o

o

o

o

o

o

o

How often do you
have pain? (0 =
never, 10 =
always) (5)

o

o

o

o

o

o

o

o
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Q41 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?

Do you think the instruction or the item is?

not relevant
(1)

somewhat
relevant (2)

quite
relevant (3)

highly
relevant (4)

not clear at
all (1)

needs major
revision (2)

needs minor
revision (3)

very clear
(4)

Rate how
difficult it was
doing the things
listed below, this
week - Fasten
buttons on your
shirt? (1)

o

o

o

o

o

o

o

o

"Rate how
difficult it was
doing the things
listed below, this
week - Cut meat
(or vegetables)
using a knife?
(2)

o

o

o

o

o

o

o

o

"Rate how
difficult it was

o

o

o

o

o

o

o

o
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doing the things
listed below, this
week - Turn a
door knob with
your affected
hand (3)
"Rate how
difficult it was
doing the things
listed below, this
week - Use your
affected hand to
push up from a
chair? (4)

o

o

o

o

o

o

o

o

"Rate how
difficult it was
doing the things
listed below, this
week - Carry a
heavy object in
your affected
hand? (5)

o

o

o

o

o

o

o

o

"Rate how
difficult it was

o

o

o

o

o

o

o

o
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doing the things
listed below, this
week - Use
bathroom tissue
with your
affected hand?
(6)
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Q42 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
Do you think the instruction or the item is?
not relevant
somewhat
quite relevant highly
not clear item needs
item needs
very
(1)
relevant (2)
(3)
relevant (4)
at all (1) major
minor
clear (4)
revision (2)
revision (3)
"Rate how difficult it was
doing your usual
activities, this week. By
usual activities, we mean
what you did before you
started having a problem
with your wrist/hand." Personal care activities
(like dressing/washing)
(1)
"Rate how difficult it was
doing your usual
activities, this week. By
usual activities, we mean
what you did before you
started having a problem
with your wrist/hand." Household work (like

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

207

cleaning or maintenance)
(2)

"Rate how difficult it was
doing your usual
activities, this week. By
usual activities, we mean
what you did before you
started having a problem
with your wrist/hand." Work (your job or other
work) (3)
"Rate how difficult it was
doing your usual
activities, this week. By
usual activities, we mean
what you did before you
started having a problem
with your wrist/hand." Recreational activities
(4)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q44 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
Do you think the instruction or the item is?
not relevant
(1)
"Please indicate
your ability to
perform these
activities with the
affected hand."Turn a Key (1)
"Please indicate
your ability to
perform these
activities with the
affected hand."Pick up a coin (2)
"Please indicate
your ability to
perform these
activities with the
affected hand."Write (3)

somewhat
relevant (2)

quite relevant
(3)

highly
relevant (4)

not clear
at all (1)

item needs
major
revision (2)

item needs
minor
revision (3)

very
clear (4)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

"Please indicate
your ability to
perform these
activities with the
affected hand."Squeeze
Toothpaste (4)
"Please indicate
your ability to
perform these
activities with the
affected hand."Hold a glass of
water (5)
"Please indicate
your ability to
perform these
activities with the
affected hand."Turn a Doorknob
(6)
"Please indicate
your ability to
perform these
activities with the
affected hand."Use a Knife to Cut
Food (7)
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Q45 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
Do you think the instruction or the item is?
not relevant somewhat
quite
highly
not
item needs
item needs
very
(1)
relevant (2)
relevant (3) relevant (4) clear at major
minor
clear
all (1)
revision (2) revision (3) (4)
"Please indicate your ability
to perform the following task
while using both your
hands?" - Open a Jar (1)
"Please indicate your ability
to perform the following task
while using both your
hands?" - Button a
shirt/blouse (2)
"Please indicate your ability
to perform the following task
while using both your
hands?" - Tie your shoes (3)
"Please indicate your ability
to perform the following task
while using both your
hands?" - Wring a
dishcloth/washcloth (4)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

211

"Please indicate your ability
to perform the following task
while using both your
hands?" - How often did you
have pain in your thumb at
rest? (5)
"Please indicate your ability
to perform the following task
while using both your
hands?" - How often did the
pain in your thumb interfere
with your daily activities? (6)
"Please indicate your ability
to perform the following task
while using both your
hands?" - How often did the
pain in your hand interfere
with recreational activities?
(7)
"Please indicate your ability
to perform the following task
while using both your
hands?" - How often did the
pain in your thumb interfere
with your sleep? (8)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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"Please indicate your ability
to perform the following task
while using both your
hands?" - How often did the
pain in your thumb worsen
your mood? (9)

o

o

o

o
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o

o

o

o

Q46 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
Do you think the instruction or the item is?
not relevant (1)

"The following questions
ask about your
satisfaction with the
indicated hand or thumb
over the past week." Motion in your affected
thumb (1)
"The following questions
ask about your
satisfaction with the
indicated hand or thumb
over the past week." Strength of your affected
hand (2)
"The following questions
ask about your
satisfaction with the
indicated hand or thumb
over the past week." Pain level of your
affected thumb (3)

somewhat
relevant (2)

quite relevant
(3)

highly relevant
(4)

not clear
at all (1)

item needs
major revision
(2)

item needs
minor revision
(3)

very clear
(4)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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"The following questions
ask about your
satisfaction with the
indicated hand or thumb
over the past week."Overall function of your
hand (4)

o

o

o

o
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o

o

o

o

Q47 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
not relevant
(1)
"Rate your pain" At rest (1)
"Rate your pain" Gripping (2)
"Rate your pain" Lifting (3)
"Rate your pain" Turning (4)
"Rate your pain" Squeezing (5)
"Rate your
stiffness" - After
first wakening in
the morning (6)

somewhat relevant
(2)

Do you think the instruction or the item is?

quite relevant
(3)

highly relevant
(4)

not clear
(1)

item need
some revision
(2)

clear but need
minor revision
(3)

very clear
(4)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q49 "Instructions" and Items that could be listed on a patient questionnaire are listed below. In each section there is an instruction
1st and then the items. For each item we would like you to tell us: (1) how relevant that item would be to you and other people living
with arthritis, and (2) how clear that item is
Do you think the instruction or the item is?
Do you think the instruction or the item is?
not relevant
somewhat
quite relevant highly
not clear item needs
item needs
very
(1)
relevant (2)
(3)
relevant (4)
at all (1) major
minor
clear (4)
revision (2)
revision (3)
"Rate your difficulty when"
- Turning taps/faucets on
(1)
"Rate your difficulty when"
- Turning a round
doorknob or handle (2)
"Rate your difficulty when"
- Doing up buttons (3)
"Rate your difficulty when"
- Fastening jewellery (4)
"Rate your difficulty when"
- Opening a new jar (5)
"Rate your difficulty
when"- Carrying a full pot
with one hand (6)
"Rate your difficulty when"
- Peeling vegetables/fruits
(7)
"Rate your difficulty
when"- Picking up large
heavy objects (8)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
o
o
o

o
o
o
o

o
o
o
o

o
o
o
o

o
o
o
o

o
o
o
o

o
o
o
o

o
o
o
o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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"Rate your difficulty
when"- Wringing out wash
cloths (9)

o

o

o

o
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o

o

o

o
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